JAÈøÆ»Áí¹çɱ¡¤Ç¤ÏÀ¸Ì¿¤Îº¤µ¤È¿Í´Ö°¦¤ò´ðÄ´¤Ë¡¢°å»Õ¡¦´Ç¸î»Õ¤È¤â¤ËÎϤò¹ç¤ï¤»¡¢É¤á¤ë¿Í¡¹¤ò¼é¤ê¡¢ÃÏ°è¤Î´ð´´É±¡¤È¤·¤Æ¤Î¼«³Ð¤ò»ý¤Á¡¢¾ï¤Ë¿·¤·¤¯¤è¤ê¹â¤¤Ãμ±¤Î½¬ÆÀ¤Èµ»½Ñ¤Î¸¦ïÓ¤ËÎå¤ß¤Þ¤¹¡£

JAÈøÆ»Áí¹çɱ¡

¥Û¡¼¥à ¡ä°åÎÅ´Ø·¸¼Ô¤ÎÊý¤Ø ¡äÃø½ñ¡¦³Ø²ñ¡¦ÏÀʸ

Ãø½ñ¡¦³Ø²ñ¡¦ÏÀʸ

ÅöÈøÆ»Áí¹çɱ¡¡¢¤ª¤è¤Ó³Æ°å»Õ¤Ë¤è¤Ã¤Æȯɽ¤µ¤ì¤¿Ãø½ñ¡¢³Ø²ñ¤Ç¤ÎȯɽÏÀʸ¤Ê¤É¤ò¸ø³«¤·¤Æ¤¤¤Þ¤¹¡£

ÈøÆ»Áí¹çɱ¡¡¦Ãø½ñ¡¦³Ø²ñ¡¦ÏÀʸ
 

[ ¾Ã²½´ïÆâ²Ê ] ¤Ë¤è¤ëÃø½ñ¡¦³Ø²ñ¡¦ÏÀʸ

¡ÖÃø½ñ¡×¡Ö³Ø²ñ¡×¡ÖÏÀʸ¡×¤ÎʬÌî¤Ëʬ¤«¤ì¤Æ¤¤¤Þ¤¹¡£¤´´õ˾¤ÎʬÌî¤ò¥¯¥ê¥Ã¥¯¤¹¤ë¤È°ìÍ÷¤¬É½¼¨¤µ¤ì¤Þ¤¹¡£

¥Ç¡¼¥¿¹Ê¹þ
¥­¡¼¥ï¡¼¥É

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë ´í¸±°ø»Ò¤ËÃåÌܤ·¤¿ç¹´âÁá´ü¿ÇÃÇ¥×¥í¥¸¥§¥¯¥È
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÆý´â¸¡¿Ç³Ø²ñ»ï¡¡32(1)
¥Ú¡¼¥¸ÈÖ¹æ ¡ü1-4
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë ´Îž°ÜÁã¤ÎÇËÎö¤ËÂФ·¤ÆTAE¤ò»Ü¹Ô¤·²½³ØÎÅË¡¤È¤·¤Æmodified FOLFIRINOX¤òƳÆþ¤·¤¿ç¹´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ç¹´â¡¡38
¥Ú¡¼¥¸ÈÖ¹æ 73-81
Ãø¼Ô »³»ÒÂÙ²Ã
¶¦Ãø ²ÖÅķɻΡ¤»³ËÜÂîºÈ¡¤±üÅĹ¯ÇÃÓÅļéÅС¤·ª¸¶·¼²ð¡¤À¶¿å¹¸Åµ¡¤¾¾ËÜ¡¡Ë¾¡¤ÊÒ¼²ÅÃË¡¤Åĺʡ¡¿Ê¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¤ÎÁá´ü¿ÇÃǤòÌܻؤ·¤¿¥¹¥¯¥ê¡¼¥Ë¥ó¥°
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÆâ²Ê³Ø²ñ»¨»ï¡¡112(2)
¥Ú¡¼¥¸ÈÖ¹æ 250-256
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤ÄÅÅç¡¡·ò¡¤ÃÓÅļéÅС¤Åĺʡ¡¿Ê.

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¤ÎÁá´üȯ¸«¤ÈÉ¿ÇÏ¢·È
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×஡¡81(2)
¥Ú¡¼¥¸ÈÖ¹æ 513-518
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤ÄÅÅç¡¡·ò¡¤ÃÓÅļéÅС¤Åĺʡ¡¿Ê¡¤

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë ÃÏ°èȯ¤Îç¹´âÁá´ü¿ÇÃÇ¥×¥í¥¸¥§¥¯¥È
»¨»ï¥¿¥¤¥È¥ë Î×ாò½´ïÆâ²Ê¡¡38(2)
¥Ú¡¼¥¸ÈÖ¹æ 158-164
Ãø¼Ô À¶¿å¹¸Åµ
¶¦Ãø ²ÖÅķɻΡ¤Åĺʡ¡¿Ê¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¤ÎÁá´ü¿ÇÃǤϤʤ¼É¬Íפ«
»¨»ï¥¿¥¤¥È¥ë Î×ாò½´ïÆâ²Ê¡¡38(2)
¥Ú¡¼¥¸ÈÖ¹æ 127-130
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2023
ÏÀʸ¥¿¥¤¥È¥ë ´¬Æ¬¸À
»¨»ï¥¿¥¤¥È¥ë Î×ாò½´ïÆâ²Ê¡¡38(2)
¥Ú¡¼¥¸ÈÖ¹æ 125
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ÃÀÀоɤαֳء¡¡ÝºÇ¶á¤ÎÆ°¸þ¡Ý
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀ´â¡¡86(1)
¥Ú¡¼¥¸ÈÖ¹æ ¡ü7-11
Ãø¼Ô À¶¿å¹¸Åµ
¶¦Ãø Åĺʡ¡¿Ê¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë µÞÀ­¤Îžµ¢¤òé¤Ã¤¿´Î¾ã³²¤òȼ¤¦¤Ó¤Þ¤óÂçºÙ˦À­BºÙ˦À­¥ê¥ó¥Ñ¼ð¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡32
¥Ú¡¼¥¸ÈÖ¹æ 41-50
Ãø¼Ô ´ß¡¡ÂÙÀµ
¶¦Ãø ·ª¸¶·¼²ð¡¤±üÅĹ¯Ç²ÖÅķɻΡ¤À¾Åĸ­»Ê¡¤ÊƸ¶½¤¼£¡¤

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ç¹¹ÚÁÇ¡¦¼ðáç¥Þ¡¼¥«¡¼¾å¾º¡¤ç¹´É¶¹ºõ¡¤ç¹¼ðáÅüÇ¢ÉÂÁý°­¤Ç¾Ò²ð¤µ¤ì¤¿¾ÉÎã
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡43
¥Ú¡¼¥¸ÈÖ¹æ 1335-1341
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤκÇÁ°Àþ
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²ºÙ˦³Ø²ñ¶å½£Ï¢¹ç²ñ»¨»ï¡¡53
¥Ú¡¼¥¸ÈÖ¹æ ¡ü1-4
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë 繤¬¤óÁá´ü¿ÇÃǤΤ¿¤á¤ÎÉ¿ÇÏ¢·È
»¨»ï¥¿¥¤¥È¥ë Æâ²Ê¡¡130(1)
¥Ú¡¼¥¸ÈÖ¹æ 49-53
Ãø¼Ô ÃÓÅļéÅÐ
¶¦Ãø ²ÖÅķɻΡ¤·ª¸¶·¼²ð¡¤À¶¿å¹¸Åµ¡¤Åĺʡ¡¿Ê¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ÆüËܤλ°¼¡°åÎŵ¡´Ø¤Ë¤ª¤±¤ëÁÈ¿¥³ØŪ¿ÇÃǤΤ¿¤á¤ÎĶ²»ÇÈÆâ»ë¶À²¼Àü»ÉµÛ°úË¡¤Ë¤è¤ëÍ­³²»ö¾Ý¿»ÜÀ߶¦Æ±¸å¤í¸þ¤­¸¦µæ
»¨»ï¥¿¥¤¥È¥ë Gastroenterological Endoscopy¡¡64(7)
¥Ú¡¼¥¸ÈÖ¹æ 1371-1385
Ãø¼Ô ¿ûÌî¡¡ÆØ
¶¦Ãø °ÂÅÄ°ìϯ¡¤Æþß·Æƻ֡¤¸¶ÏÂÀ¸¡¤éÃÅÄÎè»Ò¡¤´ä²¼Âó»Ê¡¤ÃÝÃæ¡¡´°¡¤³ã¾ÂϯÀ¸¡¤ÂìÀîůÌ顤·¦Åĸ­Ê塤²ÃÆ£ÇîÌ顤Ãæ°æÍÛ²ð¡¤ÎÉÂô¾¼Ìá¤ËÌÌî²íÇ·¡¤°Ëº´»³¹ÀÄÌ¡¤³ùÅıѵª¡¤²¬ÉôµÁ¿®¡¤²ÖÅķɻΡ¤ÂçÄÚ¸ø»ÎϺ¡¤Åڰ濸ʿ¡¤µ×µï¹°¹¬¡¤½ÂÀî¸çϯ¡¤º£ÄÅÇîͺ¡¤Àµ½¡¡¡½ß¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ÃÀ¡¦ç¹¡¡ç¹´âÁá´ü¿ÇÃǤΤ¿¤á¤Î¼è¤êÁȤß
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ²Ê¥ì¥Ó¥å¡¼¡¡23
¥Ú¡¼¥¸ÈÖ¹æ 314-317
Ãø¼Ô À¶¿å¹¸Åµ.
¶¦Ãø ²ÖÅķɻΡ¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤˤª¤±¤ëERCP¤ÎÌò³ä
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ²Ê¡¡4(7)
¥Ú¡¼¥¸ÈÖ¹æ 65-70
Ãø¼Ô ·ª¸¶·¼²ð
¶¦Ãø ²ÖÅķɻΡ¤À¶¿å¹¸Åµ¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤòÌܻؤ·¤¿É¿ÇÏ¢·È
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ²Ê 4(7)
¥Ú¡¼¥¸ÈÖ¹æ 82-87
Ãø¼Ô À¶¿å¹¸Åµ.
¶¦Ãø ÄÅÅç·ò¡¤²ÖÅķɻΡ¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Æý¸¤Ë¤¢¤¿¤Ã¤Æ
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ²Ê
¥Ú¡¼¥¸ÈÖ¹æ ¡ü2-3
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ¿Î̤ÎÊ¢¿å¤Ë¤è¤ê¾®Ä²¥«¥×¥»¥ëÆâ»ë¶À¸¡ºº¤Î¼õ¿®¾ã³²¤òÀ¸¤¸¤¿£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡75(5)
¥Ú¡¼¥¸ÈÖ¹æ 218-222
Ãø¼Ô ÈÓÈøÀ¡É×.
¶¦Ãø ²¬¡¡»ÖϺ¡¤Ê¿ÅÄ°ìÀ®¡¤¶ù²¬¾¼É§¡¤ÄÛ°æ¾Ï¹î¡¤ÁêÊý¡¡¹À¡¤ÅÄÃæ¿®¼£¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ¤¬¤ó¼£ÎŤθ¡ºº¤Î´ðÁÃÃμ±¡¤·ì±Õ¸¡ºº¡¦Ç¢¸¡ºº¡¦¥Ð¥¤¥¿¥ë¥µ¥¤¥ó¡¦·ì±Õ¥¬¥¹¸¡ºº¤ò´Þ¤à
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ²Ê
¥Ú¡¼¥¸ÈÖ¹æ ¡ü9-13
Ãø¼Ô ¾®ÌîÀîÌ÷Æó.
¶¦Ãø Åĺʡ¡¿Ê¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ÃÀÆ»¡¦ç¹ÉÂÊѤËÂФ¹¤ë·ÐÆýƬŪÀ¸¸¡¡¦ºÙ˦¿Ç¡ÝERCP
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À34(4)
¥Ú¡¼¥¸ÈÖ¹æ 773-778
Ãø¼Ô ¡Ê·ª¸¶·¼²ð¡Ë
¶¦Ãø À¶¿å¹¸Åµ¡¤ÃÓÅļéÅС¤²ÖÅķɻΡ¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ´¬Æ¬¸À
»¨»ï¥¿¥¤¥È¥ë Î×ாò½´ïÆâ²Ê
¥Ú¡¼¥¸ÈÖ¹æ 485-486
Ãø¼Ô Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Curative surgery for primary squamous cell carcinoma of the liver: a rare case study¡¥
»¨»ï¥¿¥¤¥È¥ë Clin J Gastroenterol¡¥16(2)
¥Ú¡¼¥¸ÈÖ¹æ 263-269
Ãø¼Ô Okuda Y.
¶¦Ãø Abe T¡¤Ikeda M¡¤Kurihara K¡¤Shimizu A¡¤Oshita A¡¤Yonehara S¡¤Hanada K¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Focal Neurological Symptoms at Initial Presentation Could Be a Potential Risk Factor for Poor Prognosis Among Patients With Multiple Brain Abscesses by Streptococcus anginosus Group: A Case Report With Literature Review
»¨»ï¥¿¥¤¥È¥ë Case Reports Cureus¡¥14¡Ê11¡Ë
Ãø¼Ô Shibamura N.
¶¦Ãø Miyamori D¡¤Tanabe T¡¤Yamada N¡¤Tazuma S¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Efficacy of bailout surgery for preventing intraoperative biliary injury in acute cholecystitis¡¥
»¨»ï¥¿¥¤¥È¥ë Surg Endosc¡¥37¡Ê4)
¥Ú¡¼¥¸ÈÖ¹æ 2595-2603
Ãø¼Ô Abe T.
¶¦Ãø Oshita A¡¤Fujikuni N¡¤Hattori M¡¤Kobayashi T¡¤Hanada K¡¤Noriyuki T¡¤Ohdan H¡¤Nakahara M¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Delayed local recurrence of pancreatic adenosquamous cell carcinoma after curative surgery: A case report¡¥
»¨»ï¥¿¥¤¥È¥ë A case report¡¥100
Ãø¼Ô Watanabe A.
¶¦Ãø Abe T¡¤Oshita A¡¤Hanada K¡¤Noriyuki T¡¤Nakahara M¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Depletion of hepatic stellate cells inhibits hepatic steatosis in mice¡¥
»¨»ï¥¿¥¤¥È¥ë J Gastroenterol Hepatol¡¥37(10)
¥Ú¡¼¥¸ÈÖ¹æ 1946-1954
Ãø¼Ô Kawahara A.
¶¦Ãø Kanno K¡¤Yonezawa S¡¤Otani Y¡¤Kobayashi T¡¤Tazuma S¡¤Ito M¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë linical utility of computed tomography-based evaluation of trunk muscles in primary sclerosing cholangitis¡¥
»¨»ï¥¿¥¤¥È¥ë Jpn J Radiol¡¥40(10)
¥Ú¡¼¥¸ÈÖ¹æ 1053-1060
Ãø¼Ô Kikuchi Y.
¶¦Ãø Miyamori D¡¤Kanno K¡¤Tazuma S¡¤Kimura H¡¤Yoshimura K¡¤Serikawa M¡¤Chayama K¡¤Ito M¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Endoscopic approach in the diagnosis of high-grade pancreatic intraepithelial neoplasia¡¥
»¨»ï¥¿¥¤¥È¥ë Dig Endosc¡¥34(5)
¥Ú¡¼¥¸ÈÖ¹æ 927-93
Ãø¼Ô Hanada K.
¶¦Ãø Shimizu A¡¤Kurihara K¡¤Ikeda M¡¤Yamamoto T¡¤Okuda Y¡¤Tazuma S¡¥

!¹¹¿·Æü¡§2023/12/29

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Acute necrotic disorder of the small intestine post-coronavirus disease-2019 vaccination¡¥
»¨»ï¥¿¥¤¥È¥ë DEN Open¡¥3(1)
Ãø¼Ô Nishimura T.
¶¦Ãø Onogawa S¡¤Yamamoto T¡¤Okuda Y¡¤Ikeda M¡¤Matsumoto N¡¤Kurihara K¡¤Shimizu A¡¤Kitamura S¡¤Katamura Y¡¤Hirano N¡¤Itamoto S¡¤Nakahara M¡¤Yonehara S¡¤Shimamoto F¡¤Hanada K¡¥

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¤Î¸¡¿Ç¡¦¥¹¥¯¥ê¡¼¥Ë¥ó¥°
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀ繡¡84¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 135¡Ý141
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ·ª¸¶·¼²ð¡¤À¶¿å¹¸Åµ¡¤ÃÓÅļéÅС¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ¿Í¹©Æ©ÀϤòÇطʤËÁíÃÀ´É½½Æó»ØIJáñ¤Ë¤è¤ë½Ð·ì¤Ç»àË´¤·¤¿°ìÎã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡31
¥Ú¡¼¥¸ÈÖ¹æ 71¡Ý77
Ãø¼Ô ¡ÊÇϱ۷ú¹¬¡Ë
¶¦Ãø ·ª¸¶·¼²ð¡¤¡ÊÀ¾Åĸ­»Ê¡Ë¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ÅÇ·ì¸å¤ËµÞ·ã¤Êžµ¢¤òÍ褿¤·»àË´¤·¤¿¾ÉÎã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡31
¥Ú¡¼¥¸ÈÖ¹æ 65¡Ý70
Ãø¼Ô ¡Ê¾®ÁáÀîμÂÀ¡Ë
¶¦Ãø À¶¿å¹¸Åµ¡¤¡ÊÀ¾Åĸ­»Ê¡Ë¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â½Ñ¸åºÆȯ¤Ë¤è¤ëÃÀ´É¶¹ºõ¤òÍ褷¤¿£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡31
¥Ú¡¼¥¸ÈÖ¹æ 51¡Ý63
Ãø¼Ô ¡ÊÂçÅijÀ¿¿¡Ë
¶¦Ãø À¶¿å¹¸Åµ¡¤²ÖÅķɻΡ¤¡ÊÀ¾Åĸ­»Ê¡Ë¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ´ÎºÙ˦´â¤Ë¤è¤ëÊĺÉÀ­²«áդβÃÎÅÃæ¤ËÅÇ·ì¤òÍ褷»àË´¤·¤¿°ìÎ㡤繴â½Ñ¸åºÆȯ¤Ë¤è¤ëÃÀ´É¶¹ºõ¤òÍ褷¤¿£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡31
¥Ú¡¼¥¸ÈÖ¹æ 35¡Ý43
Ãø¼Ô ¡Ê»³Ãæͺ¾ë¡Ë
¶¦Ãø À¶¿å¹¸Åµ¡¤²ÖÅķɻΡ¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Â裴²ó ´ÎÆâ·ëÀФμ£ÎÅ
»¨»ï¥¿¥¤¥È¥ë ÃÀÆ»¡¡35¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 758¡Ý765
Ãø¼Ô ¡ÊÎëÌÚ¡¡Íµ¡Ë
¶¦Ãø ¡Ê¿¹¡¡½Ó¹¬¡Ë¡¤¡Ê°Ëº´»³¹ÀÄÌ¡Ë¡¤Åĺʡ¡¿Ê¡¤¡ÊÅÄÃæ¡¡ÆÆ¡Ë¡¤¡ÊºåËÜÎɹ°¡Ë

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Åö±¡¤Ë¤ª¤±¤ë COVID-19 ¤ËÂФ¹¤ë¹³ÂÎ¥«¥¯¥Æ¥ëÎÅË¡¤Î»ÈÍѷи³
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡74¡Ê11¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 520¡Ý524
Ãø¼Ô ±§º¬°ìĪ
¶¦Ãø ÃæÉÛζ°ì¡¤¿¹Åç¿®¹Ô¡¤Â§¹ÔÉÒÀ¸¡¤²ÖÅķɻΡ¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë À¸³è½¬´·É¤ÈIJÆâºÙ¶ÝÁÑ
»¨»ï¥¿¥¤¥È¥ë À¸Êª¹©³Ø¡¡99¡Ê11¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 573¡Ý576
Ãø¼Ô Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ç¹¼À´µ¤ËÂФ¹¤ëÆâ»ë¶À¿ÇÃÇ¡¡ç¹´â¿ÇÃǤˤª¤±¤ë·ÐÆýƬŪÉÂÍý³ØŪ¿ÇÃÇ
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À¡¡33¡Ê9¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1379¡Ý1385
Ãø¼Ô ·ª¸¶·¼²ð
¶¦Ãø ²ÖÅÄ·É»Î,À¶¿å¹¸Åµ,ÃÓÅļéÅÐ,±üÅĹ¯Çî,»³ËÜÂîºÈ,º´¡¹ÌÚ·ò»Ê,¿ÀÅÄ¿¿ÄÐ,ÃæÅè°¦³¤¡¤ÊƸ¶½¤¼£¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ç¹Â¡¤¬¤óÁá´ü¿ÇÃǤκÇÁ°Àþ
»¨»ï¥¿¥¤¥È¥ë Medical Science Digest¡¡47¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 19¡Ý22
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ¾®ç¹´â
»¨»ï¥¿¥¤¥È¥ë Ê̺ýÆüËÜÎ×஡¡16
¥Ú¡¼¥¸ÈÖ¹æ 153-157
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ·ª¸¶·¼²ð¡¤À¶¿å¹¸Åµ¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë IPMN ¤Ë¤ª¤±¤ëERCP ¤ÎŬ±þ
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀ繡¡82¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 839-845
Ãø¼Ô ·ª¸¶·¼²ð
¶¦Ãø ²ÖÅķɻΡ¤À¶¿å¹¸Åµ¡¤ÃÓÅļéÅС¤±üÅĹ¯Ç»³ËÜÂîºÈ¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë É¿ÇÏ¢·È¤òÀ¸¤«¤·¤¿ç¹´âÁá´ü¿ÇÃÇ
»¨»ï¥¿¥¤¥È¥ë ´ôÉ츩°å»Õ²ñ°å³Ø»¨»ï¡¡34
¥Ú¡¼¥¸ÈÖ¹æ 10·î12Æü
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë 繴ɾåÈéÆâ¼ðáç¤Î¿ÇÃǤθ½¾õ¡¡WHOʬÎà2019¤È¤Î´ØÏ¢¤â´Þ¤á¤Æ
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡42¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 529-535
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤ÃÓÅļéÅС¤·ª¸¶·¼²ð¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë JA ÈøÆ»Áí¹çɱ¡¤ÎÃÀç¹¼À´µ¤ËÂФ¹¤ë¿ÇÎŲʲ£ÃÇŪ¥Á¡¼¥à°åÎÅ¡§¹â¤¤Áê¸ß¿®Íê¤Ë´ð¤Å¤¯ÃÀ繿ÇÎÅ
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡42¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 463-468
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤·ª¸¶·¼²ð¡¤ÃÓÅļéÅС¤°ÂÉôÃÒÇ·¡¤Âç²¼¾´É§¡¤ÁýÅľ°Èþ¡¤Æ︫ϯ»Ò¡¤ ¼¾åÈþ¹á¡¤Â§¹ÔÉÒÀ¸¡¤ÃɾåÈþͳµª¡¤ÈõËܿ𹾡¤ÊƸ¶½¤¼£¡¤¿¹¡¡¹À´õ¡¤ËÙÀî½ÓÆó¡¤ÎëÌÚÊþ»Ò¡¤ °Âͧ͵·Ã¡¤¾®ÌîÀîÌ÷Æ󡤡ÊÅÄÃ涵ʸ¡Ë¡¤Ê¿Æ£µ×Èþ»Ò¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó2019
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ï¡¦´Î¡Æâ²Ê¡¡9¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 493-497
Ãø¼Ô ¡Ê ¿ûÌî¡¡ÆØ¡Ë
¶¦Ãø ¡ÊËÌÌî²íÇ·¡Ë¡¤¡ÊÃæ¼²í»Ë¡Ë¡¤¡Ê¾åºä¹îɧ¡Ë¡¤¡Ê°Ëƣ˧µª¡Ë¡¤¡Ê¸ÅÀ¥½ã»Ê¡Ë¡¤²ÖÅķɻΡ¤¡Ê±üºäÂó»Ö¡Ë

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Â裴²ó ´ÎÆâ·ëÀФμ£ÎÅ
»¨»ï¥¿¥¤¥È¥ë ÃÀÆ»¡¡35¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 758-765
Ãø¼Ô ¡Ê ÎëÌÚ¡¡Íµ¡Ë
¶¦Ãø ¡Ê¿¹¡¡½Ó¹¬¡Ë¡¤¡Ê°Ëº´»³¹ÀÄÌ¡Ë¡¤Åĺʡ¡¿Ê¡¤¡ÊÅÄÃæ¡¡ÆÆ¡Ë¡¤¡ÊºåËÜÎɹ°¡Ë

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë IgG4 ´ØÏ¢¹Å²½¾ÉÃÀ´É±ê
»¨»ï¥¿¥¤¥È¥ë ¡Ê1¡Ë±Ö³Ø¡¡Î×ாò½´ïÆâ²Ê¡¡36¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 635-638
Ãø¼Ô À¶¿å¹¸Åµ
¶¦Ãø Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë ÃÀǹÁ£¶Ú¼ð¾É
»¨»ï¥¿¥¤¥È¥ë Ê̺ýÆüËÜÎ×஡¡15
¥Ú¡¼¥¸ÈÖ¹æ 260-265
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤·ª¸¶·¼²ð

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Pathological Features and Imagin Findings in Pancreatic Carcinoma In Situ
»¨»ï¥¿¥¤¥È¥ë Pancreas¡¥50
¥Ú¡¼¥¸ÈÖ¹æ 399-404
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊFukuhara M¡Ë¡¤¡ÊMinami T¡Ë¡¤¡ÊYano S¡Ë¡¤¡ÊIkemoto J¡Ë¡¤Shimizu A¡¤Kurihara K¡¤Okuda Y¡¤Ikeda M¡¤¡ÊYokode M¡Ë¡¤Abe T¡¤Yonehara S¡¤¡ÊYanagisawa A¡Ë¡¥

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Gradually progressive cholangiolocellular carcinoma: a case report
»¨»ï¥¿¥¤¥È¥ë Surg Case Rep¡¥7¡Ê1¡Ë¡§
¥Ú¡¼¥¸ÈÖ¹æ 263
Ãø¼Ô ¡Ê Akiyama K¡Ë
¶¦Ãø Abe T¡¤ Oshita A¡¤ Shimizu A¡¤ Hanada K¡¤ Yonehara S¡¤¡ÊKobayashi T¡Ë¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T¡¤ Nakahara M

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Pyloric adenomatous carcinoma of the gallbladder following laparoscopic cholecystectomy: A case report
»¨»ï¥¿¥¤¥È¥ë International Journal of Surgery Case Reports
Ãø¼Ô ¡Ê Kitasaki N¡Ë
¶¦Ãø Abe T¡¤Oshita A¡¤Hanada K¡¤Noriyuki T¡¤Nakahara M

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Endoscopic placement of covered versus uncovered self-expandable metal stents for palliation of malignant gastric outlet obstruction
»¨»ï¥¿¥¤¥È¥ë Gut¡¥70¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1244-1252
Ãø¼Ô ¡ÊYamao K¡Ë
¶¦Ãø ¡ÊKitano M¡Ë¡¤¡ÊChiba Y¡Ë¡¤¡ÊOgura T¡Ë¡¤¡ÊEguchi T¡Ë¡¤¡ÊMoriyama I¡Ë¡¤¡ÊYamashita Y¡Ë¡¤¡Ê Kato H¡Ë¡¤¡ÊKayahara T¡Ë¡¤¡ÊHoki N¡Ë¡¤¡ÊOkabe Y¡Ë¡¤¡ÊShiomi H¡Ë¡¤¡ÊNakai Y¡Ë¡¤¡ÊKushiyama Y¡Ë¡¤¡Ê Fujimoto Y¡Ë¡¤¡ÊHayashi S¡Ë¡¤¡ÊBamba S¡Ë¡¤¡ÊKudo Y¡Ë¡¤¡ÊAzemoto N¡Ë¡¤¡ÊUeki T¡Ë¡¤¡ÊUza N¡Ë¡¤¡ÊAsada M¡Ë¡¤¡Ê Matsumoto K¡Ë¡¤¡ÊNebiki H¡Ë¡¤¡ÊTakihara H¡Ë¡¤¡ÊNoguchi C¡Ë¡¤¡ÊKamada H¡Ë¡¤¡ÊNakase K¡Ë¡¤¡ÊGoto D¡Ë¡¤¡Ê Sanuki T¡Ë¡¤¡ÊKoga T¡Ë¡¤¡ÊHashimoto S¡Ë¡¤¡ÊNishikiori H¡Ë¡¤¡ÊSerikawa M¡Ë¡¤Hanada K¡¤¡ÊHirao K¡Ë¡¤¡Ê Ohana M¡Ë¡¤¡ÊKazuyuki I¡Ë¡¤¡ÊKato T¡Ë¡¤¡ÊYoshida M¡Ë¡¤¡ÊKawamoto H¡Ë

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Adoption of Hospitalist Care in Asia: Experiences From Singapore¡¤Taiwan¡¤Korea¡¤and Japan
»¨»ï¥¿¥¤¥È¥ë J Hosp Med.16(7)
¥Ú¡¼¥¸ÈÖ¹æ 443-445
Ãø¼Ô ¡ÊYan Y¡Ë
¶¦Ãø ¡ÊNaito T¡Ë¡¤¡ÊHsu NC¡Ë¡¤¡ÊShin DH¡Ë¡¤¡ÊKang HJ¡Ë¡¤¡ÊVidyarthi AR¡Ë¡¤Tazuma S¡¤¡ÊHayashi J¡Ë¡¤¡Ê Deshpande GA¡Ë¡¥

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë A Prospective Multicenter Study of ¡ÈInside Stents¡É for Biliary Stricture: Multicenter Evolving Inside Stent Registry¡ÊMEISteR¡Ë¡¥
»¨»ï¥¿¥¤¥È¥ë Journal of Clinical edicine¡¥10¡Ê13¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 2936
Ãø¼Ô ¡ÊKogure H¡Ë
¶¦Ãø ¡ÊKato H¡Ë¡¤¡ÊKawakubo K¡Ë¡¤¡ÊIshiwatari H¡Ë¡¤¡ÊKatanuma A¡Ë¡¤¡ÊOkabe Y¡Ë¡¤¡ÊUeki T¡Ë¡¤¡Ê Ban T¡Ë¡¤Hanada K¡Ê¡¤Sugimori K¡Ë¡Ê¡¤Nakai Y¡Ë¡Ê¡¤Isayama H¡Ë¡¥

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Donor age¡Ê¡æ45 years¡Ëand reduced immunosuppression are associated with the recurrent primary sclerosing cholangitis after liver transplantation - a multicenter retrospective study
»¨»ï¥¿¥¤¥È¥ë Transpl Int34¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 916-929
Ãø¼Ô ¡ÊAkamatsu N¡Ë
¶¦Ãø ¡ÊHasegawa K¡Ë¡¤¡ÊEgawa H¡Ë¡¤¡ÊOhdan H¡Ë¡¤¡ÊYoshizawa A¡Ë¡¤¡ÊKokudo N¡Ë¡¤Tazuma S¡¤¡ÊTanaka A¡Ë¡¤¡ÊTakikawa H¡Ë

!¹¹¿·Æü¡§2023/04/28

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Endoscopic ultrasonography findings of pancreatic¡¡parenchyma for predicting subtypes of intraductal papillary mucinous neoplasms
»¨»ï¥¿¥¤¥È¥ë Pancreatology¡¥21¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 622-629
Ãø¼Ô ¡ÊFujii Y¡Ë
¶¦Ãø ¡ÊMatsumoto K¡Ë¡¤¡ÊKato H¡Ë¡¤¡ÊYamazaki T¡Ë¡¤¡ÊTomoda T¡Ë¡¤¡ÊHoriguchi S¡Ë¡¤¡ÊTsutsumi K¡Ë¡¤¡Ê Nishida K¡Ë¡¤¡ÊTanaka T¡Ë¡¤Hanada K¡¤¡ÊOkada H¡Ë¡¥

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ÇÙž°ÜÁãÀÚ½ü¸å¡¤²½³ØÎÅË¡¤ª¤è¤Ó繸¶È¯ÁãÀÚ½ü¤ò¹Ô¤¤36¥õ·î¤ÎÀ¸Â¸´ü´Ö¤òÆÀ¤¿¡¤Stage­¸ç¹´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡30
¥Ú¡¼¥¸ÈÖ¹æ 39¡Ý46
Ãø¼Ô »³ËÜÂîºÈ
¶¦Ãø ¡ÊÌðÌîÀ®¼ù¡Ë¡¤¡ÊÊ¡¸¶´ð°ô¡Ë¡¤²ÖÅķɻΡ¤¡ÊÀ¾Åĸ­»Ê¡Ë¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ÃÀÀоɿÇÎÅ¥¬¥¤¥É¥é¥¤¥ó¤«¤é¤ß¤¿ÃÀÀоɥޥ͡¼¥¸¥á¥ó¥È¤Î»Ä¤µ¤ì¤¿ÌäÂêÅÀ
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡41¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1395¡Ý1396
Ãø¼Ô Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ¥é¥¸¥¢¥ëÁöºº¼° EUS ¤Îɸ½àŪÉÁ½ÐË¡
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À¡¡32¡Ê11¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1688¡Ý1691
Ãø¼Ô ¡Ê°ÂÅÄ°ìϯ¡Ë
¶¦Ãø ¡Ê»å°æδÉסˡ¤¡Ê³ã¾ÂϯÀ¸¡Ë¡¤¡Ê¿ûÌî¡¡ÆØ¡Ë¡¤²ÖÅķɻΡ¤¡ÊÌÚÅĸ÷¹­¡Ë¡¤¡Ê°ÂÅÄ·ò¼£Ï¯¡Ë¡¥

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤˤª¤±¤ë EUS ¤ÎÌò³ä
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À¡¡32¡Ê11¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1680¡Ý1683
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ·ª¸¶·¼²ð¡¤ÃÓÅļéÅС¤»³»ÒÂٲá¤À¶¿å¹¸Åµ

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë IPMN ´ØϢ繴â¤ÎÁá´ü¿ÇÃǤò¤á¤¶¤·¤¿É¿ÇÏ¢·È
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡41
¥Ú¡¼¥¸ÈÖ¹æ 1363¡Ý1366
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤·ª¸¶·¼²ð¡¤ÃÓÅļéÅС¤±üÅĹ¯Ç»³ËÜÂîºÈ¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Ìȱ֡¦±ê¾É¼À´µ¤Î¤¹¤Ù¤Æ¡¥Ìȱ֡¦±ê¾É¼À´µ³ÆÏÀ¡¥¾Ã²½´ï¼À´µ¡¥¸¶È¯À­¹Å²½À­ÃÀ´É±ê¡ÊPSC¡Ë
»¨»ï¥¿¥¤¥È¥ë ÆüËÜ°å»Õ²ñ»¨»ï¡¡149¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ S241¡ÝS243
Ãø¼Ô Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤΤ¿¤á¤ÎÃÏ°è°åÎÅÏ¢·È¥·¥¹¥Æ¥à¡ÊÈøÆ»Êý¼°¡Ë
»¨»ï¥¿¥¤¥È¥ë ¡¡Î×¾²³°²Ê¡¡75¡Ê£¸¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 968¡Ý972
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¤ÎÁá´ü¿ÇÃǤòÌܻؤ·¤Æ
»¨»ï¥¿¥¤¥È¥ë ¿ÇÃǤȼ£ÎÅ¡¡108¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 977¡Ý981
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤·ª¸¶·¼²ð

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ´ÎÃÀ繤ˤª¤±¤ë·ëÀпÇÎŤΥ٥¹¥È¥×¥é¥¯¥Æ¥£¥¹¡Ý EBM ¤«¤é SDGs ¤Ø
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀ繡¡81¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 163-164
Ãø¼Ô Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë É¿ÇÏ¢·È¤òÀ¸¤«¤·¤¿ç¹Â¡¤¬¤óÁá´ü¿ÇÃǤ¬É¬Í×ÉԲķç
»¨»ï¥¿¥¤¥È¥ë Vita¡¡37¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1-14
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊËÌÌî²íÇ·¡Ë¡¤¡ÊȬ¶ù½¨ÆóϺ¡Ë¡¤¡Ê¾¾ËÜÏÂÌé¡Ë

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ±¦²¼»è¼ðı¤Ç¼õ¿Ç¤·¤¿·ìÀ¶ IgG4 ±¢À­¸åÊ¢ËìÁ¡°Ý¾É¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡73¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 425¡Ý430
Ãø¼Ô ¡ÊÃÓÅŸÂÀϯ¡Ë
¶¦Ãø ¡Ê¾®ÎÓÃε®¡Ë¡¤¡Ê¸ÅËÜ·òÂÀϺ¡Ë¡¤¡Ê±ÊÅÄ¡¡·ò¡Ë¡¤¡ÊËåÈøÏ·û¡Ë¡¤¡Ê²¬ËÜÎÉ°ì¡Ë¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ¿»ÜÀߤˤè¤ë Web ¥Æ¥¹¥È¤òÍѤ¤¤¿ÁÐÊý¸þÀ­´ÁÊý¶µ°é¤Îɸ½à²½¤Ø¤Î»î¤ß¡¡
¡ÁÂç³Øɱ¡Áí¹çÆâ²Ê¡¦Áí¹ç¿ÇÎŲʤˤè¤ë¥°¥ë¡¼¥×¸¦µæ¡Á
»¨»ï¥¿¥¤¥È¥ë ÆüËÜ´ÁÊý°å³Ø¶µ°é¿¶¶½ºâÃÄ¡¡³èÆ°¶ÈÀÓ½¸
¥Ú¡¼¥¸ÈÖ¹æ 40¡Ý51
Ãø¼Ô ¡Ê¾¾ËÜÀµ½Ó¡Ë
¶¦Ãø Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ¾Ã²½´ïÉÂÀìÌç°å¤È¤·¤ÆÃΤäƤª¤­¤¿¤¤¡ÈÃÀ½Á»À¤Î´ðÁäÈÎ×¾²¡É
»¨»ï¥¿¥¤¥È¥ë ÆüËܾò½µÛ¼ý³Ø²ñ»¨»ï¡¡42¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 139¡Ý142
Ãø¼Ô Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ¥×¥é¥¤¥Þ¥ê¥±¥¢¤È¹âÎð¼Ô°åÎÅ¡Á¿Í¸ýÌäÂê¤Ë´ð¤Å¤¯ÃÏ°è°åÎŹ½ÁۤΤʤ«¤Ç¡Á
»¨»ï¥¿¥¤¥È¥ë Geriatric Medicine¡¡58¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 585¡Ý589
Ãø¼Ô Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë µÞÀ­ÃÀ´É±ê¡ÊÁíÃÀ´É·ëÀС¤°­À­ÃÀÆ»¶¹ºõ¡Ë¤ËÂФ¹¤ëÆâ»ë¶À¼£ÎÅ
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ï´Ç¸î¡§¤¬¤ó¡¦²½³ØÎÅË¡¡¦Æâ»ë¶À¡¡25¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 30¡Ý37
Ãø¼Ô ·ª¸¶·¼²ð
¶¦Ãø ²ÖÅÄ¡¡·É»Î

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ÃÀǹ¡¦ÃÀ´ÉÉÂÊѤËÂФ¹¤ë EUS-FNA¡¡Å¬±þ¤ÈÍ­ÍÑÀ­
»¨»ï¥¿¥¤¥È¥ë ´Î¡¦ÃÀ¡¦ç¹¡¡80¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1005¡Ý1010
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤·ª¸¶·¼²ð¡¤¡Ê²£½ÐÀµÎ´¡Ë¡¤ÃÓÅļéÅС¤¡ÊÌðÌîÀ®¼ù¡Ë¡¤±üÅĹ¯ÇÅĺʡ¡¿Ê¡¤¿ÀÅÄ¿¿µ¬¡¤º´¡¹ÌÚ·ò»Ê¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Áí¹çÆâ²Ê¿ÇÎŤΥԥåȥե©¡¼¥ë
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²Æâ²Ê°å²ñ²ñ»ï¡¡35¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 72¡Ý77
Ãø¼Ô Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë 繤¬¤ó¤ÎÁá´üȯ¸«¡¡ÈøÆ»Êý¼°
»¨»ï¥¿¥¤¥È¥ë Î×தȸ¦µæ¡¡97¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 564¡Ý568
Ãø¼Ô ÃÓÅļéÅÐ
¶¦Ãø ²ÖÅķɻΡ¤¡Ê²£½ÐÀµÎ´¡Ë¡¤·ª¸¶·¼²ð¡¤À¶¿å¹¸Åµ¡¤Ê¿ÌîµðÄÌ¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Ω°Ìº¤Æñ¤ò¼çÁʤËÍ象¤µ¤ì¤¿ÆüËܹÈÈÃÇ®¤Î£±¾ÉÎã
»¨»ï¥¿¥¤¥È¥ë ÆüËÜɱ¡Áí¹ç¿ÇÎÅ°å³Ø²ñ»¨»ï¡¡16¡Ê5¡Ë¡§
¥Ú¡¼¥¸ÈÖ¹æ 372¡Ý377
Ãø¼Ô ¡ÊÆü¹â¡¡°Ô¡Ë
¶¦Ãø ±§º¬°ìĪ¡¤Ê¿ÌîµðÄÌ¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ²È²À­ç¹´â¹â´í¸±·²¤Î¥µ¡¼¥Ù¥¤¥é¥ó¥¹Ë¡¡Ê¥¨¥­¥¹¥Ñ¡¼¥È¡¦¥³¥ó¥»¥ó¥µ¥¹¡Ë¡½ÆüËÜç¹Â¡³Ø²ñ²È²À­ç¹´â¥ì¥¸¥¹¥È¥ê°Ñ°÷²ñ¡¦²È²À­ç¹´â¤Ë´Ø¤¹¤ë¾®ÈɲñµÄ¡½
»¨»ï¥¿¥¤¥È¥ë ç¹Â¡¡¡35¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 322¡Ý330
Ãø¼Ô ¡ÊËÌÌî²íÇ·¡Ë
¶¦Ãø ¡Ê¿¹¼ÂÀé¼ï¡Ë¡¤¡Ê¹Ï²¬¡¡ÈÏ¡Ë¡¤¡Ê¾¾ÎÓ¹¨¹Ô¡Ë¡¤¡ÊéÃÅÄÎè»Ò¡Ë¡¤¡ÊÃÓ±º¡¡»Ê¡Ë¡¤¡Ê°ËƣŴ±Ñ¡Ë¡¤¡Ê¿Àß·µ±¼Â¡Ë¡¤¡ÊÀî¸ý¶¬µ×¡Ë¡¤¡Ê²Ï¡¸²¡Ë¡¤¡Ê¾®¿ùâûʡˡ¤¡Ê»ù¶Ì͵»°¡Ë¡¤¡ÊÀ¶¿åµþ»Ò¡Ë¡¤¡Ê¹â¶¶½¨ÌÀ¡Ë¡¤¡ÊëÆâÅÄ¿¿°ì¡Ë¡¤¡Ê»ûÅç·ò»Ö¡Ë¡¤¡ÊÄ»Åè²í»Ò¡Ë¡¤²ÖÅķɻΡ¤¡Ê¸ÅÀî¡¡Å°¡Ë¡¤¡Ê¸ÅÀîÀµ¹¬¡Ë¡¤¡Ê¸ÅÀ¥½ã°ì¡Ë¡¤¡Ê¿¿¸ý¹¨²ð¡Ë¡¤¡ÊâÃÅç´î¹¬¡Ë¡¤¡Ê¿åÌî¿­¶©¡Ë¡¤¡Ê¿å´ÖÀµÆ»¡Ë¡¤¡Ê¿åËܲí¸Ê¡Ë¡¤¡ÊµÈÅijٻԡˡ¤¡ÊÏÂÅÄ·ÄÂÀ¡Ë¡¤¡Ê¹âÀÞ¶³°ì¡Ë

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë 繤¬¤ó¶µ¼¼¤Î¤¢¤êÊý¸¡Æ¤¡¡¼çÍ×£¹»ÜÀߤγèÆ°¾õ¶·Êó¹ð
»¨»ï¥¿¥¤¥È¥ë ç¹Â¡¡¡35¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 107¡Ý114
Ãø¼Ô ¡ÊºäËܤϤȷáË
¶¦Ãø ¡ÊÃÓÅĸø»Ë¡Ë¡¤¡ÊÈøºå¾­¿Í¡Ë¡¤¡Ê¾åÌî¡¡À¿¡Ë¡¤¡Ê´ßÏÂÅľ»Ç·¡Ë¡¤¡Ê°æ²¬Ã£Ìé¡Ë¡¤²ÖÅķɻΡ¤¡Ê¸ÅÀîÀµ¹¬¡Ë¡¤¡ÊÆ£Ëܲ»ˡˡ¤¡Ê±üºäÂó»Ö¡Ë

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤˤª¤±¤ëÃÏ°è°åÎÅÏ¢·È¥·¥¹¥Æ¥à¹½ÃۤβÝÂê¤ÈÌò³ä
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡41¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 375¡Ý379
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ·ª¸¶·¼²ð¡¤À¶¿å¹¸Åµ¡¤¡ÊÌðÌîÀ®¼ù¡Ë¡¤±üÅĹ¯Ç¡Ê²£½ÐÀµÎ´¡Ë¡¤ÃÓÅļéÅС¤Ê¿ÌîµðÄÌ¡¤ÆüÌîʸÌÀ¡¤Ë­ÅÄľǷ¡¤°Âͧ͵·Ã¡¤Åĺʡ¡¿Ê¡¤¡Ê»°Âðµ¬Ç·¡Ë¡¤¡ÊµÜÌîÎÉδ¡Ë

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2020¡§¡ÊRevision of the clinical diagnostic criteria for IgG4-related sclerosing cholangitis 2012¡Ë
»¨»ï¥¿¥¤¥È¥ë J Hepatobiliary Pancreat Sci¡¥28¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 235-242
Ãø¼Ô ¡ÊNakazawa T¡Ë
¶¦Ãø ¡ÊKamisawa T¡Ë¡¤¡ÊOkazaki K¡Ë¡¤¡ÊKawa S¡Ë¡¤Tazuma S¡¤¡ÊNishino T¡Ë¡¤¡ÊInoue D¡Ë¡¤¡ÊNaitoh I¡Ë¡¤¡ÊWatanabe T¡Ë¡¤¡ÊNotohara K¡Ë¡¤¡ÊKubota K¡Ë¡¤¡ÊOhara H¡Ë¡¤¡ÊTanaka A¡Ë¡¤¡ÊTakikawa H¡Ë¡¤¡ÊMasamune A¡Ë¡¤¡ÊUnno M¡Ë

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Efficacy of the physiobiological parameter-based grading system for predicting the long-term prognosis after curative surgery for resectable pancreatic cancer
»¨»ï¥¿¥¤¥È¥ë Eur J Surg Oncol¡¥47¡Ê3 Pt B¡Ë¡§
¥Ú¡¼¥¸ÈÖ¹æ 613¡Ý619
Ãø¼Ô Abe T
¶¦Ãø ¡ÊAmano H¡Ë¡¤¡ÊKobayashi T¡Ë¡¤¡ÊHattori M¡Ë¡¤Hanada K¡¤Nakahara M¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Pathological Features and Imaging Findings in Pancreatic Carcinoma In Situ
»¨»ï¥¿¥¤¥È¥ë Pancreas¡¥50¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 399¡Ý404
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊFukuhara M¡Ë¡¤¡ÊMinami T¡Ë¡¤¡ÊYano S¡Ë¡¤¡ÊIkemoto J¡Ë¡¤Shimizu A¡¤Kurihara K¡¤Okuda Y¡¤Ikeda M¡¤¡ÊYokode M¡Ë¡¤Abe T¡¤Yonehara S¡¤¡ÊYanagisawaA¡Ë

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Clinical Analysis of Early-Stage Pancreatic Cancer and Proposal for a New Diagnostic Algorithm: A Multicenter Observational Study
»¨»ï¥¿¥¤¥È¥ë Diagnostics¡ÊBasel¡Ë¡¥11¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 287
Ãø¼Ô ¡ÊIkemoto J¡Ë
¶¦Ãø ¡ÊSerikawa M¡Ë¡¤Hanada K¡¤¡ÊEguchi N¡Ë¡¤¡ÊSasaki T¡Ë¡¤¡ÊFujimoto Y¡Ë¡¤¡ÊSugiyama S¡Ë¡¤¡ÊYamaguchi S¡Ë¡¤¡ÊNoma B¡Ë¡¤¡ÊKamigaki M¡Ë¡¤¡ÊMinami T¡Ë¡¤¡ÊOkazaki A¡Ë¡¤¡ÊYukutake M¡Ë¡¤¡ÊIshii Y¡Ë¡¤¡ÊMouri T¡Ë¡¤Shimizu A¡¤¡ÊTsuboi T¡Ë¡¤¡ÊArihiro K¡Ë¡¤¡ÊChayama K¡Ë

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Validation of the Tokyo guideline 2018 treatment proposal for acute cholecystitis from a single-center retrospective analysis
»¨»ï¥¿¥¤¥È¥ë Asian J Endosc Surg¡¥14¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 14¡Ý20
Ãø¼Ô ¡ÊBekki T¡Ë
¶¦Ãø Abe T¡¤¡ÊAmano H¡Ë¡¤Hanada K¡¤¡ÊKobayashi T¡Ë¡¤Noriyuki T¡¤¡ÊOhdan H¡Ë¡¤Nakahara M

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Unilateral versus Bilateral Endoscopic Nasobiliary Drainage and Subsequent
Metal Stent Placement for Unresectable Malignant Hilar Obstruction: A Multicenter Randomized Controlled Trial
»¨»ï¥¿¥¤¥È¥ë J Clin Med¡¥10¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 206
Ãø¼Ô ¡ÊHakuta R¡Ë
¶¦Ãø ¡ÊKogure H¡Ë¡¤¡ÊNakai Y¡Ë¡¤¡ÊKawakami H¡Ë¡¤¡ÊMaguchi H¡Ë¡¤¡ÊMukai T¡Ë¡¤¡ÊIwashita T¡Ë¡¤¡ÊSaito T¡Ë¡¤¡ÊTogawa O¡Ë¡¤¡ÊMatsubara S¡Ë¡¤¡ÊHayashi T¡Ë¡¤¡ÊMaetani I¡Ë¡¤¡ÊIto Y¡Ë¡¤¡ÊHasebe O¡Ë¡¤¡ÊItoi T¡Ë¡¤Hanada K¡¤¡ÊIsayama H¡Ë

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2021
ÏÀʸ¥¿¥¤¥È¥ë Value of endoscopic ultrasonography in the observation of the remnant pancreas after pancreatectomy¡¥
»¨»ï¥¿¥¤¥È¥ë PLoS One¡¥16¡Ê1¡Ë¡§ e0245447
¥Ú¡¼¥¸ÈÖ¹æ doi:10¡¥1371/journal¡¥pone¡¥0245447¡¥eCollection 2021
Ãø¼Ô ¡ÊMaruyama H¡Ë
¶¦Ãø Hanada K¡¤ Shimizu A¡¤¡ÊMinami T¡Ë¡¤Hirano N¡¤Hino F¡¤Abe T¡¤¡ÊAmano H¡Ë¡¤¡ÊFujiwara Y¡Ë

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Identification of Risk Factors for Open Conversion From Laparoscopic Cholecystectomy for Acute Cholecystitis Based on Computed Tomography Findings
»¨»ï¥¿¥¤¥È¥ë Surg Today¡¥50¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1657¡Ý1663
Ãø¼Ô ¡ÊHirohata R¡Ë
¶¦Ãø Abe T¡¤¡ÊAmano H¡Ë¡¤Hanada K¡¤¡ÊKobayashi T¡Ë¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T¡¤Nakahara M

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Adverse events of endoscopic ultrasound-guided fine needle aspiration for histologic diagnosis in Japanese tertiary centers: Multicenter retrospective study¡¥
»¨»ï¥¿¥¤¥È¥ë Dig Endosc
¥Ú¡¼¥¸ÈÖ¹æ doi: 10¡¥1111/den¡¥13912¡¥Online ahead of print
Ãø¼Ô ¡ÊKanno A¡Ë
¶¦Ãø ¡ÊYasuda I¡Ë¡¤¡ÊIrisawa A¡Ë¡¤¡ÊHara K¡Ë¡¤¡ÊAshida R¡Ë¡¤¡ÊIwashita T¡Ë¡¤¡ÊTakenaka M¡Ë¡¤¡¡¡¡¡ÊKatanuma A¡Ë¡¤¡ÊTakikawa T¡Ë¡¤¡ÊKubota K¡Ë¡¤¡ÊKato H¡Ë¡¤¡ÊNakai Y¡Ë¡¤¡ÊRyozawa S¡Ë¡¤¡ÊKitano M¡Ë¡¤¡ÊIsayama H¡Ë¡¤¡ÊKamada H¡Ë¡¤¡ÊOkabe Y¡Ë¡¤Hanada K¡¤¡ÊOhtsubo K¡Ë¡¤¡ÊDoi S¡Ë¡¤¡ÊHisai H¡Ë¡¤¡ÊShibukawa G¡Ë¡¤¡ÊImazu H¡Ë¡¤¡ÊMasamune A¡Ë

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Periostin antisense oligonucleotide prevents hepatic steatosis and fibrosis in a mouse model of non-alcoholic steatohepatitis¡¥
»¨»ï¥¿¥¤¥È¥ë J Gastroenterol Hepatol
¥Ú¡¼¥¸ÈÖ¹æ 2140¡Ý2150
Ãø¼Ô ¡ÊKobayashi T¡Ë
¶¦Ãø ¡ÊKanno K¡Ë¡¤¡ÊPhuong Thao Nguyen¡Ë¡¤¡ÊSugiyama A¡Ë¡¤¡ÊKawahara A¡Ë¡¤¡ÊOtani Y¡Ë¡¤¡ÊKishikawa N¡Ë¡¤¡ÊIto M¡Ë¡¤Tazuma S

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Senescent hepatic stellate cells caused by deoxycholic acid modulates malignant behavior of hepatocellular carcinoma¡¥
»¨»ï¥¿¥¤¥È¥ë J Cancer Res Clin Oncol¡¥146¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 3255¡Ý3268
Ãø¼Ô ¡ÊNguyen PT¡Ë
¶¦Ãø ¡ÊKanno K¡Ë¡¤¡ÊPham QT¡Ë¡¤¡ÊKikuchi Y¡Ë¡¤¡ÊKakimoto M¡Ë¡¤¡ÊKobayashi T¡Ë¡¤¡ÊOtani Y¡Ë¡¤¡ÊKishikawa N¡Ë¡¤¡ÊMiyauchi M¡Ë¡¤¡ÊArihiro K¡Ë¡¤¡ÊIto M¡Ë¡¤Tazuma S

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Endoscopic Ultrasonography Diagnosis of Early Pancreatic Cancer
»¨»ï¥¿¥¤¥È¥ë Diagnostics¡ÊBasel¡Ë¡¥10¡Ê12¡Ë¡§
¥Ú¡¼¥¸ÈÖ¹æ 1086
Ãø¼Ô Kurihara K
¶¦Ãø Hanada K¡¤Shimizu A

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Intrahepatic cholangiocarcinoma with clear cell type following laparoscopic curative surgery
»¨»ï¥¿¥¤¥È¥ë Surg Case Rep¡¥6¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 264
Ãø¼Ô Yamamoto T
¶¦Ãø Abe T¡¤Oshita A¡¤Yonehara S¡¤Katamura Y¡¤Matsumoto N¡¤¡ÊKobayashi T¡Ë¡¤Nakahara M¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Preoperative anthropomorphic and nutritious status and fistula risk score for predicting clinically relevant postoperative pancreatic fistula after pancreaticoduodenectomy¡¥
»¨»ï¥¿¥¤¥È¥ë BMC Gastroenterol¡¥20¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 264
Ãø¼Ô Abe T
¶¦Ãø ¡ÊAmano H¡Ë¡¤¡ÊKobayashi T¡Ë¡¤Hanada K¡¤¡ÊHattori M¡Ë¡¤Nakahara M¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T

!¹¹¿·Æü¡§2022/05/23

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Optimal Treatment for Octogenarians With Resectable and Borderline Resectable Pancreatic Ductal Adenocarcinoma:A Multicenter Retrospective Study
»¨»ï¥¿¥¤¥È¥ë Pancreas¡¥49¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 837¡Ý844
Ãø¼Ô ¡ÊSatoi S¡Ë
¶¦Ãø ¡ÊYamamoto T¡Ë¡¤¡ÊUchida K¡Ë¡¤¡ÊFujii T¡Ë¡¤¡ÊKin T¡Ë¡¤¡ÊHirano S¡Ë¡¤Hanada K¡¤¡ÊItoi T¡Ë¡¤¡ÊMurakami Y¡Ë¡¤¡ÊIgarashi H¡Ë¡¤¡ÊEguchi H¡Ë¡¤¡ÊKuroki T¡Ë¡¤¡ÊShimizu Y¡Ë¡¤¡ÊTani M¡Ë¡¤¡ÊTanno S¡Ë¡¤¡¡¡ÊTsuji Y¡Ë¡¤¡ÊHirooka Y¡Ë¡¤¡ÊMasamune A¡Ë¡¤Shimokawa T¡Ë¡¤¡ÊYamaue H¡Ë¡¤¡ÊOkazaki K¡Ë¡¥

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤˤª¤±¤ëç¹±ÕºÙ˦¿Ç¤ÎÌò³ä¤ò¸«Ä¾¤¹
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡41¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 259¡Ý261
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ·ª¸¶·¼²ð¡¤À¶¿å¹¸Åµ¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Áí¹çÆâ²Ê³°Íè¿ÇÎŤΥԥåȥե©¡¼¥ë
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÆâ²Ê³Ø²ñ»¨»ï¡¡109¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 501-505
Ãø¼Ô Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë ɱ¡Áí¹ç¿ÇÎŰ夬ÃΤäƤª¤­¤¿¤¤¾Ã²½´ÉPoint-of-care US¡ÊPOCUS¡Ë
»¨»ï¥¿¥¤¥È¥ë ÆüËÜɱ¡Áí¹ç¿ÇÎÅ°å³Ø²ñ»¨»ï¡¡16¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 98-106
Ãø¼Ô ¡Ê¾¾Â¼½ÓÆó¡Ë
¶¦Ãø ¡ÊËêÄÚÎÉ»þ¡Ë¡¤¡ÊË¡À¾Èþ²Ì¡Ë¡¤¡ÊÄÔ¡¡Ä¾¼ù¡Ë¡¤¡Ê¾¾Åĸ­²ð¡Ë¡¤¡Ê½Å¿®Í§±§Ìé¡Ë¡¤¡Ê»³²¬Ä¾¼ù¡Ë¡¤Åĺʡ¡¿Ê¡¤¡Ê°ËÆ£¸ø·±¡Ë¡¥

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë IPMN ¤Ëʻ¸¤¹¤ëÄ̾﷿繴â
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡41¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 101-104
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Âçư̮IJ´Éáñ¤Ë¤è¤ë¾Ã²½´É½Ð·ì¸å¤ËµÞÊѤò¤­¤¿¤·¤¿°ìÎã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡29
¥Ú¡¼¥¸ÈÖ¹æ 59-64
Ãø¼Ô ºç¸¶½ÓºÈ
¶¦Ãø ¼µ¸Í¹§¹¥¡¤¡ÊÊ¡¸¶´ð°ô¡Ë¡¤ÌðÌîÀ®¼ù¡¤¡Ê±­»ô½ÓÊå¡Ë¡¤²£½ÐÀµÎ´¡¤¾¾ËÜ¡¡Ë¾¡¤À¶¿å¹¸Åµ¡¤ÃæÅÚ°æ¹Ý°ì¡¤¡ÊÆî¡¡ÃÒÇ·¡Ë¡¤ÊÒ¼²ÅÃË¡¤Ê¿ÌîµðÄÌ¡¤¾®ÌîÀîÌ÷Æ󡤲ÖÅķɻΡ¤Å·Ìî¡¡»Ï¡¤ÆüÌîʸÌÀ¡¤¡ÊÀ¾Åĸ­»Ê¡Ë¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ç¹Ç¹Ë¦À­¼ðáç¤Î¥Þ¥Í¡¼¥¸¥á¥ó¥È¡ÊÁíÀâ¡Ë
»¨»ï¥¿¥¤¥È¥ë ÆüËܾò½´ïɳزñ»¨»ï¡¡116¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 961-970
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤·ª¸¶·¼²ð

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ÃÀÀС¦ç¹ÀФÎÀ®°ø¤ÈÀ­¾õ
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À¡¡31¡Ê11¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1594¡Ý1600
Ãø¼Ô ¡ÊÂç²°ÉÒ½¨¡Ë
¶¦Ãø Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ´¬Æ¬¸À
»¨»ï¥¿¥¤¥È¥ë ¹­Å縩ɱ¡ÌôºÞ»Õ²ñ»ï¡¡54¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 237¡Ý237
Ãø¼Ô Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë IPMN/ ç¹Ç¹Ë¦¤Î¿ÇÎÅ¡¡IPMN¤ò´Þ¤àç¹¼À´µ¿ÇÎŤˤª¤±¤ëÉ¿ÇÏ¢·È
»¨»ï¥¿¥¤¥È¥ë Î×¾²¾Ã²½´ïÆâ²Ê¡¡34¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ P1502¡Ý1506
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤²£½ÐÀµÎ´¡¤ÃÓÅļéÅС¤ÌðÌîÀ®¼ù¡¤·ª¸¶·¼²ð

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¤ÎÁá´ü¿ÇÃǤˤª¤±¤ëERCP ¤ÎÌò³ä
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡40¡Ê9¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 767¡Ý771
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤·ª¸¶·¼²ð¡¤±üÅĹ¯ÇÌðÌîÀ®¼ù¡¤ÃÓÅļéÅС¤²£½ÐÀµÎ´¡¤Ê¿ÌîµðÄÌ¡¤ÊÒ¼²ÅÃË¡¤¾¾ËÜ¡¡Ë¾¡¤ÃæÅÚ°æ¹Ý°ì¡¤¼µ¸Í¹§¹¥¡¤¾®ÌîÀîÌ÷Æó¡¤Å·Ìî¡¡»Ï¡¤ÆüÌîʸÌÀ¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ¸¶È¯À­¹Å²½À­ÃÀ´É±ê¥¬¥¤¥É¥é¥¤¥ó¤Ë¤Ä¤¤¤Æ
»¨»ï¥¿¥¤¥È¥ë ÆüËܾò½´ïɳزñ»¨»ï¡¡116¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 631¡Ý638
Ãø¼Ô ¡Ê°Ëº´»³¹ÀÄÌ¡Ë
¶¦Ãø ¡ÊÅÄÃæ¡¡ÆÆ¡Ë¡¤Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ¹Å²½À­ÃÀ´É±ê¿ÇÎŤθ½¾õ¤ÈŸ˾
»¨»ï¥¿¥¤¥È¥ë ÆüËܾò½´ïɳزñ»¨»ï¡¡116¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 617-623
Ãø¼Ô Åĺʡ¡¿Ê

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤκÇÁ°Àþ
»¨»ï¥¿¥¤¥È¥ë Schneller¡¡111
¥Ú¡¼¥¸ÈÖ¹æ 8-11
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Clinical Practice Guidelines for Pancreatic Cancer 2019 From the Japan Pancreas Society
»¨»ï¥¿¥¤¥È¥ë Pancreas¡¥49¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 326-335
Ãø¼Ô ¡ÊOkusaka T¡Ë
¶¦Ãø ¡ÊNakamura M¡Ë¡¤¡ÊYoshida M¡Ë¡¤¡ÊKitano M¡Ë¡¤¡ÊUesaka K¡Ë¡¤¡ÊIto Y¡Ë¡¤¡ÊFuruse J¡Ë¡¤Hanada K¡¤¡ÊOkazaki K¡Ë¡¥

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Prediction of the Probability of Malignancy in Mucinous Cystic Neoplasm of the Pancreas With Ovarian-Type Stroma: A Nationwide Multicenter Study in Japan
»¨»ï¥¿¥¤¥È¥ë Pancreas¡¥49¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 181-186
Ãø¼Ô ¡ÊOhtsuka T¡Ë
¶¦Ãø ¡ÊNakamura M¡Ë¡¤¡ÊHijioka S¡Ë¡¤¡ÊShimizu Y¡Ë¡¤¡ÊUnno M¡Ë¡¤¡ÊTanabe M¡Ë¡¤¡ÊNagakawa Y¡Ë¡¤¡ÊTakaori K¡Ë¡¤¡ÊHirono S¡Ë¡¤¡ÊGotohda N¡Ë¡¤¡ÊKimuraW¡Ë¡¤¡ÊIto K¡Ë¡¤¡ÊKatanuma A¡Ë¡¤¡ÊSano T¡Ë¡¤¡ÊUrata T¡Ë¡¤¡ÊKita E¡Ë¡¤Hanada K¡¤¡ÊTada M¡Ë¡¤¡ÊAoki T¡Ë¡¤¡ÊSerikawa M¡Ë¡¤¡ÊOkamoto K¡Ë¡¤¡ÊIsayama H¡Ë¡¤¡ÊGotoh Y¡Ë¡¤¡ÊIshigami K¡Ë¡¤¡ÊYamaguchi H¡Ë¡¤¡ÊYamao K¡Ë¡¤¡ÊSugiyama M¡Ë¡¤¡ÊOkazaki K¡Ë

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Comparison of a 22-gauge Franseen-tip needle with a 20-gauge forward-bevel needle for the diagnosis of type 1 autoimmune pancreatitis: a prospective¡¤randomized¡¤controlled¡¤multicenter study
»¨»ï¥¿¥¤¥È¥ë Gastrointest Endosc¡¥91¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 373-381
Ãø¼Ô ¡ÊKurita A¡Ë
¶¦Ãø ¡ÊYasukawa S¡Ë¡¤¡ÊZen Y¡Ë¡¤¡ÊYoshimura K¡Ë¡¤¡ÊOgura T¡Ë¡¤¡ÊOzawa E¡Ë¡¤¡ÊOkabe Y¡Ë¡¤¡ÊAsada M¡Ë¡¤¡ÊNebiki H¡Ë¡¤¡ÊShigekawa M¡Ë¡¤¡ÊIkeura T¡Ë¡¤¡ÊEguchi T¡Ë¡¤¡ÊMaruyama H¡Ë¡¤¡ÊUeki T¡Ë¡¤¡ÊItonaga M¡Ë¡¤¡ÊHashimoto S¡Ë¡¤¡ÊShiomi H¡Ë¡¤¡ÊMinami R¡Ë¡¤¡ÊHoki N¡Ë¡¤¡ÊTakenaka M¡Ë¡¤¡ÊItokawa Y¡Ë¡ÊUza N¡Ë¡¤¡ÊHashigo S¡Ë¡¤¡ÊYasuda H¡Ë¡¤¡ÊTakada R¡Ë¡¤¡ÊKamada H¡Ë¡¤¡ÊKawamoto H¡Ë¡¤¡ÊKawakami H¡Ë¡¤¡Ê Moriyama I¡Ë¡¤¡ÊFujita K¡Ë¡¤¡ÊMatsumoto H¡Ë¡¤Hanada K¡¤¡ÊTakemura T¡Ë¡¤¡ÊYazumi S¡Ë

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2020
ÏÀʸ¥¿¥¤¥È¥ë Recurrence patterns after surgical resection of intraductal papillary mucinous neoplasm¡ÊIPMN¡Ëof the pancreas; a multicenter¡¤retrospective study of 1074 IPMN patients by the Japan Pancreas Society
»¨»ï¥¿¥¤¥È¥ë J Gastroenterol¡¥55¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 86-99
Ãø¼Ô ¡ÊHirono S¡Ë
¶¦Ãø ¡ÊShimizu Y¡Ë¡¤¡ÊOhtsuka T¡Ë¡¤¡ÊKin T¡Ë¡¤¡ÊHara K¡Ë¡¤¡ÊKanno A¡Ë¡¤¡ÊKoshita S¡Ë¡¤Hanada K¡¤¡ÊKitano M¡Ë¡¤¡ÊInoue H¡Ë¡¤¡ÊItoi T¡Ë¡¤¡ÊUeki T¡Ë¡¤¡ÊShimokawa T¡Ë¡¤¡ÊHijioka S¡Ë¡¤¡ÊYanagisawa A¡Ë¡¤¡Ê Nakamura M¡Ë¡¤¡ÊOkazaki K¡Ë¡¤¡ÊYamaue H¡Ë¡¥

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Decrease in major secondary bile acid¡¤ hyodeoxycholic acid¡¤ was the main alteration in hepatic bile acid compositions in a hypertensive nonalcoholic fatty liver disease model
»¨»ï¥¿¥¤¥È¥ë J Hepatobiliary Pancreat Sci¡¥26¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 557-567
Ãø¼Ô ¡ÊKodama M¡Ë
¶¦Ãø ¡ÊKanno K¡Ë¡¤¡ÊKishikawa N¡Ë¡¤¡ÊTakei H¡Ë¡¤¡ÊNittono H¡Ë¡¤Tazuma S

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Long-term outcomes of pediatric-onset primary sclerosing cholangitis: A single-center experience in Japan
»¨»ï¥¿¥¤¥È¥ë Hepatol Res¡¥49¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1386-1397
Ãø¼Ô ¡ÊUmetsu S¡Ë
¶¦Ãø ¡ÊNotohara K¡Ë¡¤¡ÊNakazawa T¡Ë¡¤¡ÊTsunoda T¡Ë¡¤¡ÊSogo T¡Ë¡¤¡ÊKomatsu H¡Ë¡¤¡ÊTanaka A¡Ë¡¤Tazuma S¡¤¡ÊTakikawa H¡Ë¡¤¡ÊInui A¡Ë¡¤¡ÊFujisawa T¡Ë¡¥

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Pr o t e c t i v e e ffect of phosphatidylcholine on lysophosphatidylcholine-induced cellular senescence in cholangiocyte
»¨»ï¥¿¥¤¥È¥ë J Hepatobiliary Pancreat Sci¡¥26¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 568-577
Ãø¼Ô ¡ÊOhigashi T¡Ë
¶¦Ãø ¡ÊKanno K¡Ë¡¤¡ÊSugiyama A¡Ë¡¤¡ÊPhuong Thao Nguyen¡Ë¡¤¡ÊKishikawa N¡Ë¡¤¡ÊOtani Y¡Ë¡¤¡Ê Kobayashi T ¡Ë¡¤¡ÊMatsuo H¡Ë¡¤Tazuma S¡¥

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Long-term outcomes of pediatric-onset primary sclerosing cholangitis: A single-center experience in Japan¡¥
»¨»ï¥¿¥¤¥È¥ë Hepatol Res¡¥49¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1386-1397
Ãø¼Ô ¡ÊUmetsu S¡Ë
¶¦Ãø ¡ÊNotohara K¡Ë¡¤¡ÊNakazawa T¡Ë¡¤¡ÊTsunoda T¡Ë¡¤¡ÊSogo T¡Ë¡¤¡ÊKomatsu H¡Ë¡¤¡ÊTanaka A¡Ë¡¤Tazuma S¡¤¡ÊTakikawa H¡Ë¡¤¡ÊInui A¡Ë¡¤¡ÊFujisawa T¡Ë

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Investigation of Fluorodeoxyglucose Positron Emission Tomography for the Diagnosis of Solid Pseudopapillary Neoplasm of the Pancreas: A Study Associated With a National Survey of Solid Pseudopapillary Neoplasms
»¨»ï¥¿¥¤¥È¥ë ancreas¡¥48¡Ê10¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1312-1320
Ãø¼Ô Kurihara K
¶¦Ãø Hanada K¡¤¡ÊSerikawa M¡Ë¡¤¡ÊIshii Y¡Ë¡¤¡ÊTsuboi T¡Ë¡¤¡ÊKawamura R¡Ë¡¤¡ÊSekitou T¡Ë¡¤¡Ê Nakamura S¡Ë¡¤¡ÊMori T¡Ë¡¤¡ÊHirano T¡Ë¡¤¡ÊIkemoto J¡Ë¡¤¡ÊChayama K¡Ë

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Intracholecystic papillary neoplasm of the gallbladder protruding into the common bile duct: A case report
»¨»ï¥¿¥¤¥È¥ë Mol Clin Oncol¡¥11¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ P488-492
Ãø¼Ô Yokode M
¶¦Ãø Hanada K¡¤Shimizu A¡¤¡ÊMinami T¡Ë¡¤Hirohata R¡¤Abe T¡¤Amano H¡¤Yonehara S¡¤¡Ê Zen Y¡Ë

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Key diagnostic characteristics of fever of unknown origin in Japanese patients: a prospective multicentre study
»¨»ï¥¿¥¤¥È¥ë BMJ Open¡¥9¡Ê11¡Ë¡§e032059
¥Ú¡¼¥¸ÈÖ¹æ doi: 10.1136/bmjopen-2019¡Ý032059
Ãø¼Ô ¡ÊNaito T¡Ë
¶¦Ãø ¡ÊTanei M¡Ë¡¤¡ÊIkeda N¡Ë¡¤¡ÊIshii T¡Ë¡¤¡ÊSuzuki T¡Ë¡¤¡ÊMorita H¡Ë¡¤¡ÊYamasaki S¡Ë¡¤¡ÊTamura J¡Ë¡¤¡ÊAkazawa K¡Ë¡¤¡ÊYamamoto K¡Ë¡¤¡ÊOtani H¡Ë¡¤¡ÊSuzuki S¡Ë¡¤¡ÊKikuchi M¡Ë¡¤¡ÊOno S¡Ë¡¤¡ÊKobayashi H¡Ë¡¤¡ÊAkita H¡Ë¡¤Tazuma S¡¤¡ÊHayashi J¡Ë

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë A case of giant cell arteritis simultaneously diagnosed with chronic subdural hematoma
»¨»ï¥¿¥¤¥È¥ë Clin Case Rep¡¥7¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 2534-2538
Ãø¼Ô ¡ÊOtani Y¡Ë
¶¦Ãø ¡ÊKanno K¡Ë¡¤¡ÊKikuchi Y¡Ë¡¤¡ÊKametani T¡Ë¡¤¡ÊKobayashi T¡Ë¡¤Tazuma S¡¥

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Amputation neuroma derived from a remnant cystic duct 30 years after cholecystectomy: A case report¡¥
»¨»ï¥¿¥¤¥È¥ë Int J Surg Case Rep¡¥64
¥Ú¡¼¥¸ÈÖ¹æ 184-187
Ãø¼Ô Hirooka R
¶¦Ãø Abe T¡¤Amano H¡¤¡ÊKobayashi T¡Ë¡¤Shimizu A¡¤Hanada K¡¤Yonehara S¡¤Nakahara M¡¤¡Ê Ohdan H¡Ë¡¤Noriyuki T

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Prospective study of early chronic pancreatitis diagnosed based on the Japanese diagnostic criteria¡¥
»¨»ï¥¿¥¤¥È¥ë J Gastroenterol¡¥54¡Ê10¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 928-935
Ãø¼Ô ¡ÊMasamune A¡Ë
¶¦Ãø ¡ÊNabeshima T¡Ë¡¤¡ÊKikuta K¡Ë¡¤¡ÊHamada S¡Ë¡¤¡ÊNakano E¡Ë¡¤¡ÊKume K¡Ë¡¤¡ÊKanno A¡Ë¡¤¡ÊSato A¡Ë¡¤¡ÊTachibana Y¡Ë¡¤¡ÊInatomi O¡Ë¡¤¡ÊYamamoto S¡Ë¡¤¡ÊIkeura T¡Ë¡¤¡ÊFutagami S¡Ë¡¤¡ÊTaguchi M¡Ë¡¤Hanada K¡¤¡ÊShimizu K¡Ë¡¤¡ÊKageoka M¡Ë¡¤¡ÊSaito T¡Ë¡¤¡ÊEguchi T¡Ë¡¤¡Êbota K¡Ë¡¤¡ÊTakenaka M¡Ë¡¤¡¡¡¡¡ÊMima A¡Ë¡¤¡ÊIrisawa A¡Ë¡¤¡ÊIto T¡Ë¡¤¡ÊAndoh A¡Ë¡¤¡ÊInui K¡Ë¡¤¡ÊTakeyama Y¡Ë¡¤Yamaue H¡Ë¡¤¡ÊOkazaki K¡Ë¡¤¡ÊShimosegawa T¡Ë

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Geographical distribution of family physicians in Japan: a nationwide cross-sectional study
»¨»ï¥¿¥¤¥È¥ë BMC Fam Pract¡¥20¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 147
Ãø¼Ô ¡ÊYoshida S¡Ë
¶¦Ãø ¡ÊMatsumoto M¡Ë¡¤¡ÊKashima S¡Ë¡¤¡ÊKoike S¡Ë¡¤Tazuma S¡¤¡ÊMaeda T¡Ë

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Characteristics recurrence pattern of cholangiolocellular carcinoma as intrahepatic bile duct tumor growth following curative resection: a case report
»¨»ï¥¿¥¤¥È¥ë Surg Case Rep¡¥5¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 139
Ãø¼Ô ¡ÊHakoda K¡Ë
¶¦Ãø Abe T¡¤Amano H¡¤¡ÊMinami T¡Ë¡¤¡ÊKobayashi T¡Ë¡¤Hanada K¡¤¡ÊNishida K¡Ë¡¤Yonehara S¡¤Nakahara M¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Toxocariasis Suspected of Having Infiltrated Directly from the Liver to the Lung through the Diaphragm
»¨»ï¥¿¥¤¥È¥ë Intern Med¡¥58¡Ê18¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 2737-2741
Ãø¼Ô ¡ÊKakimoto M¡Ë
¶¦Ãø ¡ÊMurata M¡Ë¡¤¡ÊMitsumoto-Kaseida F¡Ë¡¤¡ÊOgawa E¡Ë¡¤¡ÊMatsumoto Y¡Ë¡¤¡ÊKusaga A¡Ë¡¤¡ÊToyoda K¡Ë¡¤¡ÊHayashi T¡Ë¡¤¡ÊUra K¡Ë¡¤¡ÊKanno K¡Ë¡¤¡ÊFurusyo N¡Ë¡¤Tazuma S¡¥

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Increase trend in the prevalence and male-to-female ratio of primary biliary cholangitis¡¤ autoimmune hepatitis¡¤ and primary sclerosing cholangitis in Japan
»¨»ï¥¿¥¤¥È¥ë Hepatol Res¡¥49¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 881-889
Ãø¼Ô ¡ÊTanaka A¡Ë
¶¦Ãø ¡ÊMori M¡Ë¡¤¡ÊMatsumoto K¡Ë¡¤¡ÊOhira H¡Ë¡¤Tazuma S¡¤¡ÊTakikawa H¡Ë

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Geographic Distribution of Regional Quota Program Graduates of Japanese Medical Schools: A Nationwide Cohort Study
»¨»ï¥¿¥¤¥È¥ë Acad Med¡¥94¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ P1244-1252
Ãø¼Ô ¡ÊMatsumoto M¡Ë
¶¦Ãø ¡ÊKashima S¡Ë¡¤¡ÊOwaki T¡Ë¡¤¡ÊIguchi S¡Ë¡¤¡ÊInoue K¡Ë¡¤Tazuma S¡¤¡ÊMaeda T¡Ë¡¥

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Emigration of regional quota graduates of Japanese medical schools to non-designated prefectures: a prospective nationwide cohort study
»¨»ï¥¿¥¤¥È¥ë BMJ Open¡¥9¡Ê7¡Ëe029335
¥Ú¡¼¥¸ÈÖ¹æ doi: 10.1136/bmjopen-2019¡Ý029335
Ãø¼Ô ¡ÊYoshida S¡Ë
¶¦Ãø ¡ÊMatsumoto M¡Ë¡¤¡ÊKashima S¡Ë¡¤¡ÊOwaki T¡Ë¡¤¡ÊIguchi S¡Ë¡¤¡ÊInoue K¡Ë¡¤Tazuma S¡¤¡Ê Maeda T¡Ë

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Successful Treatment of Acute Chest Syndrome with Manual Exchange Transfusion in a Patient with Sickle Beta + thalassemia¡¥
»¨»ï¥¿¥¤¥È¥ë Intern Med¡¥58¡Ê11¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1629-1634
Ãø¼Ô ¡ÊKawahara A¡Ë
¶¦Ãø ¡ÊMorioka T¡Ë¡¤¡ÊOtani Y¡Ë¡¤¡ÊKanno K¡Ë¡¤¡ÊEdahiro T¡Ë¡¤¡ÊFukushima N¡Ë¡¤¡ÊNagasaka S¡Ë¡¤¡ÊHousai M¡Ë¡¤¡ÊKakimoto M¡Ë¡¤¡ÊTsuji N¡Ë¡¤¡ÊAsano S¡Ë¡¤¡ÊKikuchi Y¡Ë¡¤¡ÊKobayashi T¡Ë¡¤¡ÊMiyamori D¡Ë¡¤¡ÊIshida R¡Ë¡¤¡ÊKimura K¡Ë¡¤¡ÊKishikawa N¡Ë¡¤¡ÊMizooka M¡Ë¡¤¡ÊIchinohe T¡Ë¡¤Tazuma S¡¥

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Endoscopic ultrasound findings and pathological features of pancreatic carcinoma in situ
»¨»ï¥¿¥¤¥È¥ë Endosc Int Open¡¥7¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ E585¡ÝE593
Ãø¼Ô ¡ÊIzumi Y¡Ë
¶¦Ãø Hanada K¡¤¡ÊOkazaki A¡Ë¡¤¡ÊMinami T¡Ë¡¤Hirano N¡¤¡ÊIkemoto J¡Ë¡¤¡ÊKanemitsu K¡Ë¡¤Nakadoi K¡¤Shishido T¡¤Katamura Y¡¤Onogawa S¡¤Amano H¡¤Hino F¡¤Amano H¡¤Yonehara S

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë An Atypical Case of Non-asthmatic Eosinophilic Granulomatosis with Polyangiitis Finally Diagnosed by Tissue Biopsy
»¨»ï¥¿¥¤¥È¥ë Intern Med¡¥58¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 871-875
Ãø¼Ô ¡ÊKobayashi T¡Ë
¶¦Ãø ¡ÊKanno K¡Ë¡¤¡Ê Kikuchi Y¡Ë¡¤¡ÊKakimoto M¡Ë¡¤¡Ê Kawahara A¡Ë¡¤¡ÊKimura K¡Ë¡¤¡ÊIshida R¡Ë¡¤¡ÊMiyamori D¡Ë¡¤¡ÊOtani Y¡Ë¡¤¡ÊKishikawa N¡Ë¡¤Tazuma S¡¥

!¹¹¿·Æü¡§2021/11/25

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Clinical practice guidelines for IgG4-related sclerosing cholangitis
»¨»ï¥¿¥¤¥È¥ë J Hepatobiliary Pancreat Sci¡¥26¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 9-42
Ãø¼Ô ¡ÊKamisawa T¡Ë¡×
¶¦Ãø ¡ÊNakazawa T¡Ë¡¤Tazuma S¡¤¡ÊZen Y¡Ë¡¤¡ÊTanaka A¡Ë¡¤¡ÊOhara H¡Ë¡¤¡ÊMuraki T¡Ë¡¤¡Ê Inui K¡Ë¡¤¡ÊInoue D¡Ë¡¤¡ÊNishino T¡Ë¡¤¡ÊNaitoh I¡Ë¡¤¡ÊItoi T¡Ë¡¤¡ÊNotohara K¡Ë¡¤¡ÊKanno A¡Ë¡¤¡ÊKubota K¡Ë¡¤¡ÊHirano K¡Ë¡¤¡ÊIsayama H¡Ë¡¤¡ÊShimizu K¡Ë¡¤¡ÊTsuyuguchi T¡Ë¡¤¡ÊShimosegawa T¡Ë¡¤¡ÊKawa S¡Ë¡¤¡ÊChiba T¡Ë¡¤¡ÊOkazaki K¡Ë¡¤¡ÊTakikawa H¡Ë¡¤¡Ê Kimura W¡Ë¡¤¡ÊUnno M¡Ë¡¤¡ÊYoshida M¡Ë

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤˤª¤±¤ëÆâ»ë¶À¤ÎÌò³ä¤È²ÝÂê
»¨»ï¥¿¥¤¥È¥ë Gastroenterological Endoscopy 61¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 16¡Ý24
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤À¶¿å¹¸Åµ

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤθ½¾õ¤È²ÝÂê
»¨»ï¥¿¥¤¥È¥ë °å³Ø¤Î¤¢¤æ¤ß 268¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 895-899
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ç¹Â¡ÊÔ¡¡¾Ã²½´ïÆâ²Ê°å¤Ëʹ¤¯
»¨»ï¥¿¥¤¥È¥ë ²èÁü¿ÇÃÇ 39¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 492-494
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡Ê³÷ÅÄÉÒʸ¡Ë

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ERCP ´ØÏ¢¡¡¿ÇÃǼ굻¡¡ç¹±ÕºÙ˦¿Ç¡¡¤³¤¦¤¹¤ì¤Ð¾åÈéÆâ´â¤¬È¯¸«¤Ç¤­¤ë
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À 31¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 382-385
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë ²èÁü¿ÇÃÇ ·«¤êÊÖ¤¹ÓÒÅǤθ¶°ø
»¨»ï¥¿¥¤¥È¥ë ÆüËÜ°å»ö¿·Êó 4944
¥Ú¡¼¥¸ÈÖ¹æ 1-2
Ãø¼Ô ¾®ÌîÀîÌ÷Æó
¶¦Ãø ¼µ¸Í¹§¹¥¡¤ÃæÅÚ°æ¹Ý°ì¡¤²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¤ò¤¤¤«¤Ëµ¿¤¦¤«¡¡ÃåÌܤ¹¤Ù¤­Î×¾²½ê¸«¤«¤éÁá´ü¿ÇÃÇ¥×¥í¥¸¥§¥¯¥È¤ÎºÇÁ°Àþ¤Þ¤Ç
»¨»ï¥¿¥¤¥È¥ë Hospitalist 6¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 754-759
Ãø¼Ô Æî¡¡ÃÒÇ·
¶¦Ãø ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë IPMN ¤Î·Ð²á´Ñ»¡Ë¡¡¡ºÇŬ¤Ê¥â¥À¥ê¥Æ¥£¤È´Ö³Ö¡¤´ü´Ö¤Ï¡©
»¨»ï¥¿¥¤¥È¥ë ÆüËÜ°å»ö¿·Êó 4940
¥Ú¡¼¥¸ÈÖ¹æ 31¡Ý35
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Á´¹ñÄ´ºº¤«¤é¤ß¤¿ SPN ¿ÇÃÇ¡¦¼£ÎŤθ½¶·
»¨»ï¥¿¥¤¥È¥ë ´Î¡¦ÃÀ¡¦ç¹ 77¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1027¡Ý1035
Ãø¼Ô ·ª¸¶·¼²ð
¶¦Ãø ²ÖÅķɻΡ¤Æî¡¡ÃÒÇ·¡¤¡ÊÀа湯δ¡Ë¡¤¡Ê¶ÜÀîÀµ¹À¡Ë

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¤ÎÁá´ü¿ÇÃǤˤª¤±¤ëERCP ¤ÎÍ­ÍÑÀ­
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤Èç¹ 39¡Ê9¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 799¡Ý803
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤À¶¿å¹¸Åµ¡¤Ê¿ÌîµðÄÌ¡¤²£½ÐÀµÎ´¡¤±­»ô½ÓÊ塤ÌðÌîÀ®¼ù¡¤Ê¡¸¶´ð°ô¡¤ÊÒ¼²ÅÃË¡¤¼µ¸Í¹§¹¥¡¤ÃæÅÚ°æ¹Ý°ì¡¤¾¾ËÜ¡¡Ë¾¡¤¾®ÌîÀîÌ÷Æó¡¤Å·Ìî¡¡»Ï¡¤ÆüÌîʸÌÀ

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë À­º¹¤Ë¤è¤ëÎ×¾²Áü¤Îº¹°Û
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤Èç¹ 39¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 547¡Ý551
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤À¶¿å¹¸Åµ¡¤¡Ê´Ý»³¹É»Ì¡Ë¡¤¡Ê¿¹¡¡±Ñµ±¡Ë¡¤Ê¡¸¶´ð°ô¡¤ÌðÌîÀ®¼ù¡¤°ÂÉôÃÒÇ·¡¤Å·Ìî¿ÒĪ¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âupdate ¿ÇÃÇ¡¡Áá´ü¿ÇÃǤؤΥ¢¥×¥í¡¼¥Á
»¨»ï¥¿¥¤¥È¥ë Î×¾²¾Ã²½´ïÆâ²Ê 33¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 807¡Ý810
Ãø¼Ô Æî¡¡ÃÒÇ·
¶¦Ãø ²ÖÅķɻΡ¤Ê¿ÌîµðÄÌ¡¤À¶¿å¹¸Åµ¡¤Ê¡¸¶´ð°ô¡¤ÌðÌîÀ®¼ù

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´üȯ¸«¤Ø¤Î¼è¤êÁȤߡ¡ÃÏ°è°åÎÅÏ¢·È¥·¥¹¥Æ¥à¤Î¹½ÃÛ
»¨»ï¥¿¥¤¥È¥ë ÆüËܾò½´ïɳزñ»¨»ï 115¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 327¡Ý333
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤Æî¡¡ÃÒÇ·

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Efficacy and safety of early cholecystectomy for comorbid acute cholecystitis and acute cholangitis: Retrospective cohort study
»¨»ï¥¿¥¤¥È¥ë Ann Med Surg¡Ê Lond¡Ë38
¥Ú¡¼¥¸ÈÖ¹æ 8-12
Ãø¼Ô Abe T
¶¦Ãø Amano H¡¤ Hanada K¡¤Bekki T¡¤Minami T¡¤Yonehara S¡¤Noriyuki T¡¤Nakahara M

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Outcomes of endoscopic biliary drainage in pancreatic cancer patients with an indwelling gastroduodenal stent: a multicenter cohort study in West Japan
»¨»ï¥¿¥¤¥È¥ë Gastrointest Endosc 88¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 66-75
Ãø¼Ô Yamao K
¶¦Ãø ¡ÊKitano M¡Ë¡¤¡ÊTakenaka M¡Ë¡¤¡ÊMinaga K¡Ë¡¤¡ÊSakurai T¡Ë¡¤¡ÊWatanabe T¡Ë¡¤¡ÊKayahara T¡Ë¡¤¡ÊYoshikawa T¡Ë¡¤¡ÊYamashita Y¡Ë¡¤¡ÊAsada M¡Ë¡¤¡ÊOkabe Y¡Ë¡¤Hanada K¡¤¡Ê Chiba Y¡Ë¡¤¡ÊKudo M¡Ë

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Roles of ERCP in the Early Diagnosis of Pancreatic Cancer
»¨»ï¥¿¥¤¥È¥ë Diagnostics¡Ê Basel¡Ë
¥Ú¡¼¥¸ÈÖ¹æ pii: E30¡¥doi: 10¡¥3390/diagnostics9010030
Ãø¼Ô Hanada K
¶¦Ãø Minami T¡¤Shimizu A¡¤Fukuhara M¡¤Yano S¡¤Sasaki K¡¤Koda M¡¤Sugiyama K¡¤Yonehara S¡¤¡ÊYanagisawa A¡Ë

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2019
ÏÀʸ¥¿¥¤¥È¥ë Advances in Early Detection of Pancreatic Cancer
»¨»ï¥¿¥¤¥È¥ë Diagnostics¡ÊBasel¡Ë9¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ pii: E18¡¥doi: 10¡¥3390/diagnostics9010018
Ãø¼Ô Kanno A
¶¦Ãø ¡ÊMasamune A¡Ë¡¤Hanada K¡¤¡ÊKikuyama M¡Ë¡¤¡ÊKitano M¡Ë

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë New Model for Predicting Malignancy in Patients With Intraductal Papillary Mucinous Neoplasm
»¨»ï¥¿¥¤¥È¥ë Ann Surg
¥Ú¡¼¥¸ÈÖ¹æ doi: 10¡¥1097/SLA¡¥0000000000003108¡¥¡ÎEpub ahead of print¡Ï
Ãø¼Ô Shimizu Y
¶¦Ãø ¡ÊHijioka S¡Ë¡¤¡ÊHirono S¡Ë¡¤¡ÊKin T¡Ë¡¤¡ÊOhtsuka T¡Ë¡¤¡ÊKanno A¡Ë¡¤¡ÊKoshita S¡Ë¡¤Hanada K¡¤¡ÊKitano M¡Ë¡¤¡ÊInoue H¡Ë¡¤¡ÊItoi T¡Ë¡¤¡ÊUeki T¡Ë¡¤¡ÊMatsuo K¡Ë¡¤¡ÊYanagisawa A¡Ë¡¤¡ÊYamaue H¡Ë¡¤¡Ê Sugiyama M¡Ë¡¤¡ÊOkazaki K¡Ë¡¥

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Preoperative neutrophil-to-lymphocyte ratio as a prognosticator in early stage pancreatic ductal adenocarcinoma
»¨»ï¥¿¥¤¥È¥ë Eur J Surg Oncol 44¡Ê10¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1573¡Ý1579
Ãø¼Ô Abe T¡¤
¶¦Ãø Amano H¡¤¡ÊKobayashi T¡Ë¡¤Hanada K¡¤Nakahara M¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Clinical and Pathological Features of Solid Pseudopapillary Neoplasms of the Pancreas
»¨»ï¥¿¥¤¥È¥ë Pancreas 47¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1019¡Ý1026
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊKurihara K¡Ë¡¤¡ÊItoi T¡Ë¡¤¡ÊKatanuma A¡Ë¡¤¡ÊSasaki T¡Ë¡¤¡ÊHara K¡Ë¡¤¡ÊNakamura M¡Ë¡¤¡ÊKimura W¡Ë¡¤¡ÊSuzuki Y¡Ë¡¤¡ÊSugiyama M¡Ë¡¤¡ÊOhike N¡Ë¡¤¡ÊFukushima N¡Ë¡¤¡ÊShimizu M¡Ë¡¤¡ÊIshigami K¡Ë¡¤¡Ê Gabata T¡Ë¡¤¡ÊOkazaki K¡Ë¡¥

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë A Prospective Multicenter Study of a Fully Covered Metal Stent in Patients with Distal Malignant Biliary Obstruction: WATCH-2 Study
»¨»ï¥¿¥¤¥È¥ë Dig Dis Sci 63¡Ê9¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 2466¡Ý2473
Ãø¼Ô Kogure H
¶¦Ãø ¡ÊRyozawa S¡Ë¡¤¡ÊMaetani I¡Ë¡¤¡ÊNakai Y¡Ë¡¤¡ÊKawakami H¡Ë¡¤¡ÊYasuda I¡Ë¡¤¡ÊMochizuki H¡Ë¡¤¡ÊIwano H¡Ë¡¤¡ÊMaguchi H¡Ë¡¤¡ÊKida M¡Ë¡¤¡ÊKubota K¡Ë¡¤¡ÊMukai T¡Ë¡¤¡ÊHasebe O¡Ë¡¤¡ÊIgarashi Y¡Ë¡¤Hanada K¡¤¡ÊIrisawa A¡Ë¡¤¡ÊIto K¡Ë¡¤¡ÊItoi T¡Ë¡¤¡ÊIsayama H¡Ë¡¥

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë A case of mixed adenoneuroendocrine carcinoma of the pancreas mimicking intraductal papillary mucinous carcinoma.
»¨»ï¥¿¥¤¥È¥ë Clin J Gastroenterol 11¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 320¡Ý326
Ãø¼Ô Mori H
¶¦Ãø Hanada K¡¤Minami T¡¤Yano S¡¤Fukuhara M¡¤¡ÊMaruyama H¡Ë¡¤Shimizu A¡¤Hirano N¡¤Hino F¡¤Amano H¡¤Yonehara S

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Metachronous triple cancer associated with Peutz-Jeghers syndrome treated with curative surgery: a case report.
»¨»ï¥¿¥¤¥È¥ë Surg Case Rep 4¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 84
Ãø¼Ô Yoshikawa T
¶¦Ãø Abe T¡¤Amano H¡¤Hanada K¡¤Minami T¡¤¡ÊKobayashi T¡Ë¡¤Yonehara S¡¤Nakahara M¡¤¡Ê Ohdan H¡Ë¡¤Noriyuki T

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Efficacy of the Gallbladder Cancer Predictive Risk Score Based on Pathological Findings: A Propensity Score-Matched Analysis
»¨»ï¥¿¥¤¥È¥ë Ann Surg Oncol 25¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1699¡Ý1708
Ãø¼Ô Mochizuki T
¶¦Ãø Abe T¡¤Amano H¡¤Hanada K¡¤¡ÊHattori M¡Ë¡¤¡ÊKobayashi T¡Ë¡¤Nakahara M¡¤¡Ê Ohdan H¡Ë¡¤Noriyuki T

!¹¹¿·Æü¡§2021/08/26

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Prospective Follow-up Study of the Recurrence of Pancreatic Cancer Diagnosed at an Early Stage: The Value of Endoscopic Ultrasonography for Early Diagnosis of Recurrence in the Remnant Pancreas
»¨»ï¥¿¥¤¥È¥ë Pancreas
¥Ú¡¼¥¸ÈÖ¹æ 482¡Ý488
Ãø¼Ô Ikemoto J
¶¦Ãø Hanada K¡¢Minami T¡¢¡ÊOkazaki A¡Ë¡¢Abe T¡¢Amano H¡¢Yonehara S

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë A case of cholangiolocellular carcinoma featuring intratumoral hepatic artery penetration: A case report.
»¨»ï¥¿¥¤¥È¥ë Int J Surg Case Rep.¡¡35
¥Ú¡¼¥¸ÈÖ¹æ 77¡Ý81
Ãø¼Ô Abe T
¶¦Ãø ¡ÊYamane H¡Ë¡¤Amano H¡¤¡ÊKobayashi T¡Ë¡¤Hanada K, Yonehara S¡¤¡ÊOhdan H¡Ë¡¤Nakahara M¡¤Noriyuki T.

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Early diagnosis of pancreatic cancer
»¨»ï¥¿¥¤¥È¥ë Annals of Gastroenterological Surgery¡¡1
¥Ú¡¼¥¸ÈÖ¹æ 44¡Ý51
Ãø¼Ô K Hanada
¶¦Ãø H Amano¡¤T Abe

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia¡Ê HG-PanIN¡Ë reveal paucity of alterations in TP53 and SMAD4.
»¨»ï¥¿¥¤¥È¥ë J Pathol.¡¡242¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 16¡Ý23
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊHosoda W¡Ë¡¤¡ÊChianchiano P¡Ë¡¤¡ÊGriffin JF¡Ë¡¤¡ÊPittman ME¡Ë¡¤¡ÊBrosens LA¡Ë¡¤¡ÊNo? M¡Ë¡¤¡ÊYu J¡Ë¡¤¡ÊShindo K¡Ë¡¤¡ÊSuenaga M¡Ë¡¤¡ÊRezaee N¡Ë¡¤¡ÊYonescu R¡Ë¡¤¡ÊNing Y¡Ë¡¤¡ÊAlbores-Saavedra J¡Ë¡¤¡ÊYoshizawa N¡Ë¡¤¡ÊHarada K¡Ë¡¤¡ÊYoshizawa A¡Ë¡¤Yonehara S¡¤¡ÊShimizu M¡Ë¡¤¡ÊSamra JS¡Ë¡¤¡ÊGill AJ¡Ë¡¤¡ÊWolfgang CL¡Ë¡¤¡ÊGoggins MG¡Ë¡¤¡ÊHruban RH¡Ë¡¤¡ÊWood LD¡Ë

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Clinical Practice Guidelines for Pancreatic Cancer 2016 From the Japan Pancreas Society: A Synopsis.
»¨»ï¥¿¥¤¥È¥ë Pancreas.¡¡46¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 595¡Ý604
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊYamaguchi K¡Ë¡¤¡ÊOkusaka T¡Ë¡¤¡ÊShimizu K¡Ë¡¤¡ÊFuruse J¡Ë¡¤¡ÊIto Y¡Ë¡¤¡ÊShimosegawa T¡Ë¡¤Okazaki K; Committee for Revision of Clinical Guidelines for Pancreatic Cancer of the Japan Pancreas Society.

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Mixed adenoneuroendocrine carcinoma derived from the cystic duct: A case report.
»¨»ï¥¿¥¤¥È¥ë Int J Surg Case Rep.¡¡39
¥Ú¡¼¥¸ÈÖ¹æ 29¡Ý33
Ãø¼Ô Abe T
¶¦Ãø ¡ÊTakemoto YK¡Ë¡¤Amano H¡¤Hanada K¡¤Okazaki A¡¤Minami T¡¤¡ÊKobayashi T¡Ë¡¤Nakahara M¡¤Yonehara S¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Propensity score-matching analysis of the efficacy of late cholecystectomy for acute cholecystitis.
»¨»ï¥¿¥¤¥È¥ë Am J Surg.¡¡214¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 262¡Ý266
Ãø¼Ô Abe T
¶¦Ãø ¡ÊTakemoto YK¡Ë¡¤Amano H¡¤Hanada K¡¤Fujikuni N¡¤¡ÊYoshida M¡Ë¡¤¡ÊKobayashi T¡Ë¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T¡¤Nakahara M

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Nationwide epidemiological survey of early chronic pancreatitis in Japan.
»¨»ï¥¿¥¤¥È¥ë J Gastroenterol.¡¡52¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 992¡Ý1000
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊMasamune A¡Ë¡¤¡ÊKikuta K¡Ë¡¤¡ÊNabeshima T¡Ë¡¤¡ÊNakano E¡Ë¡¤¡ÊHirota M¡Ë¡¤¡ÊKanno A¡Ë¡¤¡ÊKume K¡Ë¡¤¡ÊHamada S¡Ë¡¤¡ÊIto T¡Ë¡¤¡ÊFujita M¡Ë¡¤¡ÊIrisawa A¡Ë¡¤¡ÊNakashima M¡Ë¡¤¡ÊEguchi T¡Ë¡¤¡ÊKato R¡Ë¡¤¡ÊInatomi O¡Ë¡¤¡ÊShirane A¡Ë¡¤¡ÊTakeyama Y¡Ë¡¤¡ÊTsuji I¡Ë¡¤¡ÊShimosegawa T¡Ë

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Clinical practice guideline for post-ERCP pancreatitis.
»¨»ï¥¿¥¤¥È¥ë J Gastroenterol.¡¡52¡Ê9¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1013¡Ý1022
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊMine T¡Ë¡¤¡ÊMorizane T¡Ë¡¤¡ÊKawaguchi Y¡Ë¡¤¡ÊAkashi R¡Ë¡¤¡ÊIto T¡Ë¡¤¡ÊKanno A¡Ë¡¤¡ÊKida M¡Ë¡¤¡ÊMiyagawa H¡Ë¡¤¡ÊYamaguchi T¡Ë¡¤¡ÊMayumi T¡Ë¡¤¡ÊTakeyama Y¡Ë¡¤¡ÊShimosegawa T¡Ë

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Acute pancreatitis-onset carcinoma in situ of the pancreas with focal fat replacement diagnosed using serial pancreatic-juice aspiration cytologic examination¡Ê SPACE¡Ë.
»¨»ï¥¿¥¤¥È¥ë Clin J Gastroenterol.¡¡10¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 541¡Ý545
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊSatoh T¡Ë¡¤¡ÊKikuyama M¡Ë¡¤¡ÊKawaguchi S¡Ë¡¤¡ÊKanemoto H¡Ë¡¤¡ÊMuro H¡Ë

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Impact of comorbidities on the postoperative outcomes of acute cholecystitis following early cholecystectomy.
»¨»ï¥¿¥¤¥È¥ë Surg Today.¡¡47¡Ê10¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1230¡Ý1237
Ãø¼Ô Abe T
¶¦Ãø ¡ÊSaito R¡Ë¡¤Hanada K¡¤Minami T¡¤Fujikuni N¡¤¡ÊKobayashi T¡Ë¡¤Amano H¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T¡¤Nakahara M

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Perioperative Red Blood Cell Transfusion Is Associated with Poor Long-term Survival in Pancreatic Adenocarcinoma.
»¨»ï¥¿¥¤¥È¥ë Anticancer Res.¡¡37¡Ê10¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 5863¡Ý5870
Ãø¼Ô Abe T
¶¦Ãø Amano H¡¤Hanada K¡¤Minami T¡¤Yonehara S¡¤¡ÊHattori M¡Ë¡¤¡ÊKobayashi T¡Ë¡¤¡ÊFukuda T¡Ë¡¤Nakahara M¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë A Prospective Multicenter Study of a Fully Covered Metal Stent in Patients with Distal Malignant Biliary Obstruction: WATCH-2 Study.
»¨»ï¥¿¥¤¥È¥ë Dig Dis Sci.¡¡doi
¥Ú¡¼¥¸ÈÖ¹æ 10.1007/s10620-017-4875-5
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊKogure H¡Ë¡¤¡ÊRyozawa S¡Ë¡¤¡ÊMaetani I¡Ë¡¤¡ÊNakai Y¡Ë¡¤¡ÊKawakami H¡Ë¡¤¡ÊYasuda I¡Ë¡¤¡ÊMochizuki H¡Ë¡¤¡ÊIwano H¡Ë¡¤¡ÊMaguchi H¡Ë¡¤¡ÊKida M¡Ë¡¤¡ÊKubota K¡Ë¡¤¡ÊMukai T¡Ë¡¤¡ÊHasebe O¡Ë¡¤¡ÊIgarashi Y¡Ë¡¤¡ÊIrisawa A¡Ë¡¤¡ÊIto K¡Ë¡¤¡ÊItoi T¡Ë¡¤¡ÊIsayama H¡Ë

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Multicenter study of early pancreatic cancer in Japan.
»¨»ï¥¿¥¤¥È¥ë Pancreatology.¡¡18¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 61¡Ý67
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊKanno A¡Ë¡¤¡ÊMasamune A¡Ë¡¤¡ÊMaguchi H¡Ë¡¤¡ÊShimizu Y¡Ë¡¤¡ÊUeki T¡Ë¡¤¡ÊHasebe O¡Ë¡¤¡ÊOhtsuka T¡Ë¡¤¡ÊNakamura M¡Ë¡¤¡ÊTakenaka M¡Ë¡¤¡ÊKitano M¡Ë¡¤¡ÊKikuyama M¡Ë¡¤¡ÊGabata T¡Ë¡¤¡ÊYoshida K¡Ë¡¤¡ÊSasaki T¡Ë¡¤¡ÊSerikawa M¡Ë¡¤¡ÊFurukawa T¡Ë¡¤¡ÊYanagisawa A¡Ë¡¤¡ÊShimosegawa T¡Ë

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë International study of endoscopic management of distal malignant biliary obstruction combined with duodenal obstruction.
»¨»ï¥¿¥¤¥È¥ë Scand J Gastroenterol.¡¡53¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 46¡Ý55
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊHamada T¡Ë¡¤¡ÊNakai Y¡Ë¡¤¡ÊLau JY¡Ë¡¤¡ÊMoon JH¡Ë¡¤¡ÊHayashi T¡Ë¡¤¡ÊYasuda I¡Ë¡¤¡ÊHu B¡Ë¡¤¡ÊSeo DW¡Ë¡¤¡ÊKawakami H¡Ë¡¤¡ÊKuwatani M¡Ë¡¤¡ÊKatanuma A¡Ë¡¤¡ÊKitano M¡Ë¡¤¡ÊRyozawa S¡Ë¡¤¡ÊIwashita T¡Ë¡¤¡ÊIto Y¡Ë¡¤¡ÊYagioka H¡Ë¡¤¡ÊTogawa O¡Ë¡¤¡ÊMaetani I¡Ë¡¤¡ÊIsayama H¡Ë

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Outcomes of endoscopic biliary drainage in pancreatic cancer patients with an indwelling gastroduodenal stent: a multicenter cohort study in West Japan.
»¨»ï¥¿¥¤¥È¥ë Gastrointest Endosc.¡¡ Doi
¥Ú¡¼¥¸ÈÖ¹æ 10.1016/j.gie.2018.01.021
Ãø¼Ô Hanada K
¶¦Ãø ¡ÊYamao K¡Ë¡¤¡ÊKitano M¡Ë¡¤¡ÊTakenaka M¡Ë¡¤¡ÊMinaga K¡Ë¡¤¡ÊSakurai T¡Ë¡¤¡ÊWatanabe T¡Ë¡¤¡ÊKayahara T¡Ë¡¤¡ÊYoshikawa T¡Ë¡¤¡ÊYamashita Y¡Ë¡¤¡ÊAsada M¡Ë¡¤¡ÊOkabe Y¡Ë¡¤¡ÊChiba Y¡Ë¡¤¡ÊKudo M¡Ë

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Visceral Adipose Tissue and Skeletal Muscle Index Distribution Predicts Severe Pancreatic Fistula Development After Pancreaticoduodenectomy
»¨»ï¥¿¥¤¥È¥ë Anticancer Res.¡¡38¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1061¡Ý1066
Ãø¼Ô Abe T
¶¦Ãø ¡ÊYamane H¡Ë¡¤Amano H¡¤Hanada K¡¤Minami T¡¤¡ÊKobayashi T¡Ë¡¤¡ÊFukuda T¡Ë¡¤Yonehara S¡¤Nakahara M¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë A case of mixed adenoneuroendocrine carcinoma of the pancreas mimicking intraductal papillary mucinous carcinoma.
»¨»ï¥¿¥¤¥È¥ë Clin J Gastroenterol.¡¡Doi
¥Ú¡¼¥¸ÈÖ¹æ 10.1007/s12328-018-0833-9
Ãø¼Ô Mori H
¶¦Ãø Hanada K¡¤Minami T¡¤Yano S¡¤Fukuhara M¡¤Maruyama H¡¤Shimizu A¡¤Hirano N¡¤Hino F¡¤Amano H¡¤Yonehara S

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë IPMN ¤ò¤É¤¦¿Ç¤ë¤«¡¡GNAS °äÅÁ»Ò¤Ë¾ÇÅÀ¤ò¤¢¤Æ¤Æ
»¨»ï¥¿¥¤¥È¥ë ´Î¡¦ÃÀ¡¦ç¹¡¡74¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 627?644
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡Ê¿ÅÄ¡¡Ì­¡Ë¡¤¡Ê¸ÅÀî¡¡Å°¡Ë¡¤¡ÊÂçÄÍδÀ¸¡Ë

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤؤÎÀïά
»¨»ï¥¿¥¤¥È¥ë °å³Ø¤Î¤¢¤æ¤ß¡¡261¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 95?99
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ÃÀÆ»ÉÂÊѤˤª¤±¤ëĶ²»ÇÈÆâ»ë¶À¥¬¥¤¥É²¼Àü»ÉµÛ°úºÙ˦¿Ç¡ÊEUS-FNA¡Ë¤ÎÍ­ÍÑÀ­¡Ê2018ǯÅÙÆüËÜÃÀÆ»³Ø²ñ¾Þ¼õ¾Þ¡Ë
»¨»ï¥¿¥¤¥È¥ë ÃÀÆ»¡¡31¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 196¡Ý204
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊÃÓËܼî轡ˡ¤Æî¡¡ÃÒÇ·

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ·ÐÆýƬŪÃÀ´É¡¦ç¹´ÉÀ¸¸¡¤ÈºÙ˦¿Ç
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À¡¡29¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 847¡Ý852
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤¡ÊÃÓËܼî轡ˡ¤Ê¡¸¶´ð°ô¡¤Ê¿ÌîµðÄÌ¡¤º´¡¹ÌÚ·ò»Ê¡¤¿ù»³²ÂÂ塤¿ÀÅÄ¿¿µ¬¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ¹Å²½À­ÃÀ´É±ê¤Î´ÕÊÌ¿ÇÃǤˤª¤±¤ëEUS ¤Î°ÌÃÖÉÕ¤±
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡38¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 563¡Ý567
Ãø¼Ô Æî¡¡ÃÒÇ·
¶¦Ãø ²ÖÅķɻΡ¤Ê¿ÌîµðÄÌ¡¤¡ÊÃÓËܼî轡ˡ¤Ê¡¸¶´ð°ô

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë µÞÀ­ç¹±ê
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ï¤ÎÎ×¾²¡¡20¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 173¡Ý179
Ãø¼Ô Æî¡¡ÃÒÇ·
¶¦Ãø ²ÖÅķɻΡ¤Ê¿ÌîµðÄÌ¡¤À¶¿å¾´Åµ¡¤´Ý»³¹É»Ì¡¤¿¹¡¡±Ñµ±¡¤ÌðÌîÀ®¼ù

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ÃÏ°èÏ¢·È¤Ë¤è¤ëÁá´üç¹´â¤Î¿ÇÃǤˤĤ¤¤Æ
»¨»ï¥¿¥¤¥È¥ë Î×ாò½´ïÆâ²Ê¡¡31¡Ê13¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1735¡Ý1741
Ãø¼Ô Æî¡¡ÃÒÇ·
¶¦Ãø ²ÖÅķɻΡ¤Ê¿ÌîµðÄÌ¡¤²¬ºê¾´¿Î¡¤ÃÓËܼî轡¤Ê¡¸¶´ð°ô

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë 繤¬¤óÁá´üȯ¸«¤Î¥Ý¥¤¥ó¥È
»¨»ï¥¿¥¤¥È¥ë Î×தȸ¦µæ¡¡94¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 653¡Ý657
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊÃÓËܼî轡ˡ¤Æî¡¡ÃÒÇ·

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ¤³¤ì¤À¤±¤ÏÃΤäƤª¤­¤¿¤¤EUS ½Ñ¼Ô¤È¤·¤Æ¤Î¿´ÆÀ¡Ý¾åã¤Î¤¿¤á¤Î1st ¥¹¥Æ¥Ã¥×
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À¡¡29¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1105¡Ý1107
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊÃÓËܼî轡ˡ¤Æî¡¡ÃÒÇ·

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ¥¬¥¤¥É¥é¥¤¥ó¤Ë´ð¤Å¤¤¤¿¼ÂÃÏ°å²È¤Î¤¿¤á¤Î¥ª¡¼¥Ð¡¼¥Ó¥å¡¼¡¡ç¹´âÁá´ü¿ÇÃǤȼ£ÎŤοÊÊâ¡¡ç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó¤Î²þÄû
»¨»ï¥¿¥¤¥È¥ë Medical Practice¡¡34¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1084¡Ý1091
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ç¹¾åÈéÆâ´â½Ñ¸å¤Ë»Äç¹´â¤òǧ¤á»Äç¹Á´Å¦½Ñ¤ò»Ü¹Ô¤·¤¿£²Îã
»¨»ï¥¿¥¤¥È¥ë Gastroenterological Endoscopy¡¡59¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1638¡Ý1643
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊÃÓËܼî轡ˡ¤Æî¡¡ÃÒÇ·¡¤Ê¡¸¶´ð°ô¡¤¡Ê²¬ºê¾´¿Î¡Ë¡¤Ê¿ÌîµðÄÌ¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ç¹¾åÈéÆâ´â¤ÎÎ×¾²ÉÂÍý³ØŪÆÃħ
»¨»ï¥¿¥¤¥È¥ë ´Î¡¦ÃÀ¡¦ç¹¡¡75¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 561¡Ý566
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤¡ÊÃÓËÜ ¼î轡ˡ¤Ê¡¸¶´ð°ô¡¤Ê¿ÌîµðÄÌ¡¤º´¡¹ÌÚ·ò»Ê¡¤¿ù»³²ÂÂ塤¿ÀÅÄ¿¿µ¬¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Ê¢ËìÆ©ÀÏÃæ¤Ëç¹¼ðáî¤ò»ØŦ¤µ¤ìĶ²»ÇÈÆâ»ë¶À²¼Àü»ÉµÛ°úË¡¤Ë¤Æç¹´â¤È³ÎÄê¿ÇÃǤ·¤¿£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡70¡Ê10¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 438¡Ý441
Ãø¼Ô Ç𸶺Ìǵ
¶¦Ãø Æî¡¡ÃÒÇ·¡¤¹¾ºê¡¡Î´¡¤¡ÊÂçµ×ÊÝ°¦»Ò¡Ë¡¤Ê¡¸¶´ð°ô¡¤¡ÊÃÓËܼî轡ˡ¤²ÖÅķɻΡ¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ÃÀç¹EUS ¤ò¶Ë¤á¤ë¡Ý»ä¤Ê¤é¤³¤¦¤¹¤ë
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡38
¥Ú¡¼¥¸ÈÖ¹æ 951¡Ý957
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤´Ý»³¹É»Ì¡¤¿¹¡¡±Ñµ±¡¤Ê¡¸¶´ð°ô¡¤ÌðÌîÀ®¼ù¡¤Æî¡¡ÃÒÇ·¡¤º´¡¹ÌÚ·ò»Ê¡¤¿ù»³²ÂÂ塤¿ÀÅÄ¿¿µ¬¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ¹³´âºÞ¤ÎÊѹ¹¤Ë¤è¤ê°ì»þŪ¤ÊÃø¸ú¤ò¼¨¤·¤¿ç¹´â¤Î°ìÎã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡27
¥Ú¡¼¥¸ÈÖ¹æ 47¡Ý52
Ãø¼Ô Ê¡¸¶´ð°ô
¶¦Ãø ¡ÊÀîÌî²ÄÆà»Ò¡Ë¡¤¡Ê²¬ºê¾´¿Î¡Ë¡¤¡ÊÃÓËܼî轡ˡ¤Æî¡¡ÃÒÇ·¡¤²ÖÅķɻΡ¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Áá´ü°ß´â¤ËÂФ¹¤ëÆâ»ë¶À¼£ÎŤθ½¾õ
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡27
¥Ú¡¼¥¸ÈÖ¹æ 17¡Ý20
Ãø¼Ô ÃæÅÚ°æ¹Ý°ì

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë Æâ»ë¶À¼¼¤Î¾Ò²ð
»¨»ï¥¿¥¤¥È¥ë Gastroenterological Endoscopy¡¡60¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 82¡Ý85
Ãø¼Ô ÃæÅÚ°æ¹Ý°ì

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ¿ÇÃÇ¡¡Ä¹´üͽ¸å¤¬´üÂԤǤ­¤ëç¹´â¤Î¿ÇÃǤϤɤ¦¤¹¤ë¤«
»¨»ï¥¿¥¤¥È¥ë ´Î¡¦ÃÀ¡¦ç¹¡¡76¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 367¡Ý372
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø À¶¿å¹¸Åµ¡¤Æî¡¡ÃÒÇ·

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ç¹ÃÀÆ»Îΰè¤Ë¤ª¤±¤ë·ÐÆýƬŪºÙ˦¿Ç¡¦ÁÈ¿¥¿Ç
»¨»ï¥¿¥¤¥È¥ë Gastroenterological Endoscopy¡¡60¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 260¡Ý269
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ¸¶È¯À­¹Å²½À­ÃÀ´É±ê¡ÊPSC¡Ë¤Ë¹çÊ»¤·¤¿ÄÙáçÀ­ÂçIJ±ê
»¨»ï¥¿¥¤¥È¥ë Pharma Medica¡¡36¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 89¡Ý91
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2019/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2018
ÏÀʸ¥¿¥¤¥È¥ë ¶É½ê¿Ê¹ÔÀÚ½üÉÔǽ繴â¤ËÂФ¹¤ëÈóÀÚ½ü¼£ÎÅ¡¡ÀÚ½üÉÔǽ繴â¤Î¾Ã²½´ÉÊĺɤËÂФ¹¤ëÂнèË¡
»¨»ï¥¿¥¤¥È¥ë ´Î¡¦ÃÀ¡¦ç¹¡¡76¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 443?448
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊëºäÍ¥¼ù¡Ë¡¤¡ÊÎÉÂô¾¼Ìáˡ¤¡Ê¿å½Ð²íʸ¡Ë¡¤¡Ê¾®Èª¡¡ÎÏ¡Ë¡¤¡Ê¾®ÎÓÀµÅµ¡Ë¡¤¡ÊÆî¡¡°ìÍΡˡ¤¡ÊÆ£ÅÄ¡¡ÍË¡Ë¡¤¡ÊÅÄÅçÃÎÌÀ¡Ë¡¤¡Ê¹âÎÓ±ÑÆü¸Ê¡Ë¡¤¡Ê¿·°æ¡¡¿¸¡Ë¡¤¡ÊÌîÃ湯°ì¡Ë¡¤¡Ê¿¿²¼Í³Èþ¡Ë¡¤¡Êº´¡¹ÌÚ̱¿Í¡Ë

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¡Ê½é´ü¡Ë
»¨»ï¥¿¥¤¥È¥ë º£Æü¤ÎÎ×¾²¥µ¥Ý¡¼¥È¡¥¥¨¥ë¥»¥Ó¥¢¥¸¥ã¥Ñ¥ó¡¡¥¤¥ó¥¿¡¼¥Í¥Ã¥È½ÐÈÇ
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ¤¹¤¤Â¡¤¬¤ó¤ò¿©¤¤»ß¤á¤í
»¨»ï¥¿¥¤¥È¥ë ¥á¥Ç¥£¥«¥ë¥¸¥ã¡¼¥Ê¥ë¡¡NHK¡Ö¤­¤ç¤¦¤Î·ò¹¯¡×¡¡348
¥Ú¡¼¥¸ÈÖ¹æ 94¡Ý97
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Ķ¹âÎð¼ÔÃÀÆ»´â¤Ë¤ª¤±¤ëÃÀÆ»¥É¥ì¥Ê¡¼¥¸
»¨»ï¥¿¥¤¥È¥ë ´Î¡¦ÃÀ¡¦ç¹¡¡74¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 431¡Ý436
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤Ê¿ÌîµðÄÌ¡¤²¬ºê¾´¿Î¡¤ÃÓËܼî轡¤Ê¡¸¶´ð°ô¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ¿·µ¬·Ð¸ý¹³¶Å¸ÇÌô¡Ênovel oral anticoagulants; NOAC¡Ë¤¬¸¶°ø¤È¹Í¤¨¤é¤ì¤¿collagenous colitis ¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËܾò½´ïɳزñ»¨»ï¡¡114¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 456¡Ý463
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÃÓËܼî轡¤ÃæÅÚ°æ¹Ý°ì¡¤¾®ÌîÀîÌ÷Æó¡¤Ê¡¸¶´ð°ô¡¤¼µ¸Í¹§¹¥¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤθ½¾õ¡¡ç¹´âÁá´ü¿ÇÃǸ¦µæ²ñ¤Ë¤ª¤±¤ë¿»ÜÀ߸¦µæ¤Î·ë²Ì¤ò¤â¤È¤Ë
»¨»ï¥¿¥¤¥È¥ë ç¹Â¡¡¡32¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 16¡Ý22
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡Ê¿ûÌî¡¡ÆØ¡Ë¡¤¡ÊÀµ½¡¡¡½ß¡Ë¡¤¡Ê¿¿¸ý¹¨²ð¡Ë,¡ÊÀ¶¿åÂÙÇî¡Ë¡¤¡Ê¿¢ÌÚÉÒÀ²¡Ë¡¤¡ÊĹëÉô½¤¡Ë¡¤¡ÊÂçÄÍδÀ¸¡Ë¡¤¡Ê Ãæ¼²í»Ë¡Ë¡¤¡ÊÃÝÃæ¡¡´°¡Ë¡¤¡ÊËÌÌî²íÇ·¡Ë¡¤¡ÊµÆ»³ÀµÎ´¡Ë¡¤¡Ê³÷ÅÄÉÒʸ¡Ë¡¤¡ÊµÈÅĹÀ»Ê¡Ë¡¤¡Ê º´¡¹ÌÚ̱¿Í¡Ë¡¤¡Ê¶ÜÀîÀµ¹À¡Ë¡¤¡Ê¸ÅÀî¡¡Å°¡Ë¡¤¡ÊÌøß·¾¼Éסˡ¤¡Ê²¼À¥ÀîÅ°¡Ë¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë ç¹¾åÈéÆâ´â¤Î¿ÇÃÇ
»¨»ï¥¿¥¤¥È¥ë ç¹Â¡¡¡32¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 50-55
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤Ê¿ÌîµðÄÌ¡¤²¬ºê¾´¿Î¡¤ÃÓËܼî轡¤Ê¡¸¶´ð°ô¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¤ÎÁá´üȯ¸«¡¡´í¸±°ø»Ò¤òÊ£¿ôÍ­¤¹¤ë¾ÉÎã¤Ë¤ÏÏ¢·È»ÜÀߤ¬ÀѶËŪ¤ËÊ¢ÉôĶ²»ÇÈ¡ÊUS¡Ë¤ò»Ü¹©¤·¡¤ÉÂÊѤ¬¤¢¤ì¤ÐÃæ³Ëɱ¡¤¬Àººº¤¹¤ë
»¨»ï¥¿¥¤¥È¥ë ÆüËÜ°å»ö¿·Êó¡¡¡Ê4799¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 54-55
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡Ê¸Þ½½Íòµ×¿Í¡Ë

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë 繤¬¤ó
»¨»ï¥¿¥¤¥È¥ë Æü·Ð¥á¥Ç¥£¥«¥ëCancerReview Winter
¥Ú¡¼¥¸ÈÖ¹æ 10-14
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ç¹Â¡¤¬¤óÁá´üȯ¸«¤Ø¤Î¥¢¥×¥í¡¼¥Á
»¨»ï¥¿¥¤¥È¥ë SRL ÊõÈ¡¡¡Ê̺ý
¥Ú¡¼¥¸ÈÖ¹æ 6¡Ý12
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë É¿ÇÏ¢·È¤ò´ð¼´¤È¤·¤¿ç¹´âÁá´ü¿ÇÃÇ
»¨»ï¥¿¥¤¥È¥ë ÆüËÜ°å»ö¿·Êó¡¡4832
¥Ú¡¼¥¸ÈÖ¹æ 41¡Ý46
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø µÜÌîÎÉδ¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ÃÏ°èÏ¢·È¤Ë¤è¤ëÁá´üç¹´â¤Î¿ÇÃǤˤĤ¤¤Æ
»¨»ï¥¿¥¤¥È¥ë Î×ாò½´ïÆâ²Ê¡¡31¡Ê13¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1735¡Ý1741
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤Ê¿ÌîµðÄÌ¡¤²¬ºê¾´¿Î¡¤ÃÓËܼî轡¤Ê¡¸¶´ð°ô¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ERCP ´ØÏ¢¼êµ»ÊÔ¡¡¥È¥é¥Ö¥ë¥·¥å¡¼¥Æ¥£¥ó¥°¡¡ERCP ¸åç¹±ê¤Ø¤ÎÂнè¤ÈͽËÉ
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡37
¥Ú¡¼¥¸ÈÖ¹æ 1295¡Ý1300
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊÀî¸ýµÁÌÀ¡Ë¡¤¡ÊÌÀÀÐδµÈ¡Ë¡¤¡Ê°ËƣŴ±Ñ¡Ë¡¤¡ÊÌÚÅĸ÷¹­¡Ë¡¤¡Ê¿ûÌî¡¡ÆØ¡Ë¡¤¡ÊµÜÀǷ¡Ë¡¤¡Ê¿¹ÕéÉÒÉסˡ¤¡Ê»³¸ýÉð¿Í¡Ë¡¤¡ÊÃÝ»³µ¹Åµ¡Ë¡¤¡Ê¿¿µÝ½Óɧ¡Ë¡¤¡Ê²¼À¥ÀîÅ°¡Ë¡¤¡ÊÊ÷¡¡Å°ºÈ¡Ë

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ±Ö³Ø¡¡¤È¤¯¤ËIPMN ʻ¸繴â¤Ë¤Ä¤¤¤Æ
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡37¡Ê11¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1437¡Ý1442
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤²¬ºê¾´¿Î¡¤Ê¿ÌîµðÄÌ¡¤ÃÓËܼî轡¤Ê¡¸¶´ð°ô¡¤°ÂÉôÃÒÇ·¡¤Å·Ìî¿ÒĪ¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃÇ¥×¥í¥¸¥§¥¯¥È
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡37
¥Ú¡¼¥¸ÈÖ¹æ 1181¡Ý1186
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤²¬ºê¾´¿Î¡¤Ê¿ÌîµðÄÌ¡¤ÃÓËܼî轡¤Ê¡¸¶´ð°ô¡¤ÆüÌîʸÌÀ¡¤Ë­ÅÄľǷ¡¤°Âͧ͵·Ã¡¤ÈõËܿ𹾡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë EUS-FNA ¸¡ÂΤòÍѤ¤¤¿Ê¬»ÒÀ¸Êª³ØŪ²òÀÏ
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À¡¡28¡Ê10¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1625¡Ý1631
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ²¬ºê¾´¿Î¡¤Æî¡¡ÃÒÇ·¡¤ÃÓËܼî轡¤ÃæÅÚ°æ¹Ý°ì¡¤¼µ¸Í¹§¹¥¡¤ÊÒ¼²ÅÃË¡¤¾®ÌîÀîÌ÷Æó¡¤Ê¿ÌîµðÄÌ¡¤Å·Ìî¡¡»Ï¡¤ÆüÌîʸÌÀ¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤ˸þ¤±¤Æ¤Î²èÁü¤ª¤è¤ÓÉÂÍý½ê¸«
»¨»ï¥¿¥¤¥È¥ë Âè91²óÆüËܾò½´ïÆâ»ë¶À³Ø²ñÁí²ñ¥µ¥Æ¥é¥¤¥È¥»¥ß¥Ê¡¼¡¡¥ª¥ê¥ó¥Ñ¥¹
¥Ú¡¼¥¸ÈÖ¹æ 3¡Ý4
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë 繤¬¤ó¤ÎÁá´ü¿ÇÃÇ
»¨»ï¥¿¥¤¥È¥ë ºÇ¿·îгء¡Ê̺ý
¥Ú¡¼¥¸ÈÖ¹æ 103¡Ý104
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ¿»½áÀ­ç¹´É´â¤È¤Î´ÕÊ̤ËÆñ½Â¤·EUS-FNA ¤¬¿ÇÃǤËÍ­ÍѤǤ¢¤Ã¤¿ÇÙÁ£´âç¹Å¾°Ü¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËܾò½´ïɳزñ»¨»ï¡¡113¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1401¡Ý1407
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊÃÝ°æÂçÍ´¡Ë¡¤²¬ºê¾´¿Î¡¤Æî¡¡ÃÒÇ·¡¤ÃÓËܼî轡¤Ê¿ÌîµðÄÌ¡¤¡Ê»û²¬ÍºÍù¡Ë¡¤¡ÊÊ¡ÅÄÉÒ¾¡¡Ë¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤκÇÁ°Àþ
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀç¹¼£ÎŸ¦µæ²ñ»ï¡¡14¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 5¡Ý11
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Æî¡¡ÃÒÇ·¡¤²¬ºê¾´¿Î¡¤¡ÊÀô¡¡ÎÉ´²¡Ë¡¤ÃÓËܼî轡¤¡Ê·ó¸÷¡¡¾¿¡Ë¡¤Ê¿ÌîµðÄÌ¡¤¼µ¸Í¹§¹¥¡¤ÃæÅÚ°æ¹Ý°ì¡¤¾®ÌîÀîÌ÷Æó¡¤ÊÒ¼²ÅÃË¡¤Å·Ìî¡¡»Ï¡¤ÆüÌîʸÌÀ¡¤Å·Ìî¿ÒĪ¡¤°ÂÉôÃÒÇ·¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Áá´üËýÀ­ç¹±ê¤Î¿ÇÃǤȼ£ÎÅ¡¡Ä¶²»ÇÈÆâ»ë¶À¡ÊEUS¡Ë¤Ë¤è¤ëÆÃħŪ¤Ê²èÁü½ê¸«¤È¡¤È¿Éü¤¹¤ë¾åÊ¢ÉôÄËÅù¤ËÃí°Õ¡ÊQ&A¡Ë
»¨»ï¥¿¥¤¥È¥ë ÆüËÜ°å»ö¿·Êó¡¤4803
¥Ú¡¼¥¸ÈÖ¹æ 53¡Ý55
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊÆþß·Æƻ֡Ë

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Áá´üËýÀ­ç¹±ê¤ÎĹ´ü·Ð²á´Ñ»¡¤«¤é¤ß¤¿ç¹´âȯÀ¸¤Î²ÄǽÀ­¤Ë¤Ä¤¤¤Æ
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡37¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 399¡Ý407
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ²¬ºê¾´¿Î¡¤ÃÓËܼî轡¤¡Ê·ó¸÷¡¡¾¿¡Ë¡¤¡ÊÀô¡¡ÎÉ´²¡Ë¡¤Æî¡¡ÃÒÇ·¡¤ÃæÅÚ°æ¹Ý°ì¡¤¼µ¸Í¹§¹¥¡¤ÊÒ¼²ÅÃË¡¤¾®ÌîÀîÌ÷Æó¡¤Ê¿ÌîµðÄÌ¡¤Å·Ìî¡¡»Ï¡¤ÆüÌîʸÌÀ¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ERCP ¸åç¹±ê
»¨»ï¥¿¥¤¥È¥ë Î×¾²¾Ã²½´ïÆâ²Ê¡¡31¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 579¡Ý584
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡Ê Ê÷¡¡Å°ºÈ¡Ë¡¤¡ÊÌÀÀÐδµÈ¡Ë¡¤¡ÊÀî¸ýµÁÌÀ¡Ë¡¤¡ÊÌÚÅĸ÷¹°¡Ë¡¤¡Ê°ËƣŴ±Ñ¡Ë¡¤¡Ê»³¸ýÉð¿Í¡Ë¡¤¡ÊµÜÀî¡¡¹¨¡Ë¡¤¡Ê¿ûÌî¡¡ÆØ¡Ë¡¤¡Ê¿¹ÕéÉÒÉסˡ¤¡ÊÃÝ»³µ¹Åµ¡Ë¡¤¡Ê²¼À¥ÀîÅ°¡Ë¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Genetic analyses of isolated high-grade pancreatic intraepithelial neoplasia¡Ê HG-PanIN¡Ë reveal paucity of alterations in TP53 and SMAD4.
»¨»ï¥¿¥¤¥È¥ë J Pathol.¡¡242¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 16¡Ý23
Ãø¼Ô Hanada K
¶¦Ãø ¡Ê Hosoda W¡Ë¡¤¡ÊChianchiano P¡Ë¡¤¡ÊGriffin JF¡Ë¡¤¡ÊPittman ME¡Ë¡¤¡ÊBrosens LA¡Ë¡¤¡ÊNoe M¡Ë¡¤¡ÊYu J¡Ë,¡ÊShindo K¡Ë¡¤¡ÊSuenaga M¡Ë¡¤¡ÊRazaee N¡Ë¡¤¡ÊYonescu R¡Ë¡¤¡ÊNing Y¡Ë¡¤¡ÊAlbores-Saavedra J¡Ë,¡ÊYoshizawa N¡Ë¡¤¡ÊHarada K¡Ë¡¤¡ÊYoshizawa A¡Ë¡¤Yonehara S¡¤¡ÊShimizu M¡Ë¡¤¡ÊUehara T¡Ë¡¤¡ÊSamra JS¡Ë¡¤¡ÊGill AJ¡Ë¡¤¡ÊWolfgang CL¡Ë¡¤¡ÊGoggins MG¡Ë¡¤¡ÊHruban RH¡Ë¡¤¡ÊWood LD¡Ë

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Impact of comorbidities on the postoperative outcomes of acute cholecystitis following early cholecystectomy.
»¨»ï¥¿¥¤¥È¥ë Surg Today.¡¡doi
¥Ú¡¼¥¸ÈÖ¹æ 10.1007/s00595-017-1499-5
Ãø¼Ô Abe T
¶¦Ãø ¡ÊSaito R¡Ë¡¤Hanada K¡¤Minami T¡¤Fujikuni N,¡ÊKobayashi T¡Ë¡¤Amano H¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T¡¤Nakahara M.

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Familial pancreatic cancer: Concept¡¤ management and issues.
»¨»ï¥¿¥¤¥È¥ë World J Gastroenterol.¡¡23¡Ê6¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 935¡Ý948
Ãø¼Ô Keiji Hanada
¶¦Ãø ¡Ê Hiroyuki Matsubayashi¡Ë¡¤¡ÊKyoichi Takaori¡Ë¡¤¡ÊChigusa Morizane¡Ë¡¤¡ÊHiroyuki Maguchi¡Ë¡¤¡ÊMasamichi Mizuma¡Ë¡¤¡ÊHideaki Takahashi¡Ë¡¤¡ÊKeita Wada¡Ë¡¤¡ÊHiroko Hosoi¡Ë¡¤¡ÊShinichi Yachida¡Ë¡¤¡ÊMasami Suzuki¡Ë¡¤¡ÊRisa Usui¡Ë¡¤¡ÊToru Furukawa¡Ë¡¤¡ÊJunji Furuse¡Ë¡¤¡ÊTakamitsu Sato¡Ë¡¤¡ÊMakoto Uen¡Ë¡¤¡ÊYoshimi Kiyozumi¡Ë¡¤¡ÊSusumu¡¡Hijioka¡Ë¡¤¡ÊNobumasa Mizuno¡Ë¡¤¡ÊTakeshi Terashima¡Ë¡¤¡ÊMasaki Mizumoto¡Ë¡¤¡ÊYuzo Kodama¡Ë¡¤¡ÊMasako Torishima¡Ë¡¤¡ÊTakahisa Kawaguchi¡Ë¡¤¡ÊReiko Ashida¡Ë¡¤¡ÊMasayuki Kitano¡Ë¡¤Keiji Hanada¡¤¡ÊMasayuki Furukawa¡Ë¡¤¡ÊKen Kawabe¡Ë¡¤¡ÊYoshiyuki Majima¡Ë¡¤¡ÊToru Shimosegawa¡Ë

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Propensity score-matching analysis of the efficacy of late cholecystectomy for acute cholecystitis
»¨»ï¥¿¥¤¥È¥ë Am J Surg.¡¡ Pii
¥Ú¡¼¥¸ÈÖ¹æ S0002-9610¡Ê16¡Ë30527-X. doi
Ãø¼Ô Abe T
¶¦Ãø ¡ÊTakemoto YK¡Ë¡¤Amano H¡¤Hanada K¡¤Fujikuni N¡¤¡ÊYoshida M¡Ë¡¤¡ÊKobayashi T¡Ë¡¤¡ÊOhdan H¡Ë¡¤Noriyuki T¡¤Nakahara M.

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2017
ÏÀʸ¥¿¥¤¥È¥ë Nationwide epidemiological survey of early chronic pancreatitis in Japan.
»¨»ï¥¿¥¤¥È¥ë J Gastroenterol.¡¡
¥Ú¡¼¥¸ÈÖ¹æ 10.1007/s00535-017-1311-8
Ãø¼Ô Hanada K
¶¦Ãø ¡Ê Masamune A¡Ë¡¤¡ÊKikuta K¡Ë¡¤¡ÊNabeshima T¡Ë¡¤¡ÊNakano E¡Ë¡¤¡ÊHirota M¡Ë¡¤¡ÊKanno A¡Ë¡¤¡ÊKume K¡Ë¡¤¡ÊHamada S¡Ë¡¤¡ÊIto ¡Ë¡¤¡Ê Fujita M¡Ë¡¤¡ÊIrisawa A¡Ë¡¤¡ÊNakashima M¡Ë¡¤¡ÊEguchi T¡Ë¡¤¡ÊKato R¡Ë¡¤¡Ê Inatomi O¡Ë¡¤¡ÊShirane A¡Ë¡¤¡ÊTakeyama Y¡Ë¡¤¡ÊTsuji I¡Ë,¡ÊShimosegawa T¡Ë¡¨ Research Committee of Intractable Pancreatic Diseases in Japan.

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Methotrexate-associated primary hepatic malignant lymphoma following hepatectomy: A case report.
»¨»ï¥¿¥¤¥È¥ë Int J Surg Case Rep.¡¡31
¥Ú¡¼¥¸ÈÖ¹æ 5¡Ý9
Ãø¼Ô Abe T
¶¦Ãø ¡Ê Takei D¡Ë¡¤Abe T¡¤Amano H¡¤Hirano N¡¤¡ÊKobayashi T¡Ë¡¤¡ÊOhdan H¡Ë¡¤¡ÊKondo T¡Ë¡¤Nakahara M¡¤Noriyuki T.

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Diagnostic and Therapeutic Endoscopic Retrograde Cholangiography Using a Short-Type Double-Balloon Endoscope in Patients With Altered Gastrointestinal Anatomy: A Multicenter Prospective Study in Japan.
»¨»ï¥¿¥¤¥È¥ë Am J Gastroenterol.¡¡111¡Ê12¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1750¡Ý1758
Ãø¼Ô Hanada K
¶¦Ãø ¡Ê Shimatani M¡Ë¡¤¡ÊHatanaka H¡Ë¡¤¡ÊKogure H¡Ë¡¤¡ÊTsutsumi K¡Ë¡¤¡ÊKawashima H¡Ë¡¤¡ÊMatsuda T¡Ë¡¤¡ÊFujita T¡Ë¡¤¡ÊTakaoka M¡Ë¡¤¡ÊYano T¡Ë¡¤¡ÊYamada A¡Ë¡¤¡ÊKato H¡Ë¡¤¡ÊOkazaki K¡Ë¡¤¡ÊYamamoto H¡Ë¡¤¡ÊIshikawa H¡Ë¡¤¡ÊSugano K¡Ë¡¨Japanese DB-ERC Study Group.

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Asian consensus statements on endoscopic management of walled-off necrosis. Part 2.
»¨»ï¥¿¥¤¥È¥ë J Gastroenterol Hepatol.¡¡31¡Ê9¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1555¡Ý1565
Ãø¼Ô Hanada K
¶¦Ãø Isayama H¡Ë¡¤¡ÊNakai Y¡Ë¡¤¡ÊRerknimitr R¡Ë¡¤¡ÊKhor C¡Ë¡¤¡ÊLau J¡Ë¡¤¡ÊWang HP¡Ë¡¤¡ÊSeo DW¡Ë¡¤¡ÊRatanachu-Ek T¡Ë¡¤¡ÊLakhtakia S¡Ë¡¤¡ÊAng TL¡Ë¡¤¡ÊRyozawa S¡Ë¡¤¡ÊHayashi T¡Ë¡¤¡ÊKawakami H¡Ë¡¤¡ÊYamamoto N¡Ë¡¤¡ÊIwashita T¡Ë¡¤¡ÊItokawa F¡Ë¡¤¡ÊKuwatani M¡Ë¡¤¡ÊKitano M¡Ë¡¤¡ÊKogure H¡Ë¡¤¡ÊHamada T¡Ë¡¤¡ÊPonnudurai R¡Ë¡¤¡ÊMoon JH¡Ë¡¤¡ÊItoi T¡Ë¡¤¡ÊYasuda I¡Ë¡¤¡ÊIrisawa A¡Ë¡¤¡ÊMaetani I¡Ë¡¥

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Asian consensus statements on endoscopic management of walled-off necrosis Part 1: Epidemiology¡¤diagnosis¡¤ and treatment.
»¨»ï¥¿¥¤¥È¥ë J Gastroenterol Hepatol.¡¡31¡Ê9¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1546¡Ý54
Ãø¼Ô Hanada K
¶¦Ãø ¡Ê Isayama H¡Ë¡¤¡ÊNakai Y¡Ë¡¤¡ÊRerknimitr R¡Ë¡¤¡ÊKhor C¡Ë¡¤¡ÊLau J¡Ë¡¤¡ÊWang HP¡Ë¡¤¡ÊSeo DW¡Ë¡¤¡ÊRatanachu-Ek¡Ë¡¤¡ÊLakhtakia S¡Ë¡¤¡ÊAng TL¡Ë¡¤¡ÊRyozawa S¡Ë¡¤¡ÊHayashi T¡Ë¡¤¡ÊKawakami H¡Ë¡¤¡ÊYamamoto N¡Ë¡¤¡ÊIwashita T¡Ë¡¤¡ÊItokawa F¡Ë¡¤¡ÊKuwatani M¡Ë¡¤¡ÊKitano M¡Ë¡¤¡ÊKogure H¡Ë¡¤¡ÊHamada T¡Ë¡¤¡ÊPonnudurai R¡Ë¡¤¡ÊMoon JH¡Ë¡¤¡ÊItoi T¡Ë¡¤¡ÊYasuda I¡Ë¡¤¡ÊIrisawa A¡Ë¡¤¡ÊMaetani I¡Ë

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Preoperative Systemic Inflammation and Complications Affect Long-term Gallbladder CarcinomaOutcomes Following Surgery with Curative Intent.
»¨»ï¥¿¥¤¥È¥ë Anticancer Res.¡¡36¡Ê9¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 4887¡Ý4894
Ãø¼Ô Abe T
¶¦Ãø Amano H¡¤Hanada K¡¤Yonehara S¡¤¡ÊKobayashi T¡Ë¡¤¡ÊFukuda T¡Ë¡¤Nakahara M¡¤Kuroda Y¡¤Noriyuki T.

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë A case report on metastatic pancreatic tumor from pulmonary adenocarcinoma that difficult to differentiate from primary pancreatic ductal carcinoma.
»¨»ï¥¿¥¤¥È¥ë Nihon Shokakibyo Gakkai Zasshi.¡¡113¡Ê8¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1401¡Ý1407
Ãø¼Ô Hanada K
¶¦Ãø ¡Ê Takei D¡Ë¡¤Okazaki A¡¤Minami T¡¤Ikemoto J¡¤Hirano N¡¤¡ÊTeraoka Y¡Ë¡¤¡ÊFukuda T¡Ë¡¤Yonehara S.

!¹¹¿·Æü¡§2018/02/05

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë A spindle cell anaplastic pancreatic carcinoma with rhabdoid features following curative resection.
»¨»ï¥¿¥¤¥È¥ë Mol Clin Oncol.¡¡5¡Ê2¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 327¡Ý330
Ãø¼Ô Abe T
¶¦Ãø Amano H¡¤Hanada K¡¤ Okazaki A¡¤Yonehara S¡¤¡ÊKuranishi F¡Ë¡¤Nakahara M¡¤Kuroda Y¡¤Noriyuki T.

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Clinical usefulness of transabdominal ultrasonography prior to patency capsule for suspected small-bowel strictures.
»¨»ï¥¿¥¤¥È¥ë Scand J Gastroenterol¡¡51¡Ê3¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 281¡Ý287
Ãø¼Ô Hanada K
¶¦Ãø Onogawa S¡¤¡Ê Nakano M¡Ë¡¤¡ÊOka S¡Ë¡¤¡ÊTanaka S¡Ë¡¤¡ÊKunihara S¡Ë¡¤¡ÊIgawa A¡Ë¡¤¡ÊAoyama T¡Ë¡¤¡ÊImagawa H¡Ë¡¤¡ÊUeno Y¡Ë¡¤¡ÊChayama K¡Ë

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Diagnostic and therapeutic single-operator cholangiopancreatoscopy in biliopancreatic diseases: Prospective multicenter study in Japan.
»¨»ï¥¿¥¤¥È¥ë World J Gastroenterol¡¡22¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1891¡Ý1901
Ãø¼Ô Hanada K
¶¦Ãø ¡Ê Kurihara T¡Ë¡¤¡ÊYasuda I¡Ë¡¤¡ÊIsayama H¡Ë¡¤¡ÊTsuyuguchi T¡Ë¡¤¡ÊYamaguchi T¡Ë¡¤¡ÊKawabe K¡Ë¡¤¡ÊOkabe Y¡Ë¡¤¡ÊHayashi T¡Ë¡¤¡ÊOhtsuka T¡Ë¡¤¡ÊOana S¡Ë¡¤¡ÊKawakami H¡Ë¡¤¡ÊIgarashi Y¡Ë¡¤¡ÊMatsumoto K¡Ë¡¤¡ÊTamada K¡Ë¡¤¡ÊRyozawa S¡Ë¡¤¡ÊKawashima H¡Ë¡¤¡ÊOkamoto Y¡Ë¡¤¡ÊMaetani I¡Ë¡¤¡ÊInoue H¡Ë¡¤¡ÊItoi T¡Ë¡¥

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë Follicular cholangitis associated with focal biliary stricture treated with left hepatectomy after 8 years of follow-up: A rare case report.
»¨»ï¥¿¥¤¥È¥ë Mol Clin Oncol.¡¡£´¡Ê1¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 114¡Ý118
Ãø¼Ô Hanada K
¶¦Ãø ¡Ê Saito R¡Ë¡¤¡ÊFukuda T¡Ë¡¤¡ÊAmano H¡Ë¡¤¡ÊNakahara M¡Ë¡¤¡ÊYoshida M¡Ë¡¤¡ÊYamaki M¡Ë¡¤¡ÊYonehara S¡Ë¡¤¡ÊNoriyuki T¡Ë¡¥

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2016
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤκÇÁ°Àþ
»¨»ï¥¿¥¤¥È¥ë SRL ÊõÈ¡¡¡¡¡¡¡36¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 13¡Ý19
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë µÞ®¤Ê·Ð²á¤òé¤Ã¤¿Âà·ÁÀ®ç¹´É´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡25
¥Ú¡¼¥¸ÈÖ¹æ 21¡Ý25
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Ê¿ÌîµðÄÌ¡¤ÊƸ¶½¤¼£¡¤¡ÊÏÂÅĤ¢¤º¤µ¡Ë¡¤¡Ê»û²¬ÍºÍù¡Ë

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë Effective screening for early diagnosis of pancreatic cancer
»¨»ï¥¿¥¤¥È¥ë Best Practice & Research Clinical Gastroenterology¡¡29
¥Ú¡¼¥¸ÈÖ¹æ 929¡Ý939
Ãø¼Ô K. Hanada
¶¦Ãø A. Okazaki¡¤N. Hirano¡¤Y. Izumi¡¤T. Minami¡¤J. Ikemoto¡¤K. Kanemitsu¡¤F. Hino

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë Multicentric solid pseudopapillary neoplasms of the pancreas diagnosed by endoscopic ultrasound-guided fine needle aspiration: a case report
»¨»ï¥¿¥¤¥È¥ë Surg Case Rep.¡¡£±¡Ê1¡Ë
Ãø¼Ô K. Hanada
¶¦Ãø ¡Ê M. Yamaguchi¡Ë¡¤¡ÊT. Fukuda¡Ë¡¤¡ÊM. Nakahara¡Ë¡¤¡ÊM. Amano¡Ë¡¤¡ÊD. Takei¡Ë¡¤¡ÊM. Kawashima¡Ë¡¤¡ÊY. Sumi¡Ë¡¤¡ÊH. Amano¡Ë¡¤¡ÊS. Yonehara¡Ë¡¤¡ÊT. Noriyuki¡Ë¡¥

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ç¹ÂÎÉô¹âÅÙ»éËò½¤òCT ¤Ë¤Æ³Îǧ¤·¤¿ç¹¾åÈéÆâ´â¤Î£³Îã
»¨»ï¥¿¥¤¥È¥ë ç¹Â¡¡¡¡¡¡¡¡¡¡¡30¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 626¡Ý632
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡Ê µÆ»³ÀµÎ´¡Ë¡¤¡Ê¿¢ÌÚÉÒÀ²¡Ë

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ERCP ¸å繱ꥬ¥¤¥É¥é¥¤¥ó
»¨»ï¥¿¥¤¥È¥ë ç¹Â¡¡¡¡¡¡¡¡¡¡¡30¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 541¡Ý584
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡Ê Ê÷¡¡Å°ºÈ¡Ë¡¤¡ÊÌÀÀÐδµÈ¡Ë¡¤¡Ê°ËƣŴ±Ñ¡Ë¡¤¡ÊÀî¸ýµÁÌÀ¡Ë¡¤¡Ê¿ûÌî¡¡ÆØ¡Ë¡¤¡ÊÌÚÅĸ÷¹­¡Ë¡¤¡ÊµÜÀǷ¡Ë¡¤¡Ê»³¸ýÉð¿Í¡Ë¡¤¡Ê¿¹ÕéÉÒÉסˡ¥

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ç¹¼À´µ¤ÎÆâ»ë¶À¿ÇÃÇ¡¦¼£ÎÅUpdate
»¨»ï¥¿¥¤¥È¥ë Rad fan¡¡¡¡¡¡13¡Ê10¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 2-5
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ç¹EUS ÁöººË¡¤Î¥³¥Ä¤ÈÉÁ½Ð¸Â³¦¤Ë¤Ä¤¤¤Æ
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡¡¡¡¡¡¡36¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 633¡Ý638
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Àô¡¡ÎÉ´²¡¤Æî¡¡ÃÒÇ·¡¤ÃÓËܼî轡¤·ó¸÷¡¡¾¿¡¤²¬ºê¾´¿Î¡¥

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ç¹¾åÈéÆâ´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡¡¡68¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 367¡Ý368
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ²¬ºê¾´¿Î¡¤Àô¡¡ÎÉ´²¡¤Ê¿ÌîµðÄÌ¡¤Å·Ìî¡¡»Ï¡¤¾®ÌîÀîÌ÷Æ󡤡ʺ£À¼ù¡Ë¡¤ÃæÅÚ°æ¹Ý°ì¡¤¡Ê»û²¬ÍºÍù¡Ë¡¤ÃÓËܼî轡¤·ó¸÷¡¡¾¿¡¤ÆüÌîʸÌÀ¡¤¡ÊÊ¡ÅÄÉÒ¾¡¡Ë¡¤Å·Ìî¿ÒĪ¡¤ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2017/02/16

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ÀÖ·ìµåÁý¿¾É¤òȼ¤Ã¤¿¥¨¥ê¥¹¥í¥Ý¥¨¥Á¥ó»ºÀ¸¿ÕºÙ˦´â¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡¡¡68¡Ê7¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 380¡Ý385
Ãø¼Ô ¿¹»³¹ÀÇ·
¶¦Ãø ¡ÊµÈÌî´³¾ë¡Ë¡¤ÊƸ¶½¤¼£¡¤Ã渶²í¹À¡¤ÆüÌîʸÌÀ¡¤¿¹¡¡¹À´õ¡¤¡ÊÂçÅijÀÇîʸ)¡¥

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¤ÎÁá´üȯ¸«¤È°åÎÅÏ¢·È
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²
¥Ú¡¼¥¸ÈÖ¹æ 423¡Ý427
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ²¬ºê¾´¿Î¡¤Àô¡¡ÎÉ´²¡¤Ê¿ÌîµðÄÌ

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤκÇÁ°Àþ¡Áç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó²þÄû¤ò¤Õ¤Þ¤¨¤Æ¡Á
»¨»ï¥¿¥¤¥È¥ë ¹­Åç»ÔÆâ²Ê°å²ñÊó
¥Ú¡¼¥¸ÈÖ¹æ 18¡Ý19
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë Diagnostic strategies for early pancreatic cancer
»¨»ï¥¿¥¤¥È¥ë J. Gastroenterol.
¥Ú¡¼¥¸ÈÖ¹æ 147¡Ý154
Ãø¼Ô Hanada K
¶¦Ãø Okazaki A¡¤Hirano N¡¤Izumi Y¡¤Teraoka Y¡¤Ikemoto J¡¤Kanemitsu K¡¤Hino F¡¤Fukuda T¡¤Yonehara S

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë A trial of the use of patency capsules in combination with overnight capsule endoscopy.
»¨»ï¥¿¥¤¥È¥ë Digestion
¥Ú¡¼¥¸ÈÖ¹æ 46¡Ý49
Ãø¼Ô Imagawa H
¶¦Ãø Ikemoto J¡¤Kanemitu K¡¤Teraoka Y¡¤Izumi Y¡¤Nakadoi K¡¤Okazaki A¡¤Katamura Y¡¤Shinzato M¡¤Onogawa S¡¤Hirano N¡¤Hanada K¡¤Amano H¡¤Hino F

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2015
ÏÀʸ¥¿¥¤¥È¥ë Exploring the length of the common channel of pancreaticobiliary maljunction on magnetic resonance cholangiopancreatography.
»¨»ï¥¿¥¤¥È¥ë J. Hepatobiliary Pancreat Sci.
¥Ú¡¼¥¸ÈÖ¹æ 68¡Ý73
Ãø¼Ô ¡Ê Itokawa F¡Ë
¶¦Ãø ¡ÊKamisawa T¡Ë¡¤¡ÊNakano T¡Ë¡¤¡ÊItoi T¡Ë¡¤¡ÊHamada Y¡Ë¡¤¡ÊAndo H¡Ë¡¤¡ÊFujii H¡Ë¡¤¡ÊKoshinaga T¡Ë¡¤¡ÊYoshida H¡Ë¡¤¡ÊTamoto E¡Ë¡¤¡ÊNoda T¡Ë¡¤¡ÊKimura Y¡Ë¡¤¡ÊMaguchi H¡Ë¡¤¡ÊUrushihara N¡Ë¡¤¡ÊHoraguchi J¡Ë¡¤¡ÊMorotomi Y¡Ë¡¤¡ÊSato M¡Ë¡¤Hanada K¡¤¡ÊTanaka M¡Ë¡¤¡ÊTakahashi A¡Ë¡¤¡ÊYamaguchi T¡Ë¡¤¡ÊArai Y¡Ë¡¤¡ÊHoriguchi A¡Ë¡¤¡ÊIgarashi Y¡Ë¡¤¡ÊInui K¡Ë

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤΤ¿¤á¤Î°åÎÅÏ¢·È
»¨»ï¥¿¥¤¥È¥ë CLINICIAN
¥Ú¡¼¥¸ÈÖ¹æ 1173¡Ý1175
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë Treatment outcomes of chemotherapy between unresectable and recurrent biliary tract cancer.
»¨»ï¥¿¥¤¥È¥ë World J Gastroenterol. ¡¡
¥Ú¡¼¥¸ÈÖ¹æ 18452¡Ý18457
Ãø¼Ô ¡Ê Sasaki T¡Ë
¶¦Ãø ¡ÊIsayama H¡Ë¡¤¡ÊNakai Y¡Ë¡¤¡ÊIto Y¡Ë¡¤¡ÊYasuda I¡Ë¡¤¡ÊToda N¡Ë¡¤¡ÊYagioka H¡Ë¡¤¡ÊMatsubara S¡Ë¡¤Hanada K¡¤¡ÊMaguchi H¡Ë¡¤¡ÊKamada H¡Ë¡¤¡ÊHasebe O¡Ë¡¤¡ÊMukai T¡Ë¡¤¡ÊOkabe Y¡Ë¡¤¡ÊMaetani I¡Ë¡¤¡ÊKoike K¡Ë

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó¤Î²þÄû¤ò¤á¤°¤Ã¤Æ¡Ý²½³ØÎÅË¡¤ò´Þ¤á¤Æ¡Ý
»¨»ï¥¿¥¤¥È¥ë ÇðÉ
¥Ú¡¼¥¸ÈÖ¹æ 9·î10Æü
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë Committee for revision of clinical guidelines for pancreatic cancer of Japan Pancreas Society. EBM-based Clinical Guidelines for Pancreatic Cancer
»¨»ï¥¿¥¤¥È¥ë issued by the Japan Pancreas Society: a synopsis.
¥Ú¡¼¥¸ÈÖ¹æ 883¡Ý888
Ãø¼Ô ¡Ê Yamaguchi K¡Ë
¶¦Ãø ¡ÊOkusaka T¡Ë¡¤¡ÊShimizu K¡Ë¡¤¡ÊFuruse J¡Ë¡¤¡ÊIto Y¡Ë¡¤Hanada K¡¤¡ÊShimosegawa T¡Ë

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤˤª¤±¤ëEUS ¤ÎÌò³ä¤È¼ÂºÝ¡Ýç¹¾åÈéÆâ´â¤Ï¿ÇÃDzÄǽ¤«¡©¡Ý
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤Èç¹
¥Ú¡¼¥¸ÈÖ¹æ 677¡Ý683
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¿·Î¤²í¿Í¡¤²¬ºê¾´¿Î¡¤Àô¡¡ÎÉ´²¡¤»û²¬ÍºÍù¡¤·ó¸÷¡¡¾¿¡¤ÃÓËܼî轡¤Ê¿ÌîµðÄÌ

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë ÃÀÆ»¥¹¥Æ¥ó¥ÈÁÞÆþ¸åÃÀ´É±ê¤ÎÆÃħ
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀç¹
¥Ú¡¼¥¸ÈÖ¹æ 105¡Ý111
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø Àô¡¡ÎÉ´²¡¤¿·Î¤²í¿Í¡¤»û²¬ÍºÍù¡¤·ó¸÷¡¡¾¿¡¤ÃÓËܼî轡¤¾®ÌîÀîÌ÷Æ󡤺£À¼ù¡¤ÃæÅÚ°æ¹Ý°ì¡¤ÊÒ¼²ÅÃË¡¤Å·Ìî¡¡»Ï¡¤Ê¿ÌîµðÄÌ¡¤ÆüÌîʸÌÀ

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤΤ¿¤á¤Î¼ÂÀïŪ¥¢¥ë¥´¥ê¥º¥à
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀç¹
¥Ú¡¼¥¸ÈÖ¹æ 857¡Ý863
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ²¬ºê¾´¿Î¡¤Àô¡¡ÎÉ´²¡¤¿·Î¤²í¿Í¡¤ÃÓËܼî轡¤·ó¸÷¡¡¾¿¡¤»û²¬ÍºÍù¡¤Ê¿ÌîµðÄÌ

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë 繤¬¤ó¡¤ÃÀ´É¤¬¤ó¤ÎÁá´ü¿ÇÃÇ
»¨»ï¥¿¥¤¥È¥ë ¿ÇÃǤȼ£ÎÅ
¥Ú¡¼¥¸ÈÖ¹æ 728¡Ý734
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊÈÓÀ±ÃÎÇî¡Ë

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë committee of Diagnostic Criteria of The Japanese Study Group on Pancreaticobiliary Maljunction. with a normal pancreaticobiliary junction: a prospective multicenter study.Pancreatobiliary reflux in individuals
»¨»ï¥¿¥¤¥È¥ë ¡¡J. Gastroenterol
¥Ú¡¼¥¸ÈÖ¹æ 875¡Ý881
Ãø¼Ô ¡Ê Horaguchi J¡Ë
¶¦Ãø ¡ÊFujita N¡Ë¡¤¡ÊKamisawa T¡Ë¡¤¡ÊHonda G¡Ë¡¤¡ÊChijiiwa K¡Ë¡¤¡ÊMaguchi H¡Ë¡¤¡ÊTanaka M¡Ë¡¤¡ÊShimada M¡Ë¡¤¡ÊIgarashi Y¡Ë¡¤¡ÊInui K¡Ë¡¤Hanada K¡¤¡ÊItoi T¡Ë¡¤¡ÊHamada Y¡Ë¡¤¡ÊKoshinaga T¡Ë¡¤¡ÊFujii H¡Ë¡¤¡ÊUrushihara N¡Ë¡¤¡ÊAndo H¡Ë

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë Natural history of branch duct intraductal papillary mucinous neoplasm with mural nodules: a Japan pancreas society multicenter study.¡¡
»¨»ï¥¿¥¤¥È¥ë Pancreas
¥Ú¡¼¥¸ÈÖ¹æ 32¡Ý538
Ãø¼Ô ¡Ê Kobayashi G¡Ë
¶¦Ãø ¡ÊFujita N¡Ë¡¤¡ÊMaguchi H¡Ë¡¤¡ÊTanno S¡Ë¡¤¡ÊMizuno N¡Ë¡¤Hanada K¡¤¡ÊHatori T¡Ë¡¤¡ÊSadakari Y¡Ë¡¤¡ÊYamaguchi T¡Ë¡¤¡ÊTobita K¡Ë¡¤¡ÊDoi R¡Ë¡¤¡ÊYanagisawa A¡Ë¡¤¡ÊTanaka M¡Ë

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë Multicenter retrospective study of endoscopic ultrasound-guided biliary drainage for malignant biliary obstruction in Japan.
»¨»ï¥¿¥¤¥È¥ë J. Hepatobiliary Pancreat Sci.¡¡
¥Ú¡¼¥¸ÈÖ¹æ 328¡Ý334
Ãø¼Ô ¡Ê Kawakubo K¡Ë
¶¦Ãø ¡ÊIsayama H¡Ë¡¤¡ÊKato H¡Ë¡¤¡ÊItoi T¡Ë¡¤¡ÊKawakami H¡Ë¡¤Hanada K¡¤¡ÊIshiwatari H¡Ë¡¤¡ÊYasuda I¡Ë¡¤¡ÊKawamoto H¡Ë¡¤¡ÊItokawa F¡Ë¡¤¡ÊKuwatani M¡Ë¡¤Iiboshi T¡¤¡ÊHayashi T¡Ë¡¤¡ÊDoi S¡Ë¡¤¡ÊNakai Y¡Ë

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë ÃÀÆ»¼À´µ¤Ë¤ª¤±¤ëEUS/IDUS
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÃÀÆ»³Ø²ñ»¨»ï
¥Ú¡¼¥¸ÈÖ¹æ 163¡Ý171
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊÈÓÀ±ÃÎÇî¡Ë

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë ÀÚ½üÉÔǽ繴â¤ËºÇŬ¤Ê¥¹¥Æ¥ó¥È¤È¤Ï¡©
»¨»ï¥¿¥¤¥È¥ë 繡¦ÃÀÆ»´âFRONTIER
¥Ú¡¼¥¸ÈÖ¹æ 12·î14Æü
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2016/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë Æâ»ë¶À¤òÍѤ¤¤¿ç¹´â¤ÎÁá´ü¿ÇÃǤ轶·¤È¿·¤¿¤ÊŸ³«
»¨»ï¥¿¥¤¥È¥ë Frontiers in Gastroenterology
¥Ú¡¼¥¸ÈÖ¹æ 41¡Ý45
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ¡ÊÈÓÀ±ÃÎÇî¡Ë¡¤Ê¿ÌîµðÄÌ¡¤¾®ÌîÀîÌ÷Æ󡤡ÊÊ¡ËÜ¡¡¹¸¡Ë¡¤º£À¼ù¡¤ÊÒ¼²ÅÃË¡¤¿·Î¤²í¿Í¡¤¡ÊÅ·ÌîÈþ½ï¡Ë¡¤»û²¬ÍºÍù¡¤ÃÓËܼî轡¤Å·Ìî¡¡»Ï¡¤ÆüÌîʸÌÀ

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monothermonotherapy
for advanced biliary tract cancer
»¨»ï¥¿¥¤¥È¥ë Cancer Chemother Pharmacol.¡¡71
¥Ú¡¼¥¸ÈÖ¹æ 973¡Ý979
Ãø¼Ô ¡Ê Sasaki T¡Ë
¶¦Ãø ¡ÊIsayama H¡Ë¡¤¡ÊNakai Y¡Ë¡¤¡ÊIto Y¡Ë¡¤¡ÊYasuda I¡Ë¡¤¡ÊToda N¡Ë¡¤¡ÊKogure H¡Ë¡¤Hanada K¡¤¡ÊMaguchi H¡Ë¡¤¡ÊSasahira N¡Ë¡¤¡ÊKamada H¡Ë¡¤¡ÊMukai T¡Ë¡¤¡ÊOkabe Y¡Ë¡¤¡ÊHasebe O¡Ë¡¤¡ÊMaetani I¡Ë¡¤¡ÊKoike K¡Ë¡¥

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¤â¤Ã¤ÈÃΤäÆÍߤ·¤¤ç¹¡¦ÃÀÆ»¤¬¤ó
»¨»ï¥¿¥¤¥È¥ë ¸üÀ¸Ï¢ÈøÆ»Áí¹çɱ¡°åÊó¡¡23
¥Ú¡¼¥¸ÈÖ¹æ 57¡Ý60
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2014
ÏÀʸ¥¿¥¤¥È¥ë ÆýƬ·Á¾õ¤«¤é¤ß¤¿¥«¥Ë¥å¥ì¡¼¥·¥ç¥óÀïά
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À¡¡26
¥Ú¡¼¥¸ÈÖ¹æ 188¡Ý194
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇʿÌîµðÄÌ¡¤¿·Î¤²í¿Í¡¤Å·ÌîÈþ½ï¡¤»û²¬ÍºÍù¡¤ÃÓËܼî轡¤ÆüÌîʸÌÀ

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë PEG ¤Àß´ïºà¤Î¼ïÎà¤ÈÆÃħ
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À¡¡25
¥Ú¡¼¥¸ÈÖ¹æ 807¡Ý814
Ãø¼Ô ¾®ÌîÀîÌ÷Æó

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ·Ð²á´Ñ»¡¤ÎÀºººÊýË¡¡¤´Ö³Ö¡¤´ü´Ö¤Ï¡ÊSlow growing ¤Ï¤É¤ÎÄøÅ٤ο»½á¤Þ¤ÇÎ×¾²Åª¤Ë°ÕÌ£¤ò»ý¤Ä¤«¡Ë
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀ繡¡67
¥Ú¡¼¥¸ÈÖ¹æ 693¡Ý699
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë 繤¬¤óÁá´ü¿ÇÃǤο·¤¿¤ÊŸ³«
»¨»ï¥¿¥¤¥È¥ë ÆüËܾò½´ïɳزñ»¨»ï¡¡110
¥Ú¡¼¥¸ÈÖ¹æ 2051¡Ý2059
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë 繤¬¤óÁá´ü¿ÇÃǤ˸þ¤±¤¿¼è¤êÁȤߡ§ÃÏ°èÉ¿ÇÏ¢·È¤òÀ¸¤«¤·¤¿Æâ»ë¶À¿ÇÃǤμÂÁ©
»¨»ï¥¿¥¤¥È¥ë ¼ðáçÆâ²Ê¡¡12
¥Ú¡¼¥¸ÈÖ¹æ 245¡Ý251
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¾å²¼¾Ã²½´ÉÆâ»ë¶À¸¡ºº¤Ç½Ð·ì¸»¤¬¤Ï¤Ã¤­¤ê¤·¤Ê¤¤¤È¤­¡¤¾®Ä²Æâ»ë¶À¡¦¥«¥×¥»¥ëÆâ»ë¶À¤Î»È¤¤Ê¬¤±¤ò¶µ¤¨¤Æ¤¯¤À¤µ¤¤
»¨»ï¥¿¥¤¥È¥ë ¥ì¥¸¥Ç¥ó¥È¥Î¡¼¥È¡¡15
¥Ú¡¼¥¸ÈÖ¹æ 195¡Ý200
Ãø¼Ô Ê¡ËÜ¡¡¹¸

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ´Î¹ÅÊѤËȼ¤¦¿©Æ»ÀÅÌ®áî¤ËÂФ¹¤ë¶ÛµÞ¼£ÎŤˤĤ¤¤Æ¶µ¤¨¤Æ¤¯¤À¤µ¤¤
»¨»ï¥¿¥¤¥È¥ë ¥ì¥¸¥Ç¥ó¥È¥Î¡¼¥È¡¡15
¥Ú¡¼¥¸ÈÖ¹æ 149¡Ý154
Ãø¼Ô ¡Ê ¶¶ËܵÁÀ¯¡Ë
¶¦Ãø Å·Ìî¡¡»Ï

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¾Ã²½´É½Ð·ì¤Î´µ¼Ô¤Ë¶ÛµÞÆâ»ë¶À¤òľ¤Á¤Ë¹Ô¤¦¤Ù¤­¤«¤ÎȽÃǤΥݥ¤¥ó¥È¤Ï¡©
»¨»ï¥¿¥¤¥È¥ë ¥ì¥¸¥Ç¥ó¥È¥Î¡¼¥È¡¡15
¥Ú¡¼¥¸ÈÖ¹æ 126¡Ý131
Ãø¼Ô º£À¼ù

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë µÞÀ­ÃÀǹ±êµ¿¤¤¤Î´µ¼Ô¤ËÂФ·¤Æ¡¤ÊݸŪ¤Ê¼£ÎŤò¤¹¤ë¤«¡©³°²ÊŪ¤Ê¼£ÎŤò¹Ô¤¦¤«¡©
»¨»ï¥¿¥¤¥È¥ë ¥ì¥¸¥Ç¥ó¥È¥Î¡¼¥È¡¡15
¥Ú¡¼¥¸ÈÖ¹æ 132¡Ý140
Ãø¼Ô ÈÓÀ±ÃÎÇî
¶¦Ãø ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ±ê¾ÉÀ­Ä²¼À´µ¼£ÎÅÌô¤Ë¤ÏºÇ¶á¤µ¤Þ¤¶¤Þ¤Ê¼ïÎब¤¢¤ê¤Þ¤¹¤¬¡¤»È¤¤Ê¬¤±¤Ï¤É¤¦·è¤á¤ë¡©
»¨»ï¥¿¥¤¥È¥ë ¥ì¥¸¥Ç¥ó¥È¥Î¡¼¥È¡¡15
¥Ú¡¼¥¸ÈÖ¹æ 209¡Ý215
Ãø¼Ô ¾®ÌîÀîÌ÷Æó

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¿©Íߤ¬²óÉü¤·¤Ê¤¤Æþ±¡´µ¼Ô¤ËÂФ·¤ÆÃæ¿´ÀÅÌ®±ÉÍܤò²ðÆþ¤¹¤ë¥¿¥¤¥ß¥ó¥°¤Ï¡©
»¨»ï¥¿¥¤¥È¥ë ¥ì¥¸¥Ç¥ó¥È¥Î¡¼¥È¡¡15
¥Ú¡¼¥¸ÈÖ¹æ 59¡Ý63
Ãø¼Ô Ê¿ÌîµðÄÌ

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë Ê¢Éô¥¨¥³¡¼¤Ç繴ɳÈÄ¥¡¤ç¹Ç¹Ë¦¤ò»ØŦ¤µ¤ì¤¿´µ¼Ô¤ËÂФ¹¤ë¸¡ºº¤Î¿Ê¤áÊý¤Ï?
»¨»ï¥¿¥¤¥È¥ë ¥ì¥¸¥Ç¥ó¥È¥Î¡¼¥È¡¡15
¥Ú¡¼¥¸ÈÖ¹æ 33¡Ý41
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë Distinctive histopathologic findings of pancreatic hamartomas suggesting their hamartomatous nature a study of 9 cases¡¥
»¨»ï¥¿¥¤¥È¥ë The American Journal of Surgical Pathology
¥Ú¡¼¥¸ÈÖ¹æ 1006¡Ý13
Ãø¼Ô (Yamaguchi H)
¶¦Ãø ¡ÊAishima S¡Ë¡¤¡ÊOda Y¡Ë¡¤¡ÊMizukami H¡Ë¡¤¡ÊTajiri T¡Ë¡¤¡ÊYamada S¡Ë¡¤¡ÊTasaki T¡Ë¡¤¡ÊYamakita K¡Ë¡¤¡ÊImai K¡Ë¡¤¡ÊKawakami F¡Ë¡¤¡ÊHara S¡Ë¡¤Hanada K¡¤Iiboshi T¡¤Fukuda T¡¤¡ÊImai H¡Ë¡¤¡ÊInoue H¡Ë¡¤¡ÊNagakawa T¡Ë¡¤¡ÊMuraoka S¡Ë¡¤¡ÊFurukawa T¡Ë¡¤¡ÊShimizu M¡Ë

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë Pancreatobiliary reflux in individuals with a normal pancreaticobiliary junction: a prospective multicenter study
»¨»ï¥¿¥¤¥È¥ë Journal of Gastroenterology
Ãø¼Ô ¡ÊHoraguchi J¡Ë
¶¦Ãø ¡ÊFujita N¡Ë¡¤¡ÊKamisawa T¡Ë¡¤¡ÊHonda G¡Ë¡¤¡ÊChijiiwa K¡Ë¡¤¡ÊMaguchi H¡Ë¡¤¡ÊTanaka M¡Ë¡¤¡ÊShimada M¡Ë¡¤¡ÊIgarashi Y¡Ë¡¤¡ÊInui K¡Ë¡¤Hanada K¡¤¡ÊItoi T¡Ë¡¤¡ÊHamada Y¡Ë¡¤¡ÊKoshinaga T¡Ë¡¤¡ÊFujii H¡Ë¡¤¡ÊUrushihara N¡Ë¡¤¡ÊAndo)

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ²¼ÂçÀÅÌ®¼ðáçÀò¤òȼ¤Ã¤¿¦Á-fetoprotein »ºÀ¸°ß´â¤Î´Îž°Ü¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë ¡¡¹­Åç°å³Ø¡¡66¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 329¡Ý334
Ãø¼Ô ¡ÊÃ漿¿Ìé¡Ë
¶¦Ãø Ê¡ËÜ¡¡¹¸¡¤»û²¬ÍºÍù¡¤Å·ÌîÈþ½ï¡¤¡Ê»³Íº·òÂÀϺ¡Ë¡¤¡Ê¶¶ËܵÁÀ¯¡Ë¡¤ÈÓÀ±ÃÎÇ¾®ÌîÀîÌ÷Æó¡¤Ê¿ÌîµðÄÌ¡¤²ÖÅķɻΡ¤ÆüÌîʸÌÀ¡¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¥À¥Ö¥ë¥Ð¥ë¡¼¥ó¾®Ä²Æâ»ë¶À¤ÇÃîÂΤòŦ½Ð¤·ÆÀ¤¿¾®Ä²¥¢¥Ë¥­¥µ¥¹¾É¤Î£±Îã
»¨»ï¥¿¥¤¥È¥ë Gastroenterological Endoscopy¡¡55¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 1643¡Ý49
Ãø¼Ô Å·ÌîÈþ½ï
¶¦Ãø Ê¡ËÜ¡¡¹¸¡¤¡Ê»³Íº·òÂÀϺ¡Ë¡¤º£À¼ù¡¤¡Ê¶¶ËܵÁÀ¯¡Ë¡¤ÈÓÀ±ÃÎÇ¾®ÌîÀîÌ÷Æó¡¤Ê¿ÌîµðÄÌ¡¤²ÖÅķɻΡ¤ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë 繤¬¤ó¤Î¿ÇÃÇ¡ÝÁá´üȯ¸«¤Ë¸þ¤±¤Æ
»¨»ï¥¿¥¤¥È¥ë ¿ÇÃǤȼ£ÎÅ¡¡101¡Ê5¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 711¡Ý716
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë Åö±¡¤Ç·Ð¸³¤·¤¿°Û½êÀ­ÀÅÌ®á¿ÇÃǤ«¤é¼£ÎŤˤĤ¤¤Æ¤Î¸¡Æ¤
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø¡¡66¡Ê4¡Ë
¥Ú¡¼¥¸ÈÖ¹æ 254¡Ý260
Ãø¼Ô ¡Ê¶¶ËܵÁÀ¯¡Ë
¶¦Ãø Å·Ìî¡¡»Ï¡¤»û²¬ÍºÍù¡¤Å·ÌîÈþ½ï¡¤¡Ê»³Íº·òÂÀϺ¡Ë¡¤º£À¼ù¡¤Ê¡ËÜ¡¡¹¸¡¤ÈÓÀ±ÃÎÇ¾®ÌîÀîÌ÷Æó¡¤Ê¿ÌîµðÄÌ¡¤²ÖÅķɻΡ¤ÆüÌîʸÌÀ

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë Endoscopic ultrasound-guided celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multimulticenter
trial.
»¨»ï¥¿¥¤¥È¥ë Endoscopy
¥Ú¡¼¥¸ÈÖ¹æ 362¡Ý9
Ãø¼Ô ¡Ê Doi S¡Ë
¶¦Ãø ¡ÊYasuda I¡Ë¡¤¡ÊKawakami H¡Ë¡¤¡ÊHayashi T¡Ë¡¤¡ÊHisai H¡Ë¡¤¡ÊIrisawa A¡Ë¡¤¡ÊMukai T¡Ë¡¤¡ÊKatanuma¡¡A¡Ë¡¤¡ÊKubota K¡Ë¡¤¡ÊOhnishi T¡Ë¡¤¡ÊRyozawa S¡Ë¡¤¡ÊHara K¡Ë¡¤¡ÊItoi T¡Ë¡¤Hanada K¡¤¡ÊYamao K¡Ë¡¥

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë Percutaneous transhepatic sclerotherapy for recurrent bleeding ileal varices diagnosed by capsule endoscopy
and computed tomography during percutaneous transhepatic venography¡¥
»¨»ï¥¿¥¤¥È¥ë Hepatol Res
¥Ú¡¼¥¸ÈÖ¹æ 436¡Ý40
Ãø¼Ô ¡Ê Hashimoto Y¡Ë
¶¦Ãø Amano H¡¤Fukumoto A¡¤ Amano M¡¤¡ÊSagami S¡Ë¡¤¡ÊYamao K¡Ë¡¤Iiboshi T¡¤OnogawaS¡¤Hirano N¡¤Hanada K¡¤Hino F¡¥

!¹¹¿·Æü¡§2015/02/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2013
ÏÀʸ¥¿¥¤¥È¥ë Impact of anticancer treatment on recurrent obstruction in covered metallic stents for malignant biliaryobstruction
»¨»ï¥¿¥¤¥È¥ë Journal of Gastroenterology
¥Ú¡¼¥¸ÈÖ¹æ 1293¡Ý1299
Ãø¼Ô ¡Ê Nakai Y¡Ë
¶¦Ãø ¡ÊIsayama H¡Ë¡¤¡ÊMukai T¡Ë¡¤¡ÊItoi T¡Ë¡¤¡ÊMaetani I¡Ë¡¤¡ÊKawakami H¡Ë¡¤¡ÊYasuda I¡Ë¡¤¡ÊMaguchiH¡Ë¡¤¡ÊRyozawa S¡Ë¡¤Hanada K¡¤¡ÊHasebe O¡Ë¡¤¡ÊIto K¡Ë¡¤¡ÊKawamoto H¡Ë¡¤¡ÊMochizuki H¡Ë¡¤¡ÊIgarashiY¡Ë¡¤¡ÊIrisawa A¡Ë¡¤¡ÊSasaki T¡Ë¡¤¡ÊTogawa O¡Ë¡¤¡ÊHara T¡Ë¡¤¡ÊKamada H¡Ë¡¤¡ÊToda N¡Ë¡¤¡ÊHamada T¡Ë¡¤¡ÊKogure H¡Ë¡¥

!¹¹¿·Æü¡§2013/11/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë Distinctive histopathologic findings of pancreatic hamartomas suggesting their "hamartomatous" nature: a study of 9 cases.
»¨»ï¥¿¥¤¥È¥ë The American Journal of Surgical Pathology.
¥Ú¡¼¥¸ÈÖ¹æ 1006-13
Ãø¼Ô (Yamaguchi H),
¶¦Ãø (Aishima S), (Oda Y), (Mizukami H), (Tajiri T), (Yamada S), (Tasaki T), (Yamakita K), (Imai K), (Kawakami F), (Hara S), Hanada K, Iiboshi T, Fukuda T, (Imai H), (Inoue H), (Nagakawa T), (Muraoka S), (Furukawa T), (Shimizu M).

!¹¹¿·Æü¡§2013/11/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë Pancreatobiliary reflux in individuals with a normal pancreaticobiliary junction: a prospective multicenter study
»¨»ï¥¿¥¤¥È¥ë Journal of Gastroenterology
Ãø¼Ô (Horaguchi J),
¶¦Ãø (Fujita N), (Kamisawa T), (Honda G), (Chijiiwa K), (Maguchi H), (Tanaka M), (Shimada M), (Igarashi Y), (Inui K), Hanada K, (Itoi T), (Hamada Y), (Koshinaga T), (Fujii H), (Urushihara N), (Ando).

!¹¹¿·Æü¡§2013/11/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë Endoscopic ultrasound-guided celiac ganglia neurolysis vs. celiac plexus neurolysis: a randomized multicenter trial.
»¨»ï¥¿¥¤¥È¥ë Endoscopy.
¥Ú¡¼¥¸ÈÖ¹æ 362-9.
Ãø¼Ô (Doi S),
¶¦Ãø (Yasuda I), (Kawakami H), (Hayashi T), (Hisai H), (Irisawa A), (Mukai T), (Katanuma A), (Kubota K), (Ohnishi T), (Ryozawa S), (Hara K), (Itoi T), Hanada K, (Yamao K).

!¹¹¿·Æü¡§2013/11/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë Percutaneous transhepatic sclerotherapy for recurrent bleeding ileal varices diagnosed by capsule endoscopy and computed tomography during percutaneous transhepatic venography.
»¨»ï¥¿¥¤¥È¥ë Hepatol Res.
¥Ú¡¼¥¸ÈÖ¹æ 436-40
Ãø¼Ô Hashimoto Y
¶¦Ãø Amano H, Fukumoto A, Amano M, Sagami S, Yamao K, Iiboshi T, Onogawa S, Hirano N, Hanada K, Hino F.

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë ç¹´â¿ÇÎŤˤª¤±¤ëÆâ»ë¶À¤ÎÌò³ä¡¡¼ã¼êÆâ»ë¶À°å¤Ë¤è¤ëº£¸å¤ÎŸ˾(ºÂÃ̲ñ)
»¨»ï¥¿¥¤¥È¥ë 繡¦ÃÀÆ»´â
¥Ú¡¼¥¸ÈÖ¹æ 5-11
Ãø¼Ô ¡Ê¿¿¸ý ¹¨²ð¡Ë
¶¦Ãø ²ÖÅÄ ·É»Î, ¡Ê¸¶ ÏÂÀ¸¡Ë, ¡Ê»å°æ δÉסË

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë ³°Íè¿ÇÎŤΥï¥ó¥Ý¥¤¥ó¥È¡¦¥¢¥É¥Ð¥¤¥¹¡¡Æâ²Ê³°Íè¤Ç¤Î²«áդΤߤ«¤¿¤Î¥³¥Ä
»¨»ï¥¿¥¤¥È¥ë ¿ÇÃǤȼ£ÎÅ
¥Ú¡¼¥¸ÈÖ¹æ 316-320
Ãø¼Ô ¶¶ËÜ µÁÀ¯
¶¦Ãø ²ÖÅÄ ·É»Î

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¡ÚÃÀç¹´â¤ÎÁá´ü¿ÇÃÇ¥Õ¥í¥ó¥È¥é¥¤¥ó¡Û 繡¡Î×¾²¡¡Áá´ü¤Îç¹´â¤ÎÎ×¾²ÅªÆÃħ¤È¿ÇÃÇË¡
»¨»ï¥¿¥¤¥È¥ë ´Î¡¦ÃÀ¡¦ç¹
¥Ú¡¼¥¸ÈÖ¹æ 269-275
Ãø¼Ô ²ÖÅÄ ·É»Î
¶¦Ãø »³Íº ·òÂÀϺ, Ê¿Ìî µðÄÌ, ÈÓÀ± ÃÎÇî

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¡ÚÃÀç¹´â¤ÎÁá´ü¿ÇÃÇ¥Õ¥í¥ó¥È¥é¥¤¥ó¡Û 繡¡Î×¾²¡¡²èÁü¤Ë¤è¤ëÁá´ü¿ÇÃǤοÊÊâ¡¡ERCP
»¨»ï¥¿¥¤¥È¥ë ´Î¡¦ÃÀ¡¦ç¹
¥Ú¡¼¥¸ÈÖ¹æ 327-335
Ãø¼Ô ¡ÊµÆ»³ ÀµÎ´¡Ë
¶¦Ãø ²ÖÅÄ ·É»Î, ¡Ê¾åÅÄ Àé¼Ó»Ò¡Ë, ÈÓÀ± ÃÎÇî

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë ·ÐÆýƬŪ繴ÉÀ¸¸¡¡¦ºÙ˦¿Ç¤Ë¤è¤ë¥¢¥×¥í¡¼¥Á
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À
¥Ú¡¼¥¸ÈÖ¹æ 295-300
Ãø¼Ô ²ÖÅÄ·É»Î,
¶¦Ãø ÈÓÀ±ÃÎÇî¡¢, »³Íº·òÂÀϺ, Ê¿ÌîµðÄÌ, º´¡¹ÌÚ·ò»Ê,¡¡¿ÀÅÄ¿¿µ¬,¡¡ã·Æ£µ×Èþ»Ò,¡¡¿ù»³²ÂÂå,¡¡ÁêÉôÀ²¹á, ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¡ÚÃÀç¹Æâ»ë¶À¿·Ä¬Î®¡Û ÃÀç¹Æâ»ë¶À¿·Ä¬Î®(ºÂÃ̲ñ/Æý¸)
»¨»ï¥¿¥¤¥È¥ë ´Î¡¦ÃÀ¡¦ç¹
¥Ú¡¼¥¸ÈÖ¹æ 141-160
Ãø¼Ô ¡Ê¿ÅÄ Ì­¡Ë
¶¦Ãø ¡Ê»³Íº ·ò¼¡¡Ë, ¡Ê»å°æ δÉסË, ²ÖÅÄ ·É»Î

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë ¼êµ»¤Î²òÀâ¡¡¥À¥Ö¥ë¥Ð¥ë¡¼¥óÆâ»ë¶À¤òÍѤ¤¤¿ERCP
»¨»ï¥¿¥¤¥È¥ë Gastroenterological Endoscopy
¥Ú¡¼¥¸ÈÖ¹æ 68-76
Ãø¼Ô ²ÖÅÄ ·É»Î
¶¦Ãø Ê¡ËÜ ¹¸, ÈÓÀ± ÃÎÇî

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë Impact of anticancer treatment on recurrent obstruction in covered metallic stents for malignant biliary obstruction.
»¨»ï¥¿¥¤¥È¥ë J Gastroenterol
Ãø¼Ô (Nakai Y.)
¶¦Ãø (Isayama H), (Mukai T), (Itoi T), (Maetani I), (Kawakami H), (Yasuda I), (Maguchi H), (Ryozawa S), Hanada K, (Hasebe O), (Ito K), (Kawamoto H), (Mochizuki H), (Igarashi Y), (Irisawa A), (Sasaki T), (Togawa O), (Hara T), (Kamada H), (Toda N), (Hamada T), (Kogure H).

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2013
ÏÀʸ¥¿¥¤¥È¥ë A randomized phase II study of gemcitabine and S-1 combination therapy versus gemcitabine monotherapy for advanced biliary tract cancer.
»¨»ï¥¿¥¤¥È¥ë Cancer Chemother Pharmacol.
¥Ú¡¼¥¸ÈÖ¹æ 973-9
Ãø¼Ô (Sasaki T)
¶¦Ãø (Isayama H), (Nakai Y), (Ito Y), (Yasuda I), (Toda N), (Kogure H), Hanada K, (Maguchi H), (Sasahira N), (Kamada H), (Mukai T), (Okabe Y), (Hasebe O), (Maetani I), (Koike K).

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Æâ»ë¶ÀŪ·Ðɡ繴ɥɥì¥Ê¡¼¥¸Î±ÃÖ²¼¤ÇºÎ¼è¤µ¤ì¤¿ç¹±ÕºÙ˦¿Ç¤ÎÍ­ÍÑÀ­¡¡¾åÈéÆâ´â¤ÎºÙ˦Áü¤òÃæ¿´¤Ë
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²ºÙ˦³Ø²ñ¹­Å縩»ÙÉô²ñ»ï
¥Ú¡¼¥¸ÈÖ¹æ 57-62
Ãø¼Ô ¿ù»³ ²ÂÂå
¶¦Ãø ã·Æ£ µ×Èþ»Ò, ÁêÉô À²¹á, ¿ÀÅÄ ¿¿µ¬, º´¡¹ÌÚ ·ò»Ê, ÊƸ¶ ½¤¼£, ²ÖÅÄ ·É»Î, ÈÓÀ± ÃÎÇî

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ç¹´âÁá´ü¿ÇÃǤˤª¤±¤ëÆâ»ë¶ÀŪ¿ÇÃÇÀïά
»¨»ï¥¿¥¤¥È¥ë Gastroenterological Endoscopy
¥Ú¡¼¥¸ÈÖ¹æ 3773-3782
Ãø¼Ô ²ÖÅÄ·É»Î,
¶¦Ãø ÈÓÀ±ÃÎÇî¡¢, »³Íº·òÂÀϺ, Ê¿ÌîµðÄÌ¡¥

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë δµ¯À­ÉÂÊÑ¡¡É½Ì̤¬½½Æó»ØIJǴËì¤Ëʤ¤ï¤ì¤Æ¤¤¤ë¤â¤Î¡¡¿§Ä´ÊѲ½¤òȼ¤¦¤â¤Î¡¡»éËüð
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À
¥Ú¡¼¥¸ÈÖ¹æ 1736
Ãø¼Ô ¾®ÌîÀîÌ÷Æó
¶¦Ãø Ê¡ËÜ¡¡¹¸, ²ÖÅķɻΡ¥

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë °ÂÁ´¤Ç¸úΨŪ¤Ê¸¡ºº¡¦¼£ÎŤòÌܻؤ·¤¿Æâ»ë¶À¥»¥ó¥¿¡¼¤Î¹½ÃÛ
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀç¹²èÁü
¥Ú¡¼¥¸ÈÖ¹æ 628-634
Ãø¼Ô ²ÖÅÄ·É»Î,
¶¦Ãø ÈÓÀ±ÃÎÇî¡¢¾®ÌîÀîÌ÷Æó, Ê¿ÌîµðÄÌ, Ê¡ËÜ¡¡¹¸, º£À¼ù¡¢»³Íº·òÂÀϺ¡¢¶¶ËܵÁÀ¯¡¢Å·ÌîÈþ½ï¡¢»û²¬ÍºÍù¡¢Æ︫ϯ»Ò

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë EST¸å½Ð·ì¤ËÂФ¹¤ëÂкö
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤Èç¹
¥Ú¡¼¥¸ÈÖ¹æ 1093-1099
Ãø¼Ô ²ÖÅÄ·É»Î,
¶¦Ãø ÈÓÀ±ÃÎÇî, Ê¿ÌîµðÄÌ

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ç¹¾åÈé´â¤Î½¦¤¤¾å¤²¤Ë¤ª¤±¤ë²èÁü¿ÇÃǤμ꤬¤«¤ê
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ²Ê
¥Ú¡¼¥¸ÈÖ¹æ 116-123
Ãø¼Ô ÈÓÀ±ÃÎÇî,
¶¦Ãø ²ÖÅÄ·É»Î, Ê¿ÌîµðÄÌ, »³Íº·òÂÀϺ¡¢»û²¬ÍºÍù¡¢Å·ÌîÈþ½ï¡¢º£À¼ù¡¢¶¶ËܵÁÀ¯¡¢Ê¡ËÜ¡¡¹¸, ¾®ÌîÀîÌ÷Æó, Å·Ìî¡¡»Ï, ÆüÌîʸÌÀ, Ê¡ÅÄÉÒ¾¡, ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Åö±¡¤Ë¤ª¤±¤ë²È²À­ç¹´â¤Î°ì²È·ÏÎã
»¨»ï¥¿¥¤¥È¥ë ¹­Åç°å³Ø
¥Ú¡¼¥¸ÈÖ¹æ 532-538
Ãø¼Ô ¾åÌÌï¹á
¶¦Ãø ¡Êº´¾å¿¸ÂÀϺ¡Ë¡¢²ÖÅķɻΡ¢ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ÍñÁã·¿´Ö¼Á¤òȼ¤¦MCN¤ÎÎ×¾²ÉÂÍý³ØŪÆÃħ¤Èͽ¸å¡¡ÆüËÜç¹Â¡³Ø²ñ¿»ÜÀ߶¦Æ±¸¦µæ¤«¤é
»¨»ï¥¿¥¤¥È¥ë ç¹Â¡
¥Ú¡¼¥¸ÈÖ¹æ 9-16
Ãø¼Ô (»³Íº ·ò¼¡)
¶¦Ãø (Ìøß· ¾¼É×), (¹â¶¶ Ë®¹¬), (ÌÚ¼ Íý), (ÅÚ°æ δ°ìϺ), (Ê¡Åç ·Éµ¹), (ÂçÃÓ ¿®Ç·), (À¶¿å Æ»À¸), (±©Ä» δ), (¿®Àî ʸÀ¿), (°ìÆó»° ÎÑϺ), (¾®ÎÓ Í´¼¡), (ÈôÅÄ ¹ÀÊå), (𱩠À¿»Ö), (¿ù»³ À¯Â§), (µÜºä µÁ¹À), (Ãæ·´ ÁïÉ×), (»³¸ý Éð¿Í), ²ÖÅÄ ·É»Î, (°¤Éô ½¨¼ù), (¿ÅÄ Ì­), (Æ£ÅÄ Ä¾¹§), (ÅÄÃæ ²íÉ×)

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Ç´ËìÆ⥷¥å¥ï¥óºÙ˦À­²á¸í¼ð(mucosal Schwann cell hamartoma)¤Î1Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËܾò½´ïɳزñ»ï
¥Ú¡¼¥¸ÈÖ¹æ 94-101
Ãø¼Ô º´¾å¿¸ÂÀϺ
¶¦Ãø Ê¡ËÜ¡¡¹¸, Å·ÌîÈþ½ï, »³Íº·òÂÀϺ¡¢¶¶ËܵÁÀ¯¡¢ÈÓÀ±ÃÎÇî, ¾®ÌîÀîÌ÷Æó, Ê¿ÌîµðÄÌ, ²ÖÅķɻΡ¢Å·Ìî¡¡»Ï, ÆüÌîʸÌÀ, ÊƸ¶½¤¼£¡¥

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ¡Ú¾Ã²½´ï¤¬¤ó¡¡¿ÇÃÇ¡¦¼£ÎŤοÊÊâ(2)¡Û ç¹´âÁá´ü¿ÇÃǤκÇÁ°Àþ
»¨»ï¥¿¥¤¥È¥ë µþÅÔÉÜΩ°å²ÊÂç³Ø»¨»ï
¥Ú¡¼¥¸ÈÖ¹æ 427-433
Ãø¼Ô ²ÖÅÄ ·É»Î
¶¦Ãø ÈÓÀ± ÃÎÇî, »³Íº ·òÂÀϺ

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë IPMNͳÍè¿»½á´â¤ÈIPMNʻ¸繴â(¸¶ÃøÏÀʸ)
»¨»ï¥¿¥¤¥È¥ë ç¹Â¡
¥Ú¡¼¥¸ÈÖ¹æ 563-571
Ãø¼Ô ¡Ê»³¸ý ¹¬Æó¡Ë
¶¦Ãø ¡Ê¶â¸÷ ½¨°ì¡Ë, ¡Ê±©Ä» δ¡Ë, ¡Ê¿¿¸ý ¹¨²ð¡Ë, ¡ÊÀ¶¿å ÂÙÇî¡Ë, ¡Ê¿ÅÄ Ì­¡Ë, ¡ÊÃæ·´ ÁïÉסË, ²ÖÅÄ ·É»Î, ¡Ê¾®»³Æ⠳ءË, ¡ÊÌîÅÄ Íµ¡Ë, ¡ÊÃæÀô ÌÀɧ¡Ë,¡Ê¸ÅÀî Å°¡Ë,¡Êȼ ¿µ°ì¡Ë,¡Ê¿®Àî ʸÀ¿¡Ë,¡Ê²ÃÆ£ ÍΡË,¡ÊÅÄÃæ ²íÉסË

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ç¹Þù±ÕÀ­Ç¹Ë¦¼ðáç(Serous cystic neoplasm)¤ÎÁ´¹ñ¾ÉÎãÄ´ºº¡¡ÆüËÜç¹Â¡³Ø²ñç¹Ç¹Ë¦À­¼ðáç°Ñ°÷²ñ(¸¶ÃøÏÀʸ)
»¨»ï¥¿¥¤¥È¥ë ç¹Â¡
¥Ú¡¼¥¸ÈÖ¹æ 572-583
Ãø¼Ô ¡ÊÌÚ¼ Íý¡Ë
¶¦Ãø ¡Ê¿¹Ã« ÉÒ¹¬¡Ë, ²ÖÅÄ ·É»Î, ¡Ê°¤Éô ½¨¼ù¡Ë, ¡ÊÌøß· ¾¼ÉסË, ¡ÊÊ¡Åè ·Éµ¹¡Ë, ¡ÊÂçÃÓ ¿®Ç·¡Ë, ¡ÊÀ¶¿å Æ»À¸¡Ë, ¡Ê±©Ä» δ¡Ë, ¡ÊÆ£ÅÄ Ä¾¹§¡Ë, ¡Ê¿¿¸ý ¹¨²ð¡Ë, ¡ÊÀ¶¿å ÂÙÇî¡Ë, ¡Ê»³Íº ·ò¼¡¡Ë, ¡Êº´¡¹ÌÚ Ì±¿Í¡Ë, ¡ÊÆâÆ£ ²Åµª¡Ë, ¡ÊðÌî À¿»Ö¡Ë, ¡ÊÈôÅÄ ¹ÀÊå¡Ë, ¡ÊÅÄÃæ ²íÉסË

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ç¹±ê¤Î¿ÇÃÇ´ð½à¡¦¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó²þÄû¤ÈValidation¡Û µÞÀ­ç¹±ê¤Î¿ÇÃÇ´ð½à¡¦¿ÇÎÅ¥¬¥¤¥É¥é¥¤¥ó²þÄû¤Î¥Ý¥¤¥ó¥È¡¡À®²Ì¤¬ÂÔ¤¿¤ì¤ë²ÝÂê¡¡¿·¤·¤¤ERCP¸åç¹±ê¿ÇÃÇ´ð½à°Æ¤Ë¤Ä¤¤¤Æ¡¡Cotton¤é¤Î¿ÇÃÇ´ð½à¤ò±Û¤¨¤ë¤«
»¨»ï¥¿¥¤¥È¥ë ´Î¡¦ÃÀ¡¦ç¹
¥Ú¡¼¥¸ÈÖ¹æ 821-824
Ãø¼Ô ¡ÊÊ÷ Å°ºÈ¡Ë
¶¦Ãø ¡ÊÌÀÀРδµÈ¡Ë, ¡Ê°ËÆ£ Å´±Ñ¡Ë, ¡Ê¸Þ½½Íò ÎÉŵ¡Ë, ¡ÊÆþß· Æƻ֡Ë, ¡ÊÂ縶 ¹°Î´¡Ë, ¡ÊÊÒ²¬ ·ÄÀµ¡Ë, ¡ÊÀî¸ý µÁÌÀ¡Ë, ¡ÊÌÚÅÄ ¸÷¹°¡Ë, ¡ÊµÜÀî ¹¨Ç·¡Ë, ¡ÊµÈÅÄ ¿Î¡Ë, ¡ÊÀ¾¿¹ ¸ù¡Ë, ²ÖÅÄ ·É»Î, ¡Ê»³¸ý Éð¿Í¡Ë, ¡Ê¿¹Õé ÉÒ¡Ë, ¡Ê²¼À¥Àî Å°¡Ë.

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ½½Æó»ØIJ¾å¹ÔµÓ¤ÎÀÅÌ®áîÇËÎö¤ËÂФ·¤ÆPTO+B-RTO¤¬ÁÕ¸ù¤·¤¿1Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÌçÌ®°µÐ¶¿Ê¾É³Ø²ñ»¨»ï
¥Ú¡¼¥¸ÈÖ¹æ 177-182
Ãø¼Ô º´¾å¿¸ÂÀϺ,
¶¦Ãø ¶¶ËܵÁÀ¯¡¢Å·Ìî¡¡»Ï¡¥

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: establishing a new method for the early detection of pancreatic carcinoma in situ.
»¨»ï¥¿¥¤¥È¥ë Pancreas.
¥Ú¡¼¥¸ÈÖ¹æ 523-529
Ãø¼Ô Iiboshi T
¶¦Ãø Hanada K, Fukuda T, Yonehara S, Sasaki T, (Chayama K)

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ÉÂÂÖ¤«¤é¸«¤¿ÃÀ¡¦ç¹¼À´µ¤Ë¤ª¤±¤ë¥É¥ì¥Ê¡¼¥¸¡¦¥¹¥Æ¥ó¥È¤ÎÁªÂò
»¨»ï¥¿¥¤¥È¥ë Î×ாò½´ïÆâ²Ê
¥Ú¡¼¥¸ÈÖ¹æ 397-405
Ãø¼Ô ²ÖÅÄ·É»Î,
¶¦Ãø ÈÓÀ±ÃÎÇî, Ê¿ÌîµðÄÌ, Å·ÌîÈþ½ï, »³Íº·òÂÀϺ, (º´¾å¿¸ÂÀϺ)

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Multicenter study of serous cystic neoplasm of the Japan pancreas society.
»¨»ï¥¿¥¤¥È¥ë Pancreas
¥Ú¡¼¥¸ÈÖ¹æ 380-387
Ãø¼Ô (Kimura W)
¶¦Ãø (Moriya T), Hanada K, (Abe H), (Yanagisawa A), (Fukushima N), (Ohike N),(Shimizu M), (Hatori T), (Fujita N), (Maguchi H), (Shimizu Y), (Yamao K), (Sasaki T), (Naito Y), (Tanno S), (Tobita K), (Tanaka M)

!¹¹¿·Æü¡§2013/10/01

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Comparison of partially covered nitinol stents with partially covered stainless stents as a historical control in a multicenter study of distal malignant biliary obstruction: the WATCH study.
»¨»ï¥¿¥¤¥È¥ë Gastrointest Endoscopy
¥Ú¡¼¥¸ÈÖ¹æ 84-92
Ãø¼Ô (Isayama H)
¶¦Ãø (Mukai T), (Itoi T), (Maetani I), (Nakai Y), (Kawakami H), (Yasuda I), (Maguchi H), (Ryozawa S), Hanada K, (Hasebe O), (Ito K), (Kawamoto H), (Mochizuki H), (Igarashi Y), (Irisawa A), (Sasaki T), (Togawa O), (Hara T), (Kamada H), (Toda N), (Kogure H)

!¹¹¿·Æü¡§2012/05/20

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë Value of cytodiagnosis using endoscopic nasopancreatic drainage for early diagnosis of pancreatic cancer: establishing a new method for the early detection of pancreatic carcinoma in situ.
»¨»ï¥¿¥¤¥È¥ë Pancreas. 2012 May:41(4)
¥Ú¡¼¥¸ÈÖ¹æ 523-9
Ãø¼Ô Iiboshi T
¶¦Ãø Hanada K, Fukuda T, Yonehara S, Sasaki T, (Chayama K)

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë É¿ÇÏ¢·È¥·¥¹¥Æ¥à¤òÍѤ¤¤¿ç¹´â¤ÎÁá´ü¿ÇÃÇ
»¨»ï¥¿¥¤¥È¥ë ç¹ÃÀÆ»FRONTIER 2(1)
¥Ú¡¼¥¸ÈÖ¹æ 42-45
Ãø¼Ô »³Íº·òÂÀϺ
¶¦Ãø ÈÓÀ±ÃÎÇî, ²ÖÅķɻΡ¤¡ÊÊÒ»³Ôè¡Ë

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ¼çç¹´É·ÚÅÙ³ÈÄ¥¤ò·Àµ¡¤Ëȯ¸«¤µ¤ì¤¿ç¹¾åÈéÆâ´â¤Î1Îã
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀç¹²èÁü 14(1)
¥Ú¡¼¥¸ÈÖ¹æ 72-77
Ãø¼Ô µÝºï¡¡Î¼
¶¦Ãø ²ÖÅÄ·É»Î, ÈÓÀ±ÃÎÇî, º´¾å¿¸ÂÀϺ, Ê¡ËÜ¡¡¹¸, ¾®ÌîÀîÌ÷Æó, Ê¿ÌîµðÄÌ, Å·Ìî »Ï, ÆüÌîʸÌÀ, ÂçÎÓÎÊ¿Í, Ê¡ÅÄÉÒ¾¡, ÊƸ¶½¤¼£, ¡Êº´¡¹ÌÚ̱¿Í¡Ë, ¡ÊÃ㻳°ì¾´¡Ë

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë ÃÀ´É¶¹ºõ¤ËÂФ¹¤ë¥¹¥Æ¥ó¥È¼£ÎŤκÇÁ°Àþ
»¨»ï¥¿¥¤¥È¥ë Medical Practice 29(1)
¥Ú¡¼¥¸ÈÖ¹æ 117-121
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî, Ê¿ÌîµðÄÌ

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ͽ¸å²þÁ±¤òÌܻؤ·¤¿ç¹´â¤Î¿ÇÃǤȼ£ÎźÇÁ°Àþ
»¨»ï¥¿¥¤¥È¥ë µþÅԾò½´ï°å²ñ²ñÊó 27
¥Ú¡¼¥¸ÈÖ¹æ 17-22
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî, Ê¿ÌîµðÄÌ, º´¾å¿¸ÂÀϺ, ¡ÊµÝºï¡¡Î¼¡Ë, ¾®ÌîÀîÌ÷Æó, Ê¡ËÜ¡¡¹¸, Å·Ìî¡¡»Ï, ÆüÌîʸÌÀ, ÂçÎÓÎÊ¿Í, Ê¡ÅÄÉÒ¾¡, ÊƸ¶½¤¼£, (ÊÒ»³¡¡Ôè)

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë Á°¸þ¤­¤ÊÀ®ÀӤθ¡Æ¤¤«¤é¤ß¤¿Ê¬»Þ·¿IPMN¤Î¼£ÎÅÊý¿Ë
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ²Ê 52(6)
¥Ú¡¼¥¸ÈÖ¹æ 640-645
Ãø¼Ô ÈÓÀ±ÃÎÇî
¶¦Ãø ²ÖÅÄ·É»Î, º´¾å¿¸ÂÀϺ, ¡ÊµÝºï¡¡Î¼¡Ë, Ê¡ËÜ¡¡¹¸, ¾®ÌîÀîÌ÷Æó, Ê¿ÌîµðÄÌ, Å·Ìî¡¡»Ï, ÆüÌîʸÌÀ, ÂçÎÓÎÊ¿Í, Ê¡ÅÄÉÒ¾¡, ¹õÅĵÁ§, ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ÇØ·ÊÇ´Ëì¤Ë°à½Ì¤ò¤È¤â¤Ê¤ï¤Ê¤¤Helicobacterpylori ±¢À­¤Î´Ù±ú·¿°ßÁ£¼ð¤Î1Îã
»¨»ï¥¿¥¤¥È¥ë ÆüËܾò½´ïɳزñ»¨»ï 108(8)
¥Ú¡¼¥¸ÈÖ¹æ 1399-1404
Ãø¼Ô µÝºï¡¡Î¼
¶¦Ãø Ê¡ËÜ¡¡¹¸, º´¾å¿¸ÂÀϺ, ÈÓÀ±ÃÎÇî, ¾®ÌîÀîÌ÷Æó, Ê¿ÌîµðÄÌ, Å·Ìî¡¡»Ï, ²ÖÅÄ·É»Î, ÆüÌîʸÌÀ, ÂçÎÓÎÊ¿Í, ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë Ķ²»ÇÈÆâ»ë¶À¥¬¥¤¥É²¼ç¹²¾À­Ç¹Ë¦¥É¥ì¥Ê¡¼¥¸¤Î´ðËܼ굻
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À 23(8)
¥Ú¡¼¥¸ÈÖ¹æ 1377-1382
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë 繡¦ÃÀ´É¹çή°Û¾ï¹çÊ»ÃÀǹÁ£Ù¨Ê¿¾åÈé´â¤Î1Îã
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀç¹²èÁü 13(5)
¥Ú¡¼¥¸ÈÖ¹æ 526-532
Ãø¼Ô º´¾å¿¸ÂÀϺ
¶¦Ãø ²ÖÅÄ·É»Î, ¡ÊµÝºï¡¡Î¼¡Ë, Ê¡ËÜ¡¡¹¸, ÈÓÀ±ÃÎÇî, ¾®ÌîÀîÌ÷Æó, Ê¿ÌîµðÄÌ, Å·Ìî¡¡»Ï, ÆüÌîʸÌÀ, ÂçÎÓÎÊ¿Í, Ê¡ÅÄÉÒ¾¡, ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë ÃÀǹ²á·ÁÀ®¤ÈÃÀǹÁ£¼ð
»¨»ï¥¿¥¤¥È¥ë Î×ாò½´ïÆâ²Ê 26(5)
¥Ú¡¼¥¸ÈÖ¹æ 529-534
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî, Ê¿ÌîµðÄÌ, Ê¡ÅÄÉÒ¾¡, ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë Natural history of branch duct intraductal papillary mucinous neoplasms of the Pancreas : a multicenter study in Japan.
»¨»ï¥¿¥¤¥È¥ë Pancreas. 2011 Apr
¥Ú¡¼¥¸ÈÖ¹æ 364-70
Ãø¼Ô Maguchi H
¶¦Ãø (Tanno S), (Mizuno N), Hanada K, (Kobayashi G), (Hatori T), (Sadakari Y), (Yamaguchi T), (Tobita K), (Doi R), (Yanagisawa A), (Tanaka M)

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë Pancreatic ductal adenocarcinoma derived from IPMN and pancreatic ductal adenocarcinoma concomitant with IPMN
»¨»ï¥¿¥¤¥È¥ë Pancreas. 2011 May
¥Ú¡¼¥¸ÈÖ¹æ 571-80
Ãø¼Ô Yamaguchi K
¶¦Ãø (Kanemitsu S), (Hatori T), (Maguchi H), (Shimizu Y), (Tada M), (Nakagohri T), Hanada K, (Osanai M), (Noda Y), (Nakaizumi A), (Furukawa T), (Ban S), (Nobukawa B), (Kato Y), (Tanaka M).

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë Endoscopic pancreatic duct stents reduce the incidence of post-endoscopic retrograde cholangiopancreatography pancreatitis in high-risk patients
»¨»ï¥¿¥¤¥È¥ë Clin Gastroenterol Hepatol. 2011 Oct
¥Ú¡¼¥¸ÈÖ¹æ 851-8
Ãø¼Ô Sofuni A
¶¦Ãø (Maguchi H), (Mukai T), (Kawakami H), (Irisawa A), (Kubota K), (Okaniwa S), (Kikuyama M),( Kutsumi H), Hanada K, (Ueki T),( Itoi T).

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë Randomized phase?study of gemcitabine and S-1 combination versus gemcitabine alone in the treatment of unresectable advanced pancreatic cancer (Japan Clinical Cancer Reserch Organization PC-01 study).
»¨»ï¥¿¥¤¥È¥ë Cancer Chemother Pharmacol. 2012 Jan 17
¥Ú¡¼¥¸ÈÖ¹æ Epub ahead of print
Ãø¼Ô Ozaka M
¶¦Ãø (Matsumura Y), (Ishii H), (Omuro Y), (Itoi T), (Mouri H), Hanada K, (Kimura Y) , (Maetani I), (Okabe Y), (Tani M), (Ikeda T), (Hijioka S), (Watanabe R), (Ohoka S), (Hirose Y), (Suyama M), (Egawa N), (Sofuni A), (Ikari T), (Nakajima T).

!¹¹¿·Æü¡§2011/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2012
ÏÀʸ¥¿¥¤¥È¥ë A multicenter, prospective, randomized study of selective bile duct cannulation Performed by multiple endoscopists: the BIDMEN study.
»¨»ï¥¿¥¤¥È¥ë Gastrointest Endosc. 2012 Feb
¥Ú¡¼¥¸ÈÖ¹æ 75(2):362-72, 372
Ãø¼Ô Kawakami H
¶¦Ãø (Maguchi H), (Mukai T), (Hayashi T), (Sasaki T), (Isayama H), (Nakai Y), (Yasuda I), (Irisawa A), (Niido T), (Okabe Y), (Ryozawa S), (Itoi T), Hanada K, (Kikuyama M), (Arisaka Y), (Kikuchi S)

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ¡Ì¤³¤³¤Þ¤Ç¿Ê¤ó¤ÀÆâ»ë¶À¿ÇÃÇ¡ÍÁá´üÃÀǹ´â
»¨»ï¥¿¥¤¥È¥ë ¾Ã²½´ïÆâ»ë¶À 22
¥Ú¡¼¥¸ÈÖ¹æ 1926¡Á1932
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî, Ê¿ÌîµðÄÌ

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ÈÆÍÑ·¿GW¤Î¸Â³¦¤òõ¤ë¡¡»ØƳ°å¤ÎÌÜÀþ¤Ç¼«»ÜÀߤμã¼ê¥É¥¯¥¿¡¼¤¬»ÈÍѤ·¤¿ºÝ¤Îα°Õ¤¹¤ëÅÀ.
»¨»ï¥¿¥¤¥È¥ë ERCP¡¡Technical¡¡Report¡¡October
¥Ú¡¼¥¸ÈÖ¹æ 8
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2011
ÏÀʸ¥¿¥¤¥È¥ë Clinicopathological Features and Prognosis of Mucinous Cystic Neoplasm With Ovarian-Type Stroma: A Multi-Institutional Study of the Japan Pancreas Society.
»¨»ï¥¿¥¤¥È¥ë Pancreas 40
¥Ú¡¼¥¸ÈÖ¹æ 67¡Á71
Ãø¼Ô Yamao K
¶¦Ãø (Yanagisawa A), (Takahashi K), (Kimura W), (Doi R), (Fukushima N), (Ohike N), (Shimizu M), (Hatori T), (Nobukawa B), (Hifumi M), (Kobayashi Y), (Tobita K), (Tanno S), (Sugiyama M), (Miyasaka Y), (Nakagohri T), (Yamaguchi T), Hanada K, (Abe H), (Tada M), (Fujita N), (Tanaka M)

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë Pancreatobiliary reflux and the length of a common channel
»¨»ï¥¿¥¤¥È¥ë J Hepatobiliary Pancreat Sci 19
¥Ú¡¼¥¸ÈÖ¹æ 121¡Á124
Ãø¼Ô Kamisawa T
¶¦Ãø (Suyama M), (Fujita N), (Maguchi H), Hanada K, (Ikeda S), (Igarashi Y), (Itoi T), (Kida M), (Honda G), (Sai J), (Horaguchi J), (Igarashi Y), (Itoi T), (Kida M), (Honda G), (Sai J), (Horaguchi J), H)

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ÃÀ´É·ëÀФÎÆâ»ë¶À¼£ÎÅ-´ðËܤ«¤éº¤ÆñÎã¤Þ¤Ç
»¨»ï¥¿¥¤¥È¥ë Digestive News 2010ǯ£´·î
¥Ú¡¼¥¸ÈÖ¹æ 4¡Á6
Ãø¼Ô ²ÖÅÄ·É»Î

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ç¹ÆâʬÈç¼ðáç¤Î²èÁü¿ÇÃÇ
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀç¹²èÁü¡¡12
¥Ú¡¼¥¸ÈÖ¹æ 438¡Á448
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî, Ê¿ÌîµðÄÌ, ÆüÌîʸÌÀ, Å·Ìî»Ï, Ìܺê°ìÀ®, ¿¹¹À´õ, Ê¡ÅÄÉÒ¾¡,¡Ê»³ºêÁí°ìϺ¡Ë, (¸ÅÀîÁ±Ìé¡Ë

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ¤è¤¯»È¤¦Æü¾ï¼£ÎÅÌô¤ÎÀµ¤·¤¤»È¤¤Êý
»¨»ï¥¿¥¤¥È¥ë ¥ì¥¸¥Ç¥ó¥È¥Î¡¼¥È12
¥Ú¡¼¥¸ÈÖ¹æ 1581¡Á1586
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ´ÎºÙ˦´â°Ê³°¤Î´Î¼ðáç
»¨»ï¥¿¥¤¥È¥ë ÆüËÜÎ×¾²Ê̺ý´Î¡¦ÃÀÆ»·Ï¾É¸õ·²II
¥Ú¡¼¥¸ÈÖ¹æ 291¡Á293
Ãø¼Ô ÁêÊý¹À
¶¦Ãø ¡ÊÊ¿¾¾·û¡Ë, ²ÖÅÄ·É»Î, Å·Ìî»Ï, (Ã㻳°ì¾´¡Ë

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ÃÀ´É¶¹ºõ¤ËÂФ¹¤ëStenting Strategy °­À­Ãæ²¼ÉôÃÀ´É¶¹ºõÀÚ½üÉÔǽÃæ²¼Éô°­À­ÃÀÆ»ÊĺɤËÂФ¹¤ëStenting Strategy¡¡UMS¤ÈCMS¤ÎÀ®ÀӤȻȤ¤Ê¬¤±
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡31 Î×ÁýÆÃÂç
¥Ú¡¼¥¸ÈÖ¹æ 947¡Á954
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî, Ê¿ÌîµðÄÌ

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë ´âÀ­Ê¢Ëì±ê¤Î¿ÇÃǤˤª¤±¤ëEUS-FNA¤Î°ÕµÁ
»¨»ï¥¿¥¤¥È¥ë ÃÀ¤È繡¡31
¥Ú¡¼¥¸ÈÖ¹æ 1189¡Á1192
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî, Ê¿ÌîµðÄÌ, ¾®ÌîÀîÌ÷Æó, Ê¡Ëܹ¸, µÝºïμ, º´¾å¿¸ÂÀϺ, Å·Ìî»Ï,ÆüÌîʸÌÀ, ÂçÎÓÎÊ¿Í, (¿ÀÅÄ¿¿µ¬), (º´¡¹ÌÚ·ò»Ê¡Ë, ÊƸ¶½¤¼£

!¹¹¿·Æü¡§2010/05/03

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯÅÙ 2010
ÏÀʸ¥¿¥¤¥È¥ë 繤ÎSCN¤ÈMCN¡¡ºÇ¶á¤ÎÃθ«
»¨»ï¥¿¥¤¥È¥ë ´ÎÃÀç¹²èÁü 12
¥Ú¡¼¥¸ÈÖ¹æ 681¡Á685
Ãø¼Ô ²ÖÅÄ·É»Î
¶¦Ãø ÈÓÀ±ÃÎÇî

!¹¹¿·Æü¡§1999/11/30

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Pancreatic hamartoma: detection of harbouring NAB2::STAT6 fusion gene¡¥
»¨»ï¥¿¥¤¥È¥ë Histopathology¡¥81(3)
¥Ú¡¼¥¸ÈÖ¹æ 319-328
Ãø¼Ô Tanigawa M.
¶¦Ãø Koga Y¡¤Naito Y¡¤Yamaguchi H¡¤Iwasaki T¡¤Kohashi K¡¤Ohike N¡¤Hanada K¡¤Higashi M¡¤Komatsu M¡¤Imai H¡¤Yamakita K¡¤Nagakawa T¡¤Okabe Y¡¤Kato S¡¤Noguchi H¡¤Nakayama T¡¤Yasuda M¡¤Kusano H¡¤Akiba J¡¤Oda Y¡¤Yano H¡¥

!¹¹¿·Æü¡§1999/11/30

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë PSC guideline committee Members: Ministry of Health¡¤Labour and Welfare¡ÊJapan¡ËResearch Project¡¤The Intractable¡¥ Hepatobiliary Disease Study Group¡¥Correction to: Clinical guidelines for primary sclerosing cholangitis 2017
»¨»ï¥¿¥¤¥È¥ë J Gastroenterol¡¥57(6)
¥Ú¡¼¥¸ÈÖ¹æ 453-454
Ãø¼Ô Isayama H.
¶¦Ãø Tazuma S¡¤Kokudo N¡¤Tanaka A¡¤Tsuyuguchi T¡¤Nakazawa T¡¤Notohara K¡¤Mizuno S¡¤Akamatsu N¡¤Serikawa M¡¤Naitoh I¡¤Hirooka Y¡¤Wakai T¡¤Itoi T¡¤Ebata T¡¤Okaniwa S¡¤Kamisawa T¡¤Kawashima H¡¤Kanno A¡¤Kubota K¡¤Tabata M¡¤Unno M¡¤Takikawa H.

!¹¹¿·Æü¡§1999/11/30

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Predictive factors for subsequent intrahepatic cholangiocarcinoma associated with hepatolithiasis: Japanese
»¨»ï¥¿¥¤¥È¥ë National Cohort Study for 18 years
¥Ú¡¼¥¸ÈÖ¹æ 357-395
Ãø¼Ô Suzuki Y.
¶¦Ãø Mori T¡¤Momose H¡¤Matsuki R¡¤Kogure M¡¤Abe N¡¤Isayama H¡¤Tazuma S¡¤Tanaka A¡¤Takikawa H¡¤Sakamoto Y.

!¹¹¿·Æü¡§1999/11/30

¿ÇÎÅ²Ê ¾Ã²½´ïÆâ²Ê
ǯ 2022
ÏÀʸ¥¿¥¤¥È¥ë Repeat pancreatic resection for metachronous pancreatic metastasis from renal cell carcinoma: A case report¡¥
»¨»ï¥¿¥¤¥È¥ë Int J Surg Case Rep¡¥94¡§ 107022
Ãø¼Ô Itamoto S.
¶¦Ãø Abe T¡¤Oshita A¡¤Hanada K¡¤Nakahara M¡¤Noriyuki T¡¥
µá¿Í¾ðÊó¤Î¤ªÃΤ餻 Åö±¡¤Ï(ºâ)ÆüËÜ°åÎÅɾ²Áµ¡¹½¤Ë¤è¤ëǧÄê¤ò¼õ¤±¤Æ¤¤¤Þ¤¹¡£

JAÈøÆ»Áí¹çɱ¡Î×¾²²Ê¤Î¥Õ¥§¥¤¥¹¥Ö¥Ã¥¯ Î×¾²²Ê

JAÈøÆ»Áí¹çɱ¡Î×¾²¸¦½¤²Ê¤Î¥Õ¥§¥¤¥¹¥Ö¥Ã¥¯ Î×¾²¸¦½¤²Ê

JAÈøÆ»Áí¹çɱ¡ »Ô̱¸ø³«¹ÖºÂ »Ô̱¤Î¤¿¤á¤Î¤¬¤óºÇÁ°Àþ

JAÈøÆ»Áí¹çɱ¡ ÇÛ¿®Æ°²è°ìÍ÷

 
¥Ú¡¼¥¸ÀèƬ¤ØÌá¤ë